0001600033-24-000008.txt : 20240207 0001600033-24-000008.hdr.sgml : 20240207 20240207160342 ACCESSION NUMBER: 0001600033-24-000008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: e.l.f. Beauty, Inc. CENTRAL INDEX KEY: 0001600033 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464464131 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37873 FILM NUMBER: 24604241 BUSINESS ADDRESS: STREET 1: 570 10TH STREET CITY: OAKLAND STATE: CA ZIP: 94607 BUSINESS PHONE: (510) 778-7787 MAIL ADDRESS: STREET 1: 570 10TH STREET CITY: OAKLAND STATE: CA ZIP: 94607 FORMER COMPANY: FORMER CONFORMED NAME: J.A. Cosmetics Holdings, Inc. DATE OF NAME CHANGE: 20140212 10-Q 1 elf-20231231.htm 10-Q elf-20231231
FALSE2024Q30001600033--03-31http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations00016000332023-04-012023-12-3100016000332024-02-01xbrli:shares00016000332023-12-31iso4217:USD00016000332023-03-3100016000332022-12-31iso4217:USDxbrli:shares00016000332023-10-012023-12-3100016000332022-10-012022-12-3100016000332022-04-012022-12-310001600033us-gaap:CommonStockMember2023-03-310001600033us-gaap:AdditionalPaidInCapitalMember2023-03-310001600033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001600033us-gaap:RetainedEarningsMember2023-03-310001600033us-gaap:RetainedEarningsMember2023-04-012023-06-3000016000332023-04-012023-06-300001600033us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001600033us-gaap:CommonStockMember2023-04-012023-06-300001600033us-gaap:CommonStockMember2023-06-300001600033us-gaap:AdditionalPaidInCapitalMember2023-06-300001600033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001600033us-gaap:RetainedEarningsMember2023-06-3000016000332023-06-300001600033us-gaap:RetainedEarningsMember2023-07-012023-09-3000016000332023-07-012023-09-300001600033us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001600033us-gaap:CommonStockMember2023-07-012023-09-300001600033us-gaap:CommonStockMember2023-09-300001600033us-gaap:AdditionalPaidInCapitalMember2023-09-300001600033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001600033us-gaap:RetainedEarningsMember2023-09-3000016000332023-09-300001600033us-gaap:RetainedEarningsMember2023-10-012023-12-310001600033us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310001600033us-gaap:CommonStockMember2023-10-012023-12-310001600033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001600033us-gaap:CommonStockMember2023-12-310001600033us-gaap:AdditionalPaidInCapitalMember2023-12-310001600033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001600033us-gaap:RetainedEarningsMember2023-12-310001600033us-gaap:CommonStockMember2022-03-310001600033us-gaap:AdditionalPaidInCapitalMember2022-03-310001600033us-gaap:RetainedEarningsMember2022-03-3100016000332022-03-310001600033us-gaap:RetainedEarningsMember2022-04-012022-06-3000016000332022-04-012022-06-300001600033us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001600033us-gaap:CommonStockMember2022-04-012022-06-300001600033us-gaap:CommonStockMember2022-06-300001600033us-gaap:AdditionalPaidInCapitalMember2022-06-300001600033us-gaap:RetainedEarningsMember2022-06-3000016000332022-06-300001600033us-gaap:RetainedEarningsMember2022-07-012022-09-3000016000332022-07-012022-09-300001600033us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001600033us-gaap:CommonStockMember2022-07-012022-09-300001600033us-gaap:CommonStockMember2022-09-300001600033us-gaap:AdditionalPaidInCapitalMember2022-09-300001600033us-gaap:RetainedEarningsMember2022-09-3000016000332022-09-300001600033us-gaap:RetainedEarningsMember2022-10-012022-12-310001600033us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-310001600033us-gaap:CommonStockMember2022-10-012022-12-310001600033us-gaap:CommonStockMember2022-12-310001600033us-gaap:AdditionalPaidInCapitalMember2022-12-310001600033us-gaap:RetainedEarningsMember2022-12-31elf:segmentelf:distribution_channel0001600033country:US2023-10-012023-12-310001600033country:US2022-10-012022-12-310001600033country:US2023-04-012023-12-310001600033country:US2022-04-012022-12-310001600033us-gaap:NonUsMember2023-10-012023-12-310001600033us-gaap:NonUsMember2022-10-012022-12-310001600033us-gaap:NonUsMember2023-04-012023-12-310001600033us-gaap:NonUsMember2022-04-012022-12-310001600033us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-12-310001600033us-gaap:CashAndCashEquivalentsMember2023-12-310001600033us-gaap:CashAndCashEquivalentsMember2022-12-310001600033us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-12-310001600033elf:SocialMediaAnalyticsCompanyMember2017-04-140001600033elf:NaturiumLLCMember2023-10-042023-10-040001600033elf:NaturiumLLCMember2023-10-040001600033us-gaap:RetailMemberelf:NaturiumLLCMember2023-10-040001600033elf:ElectronicCommerceCustomerRelationshipsMemberelf:NaturiumLLCMember2023-10-040001600033us-gaap:TrademarksMemberelf:NaturiumLLCMember2023-10-040001600033elf:NaturiumLLCMember2023-10-042023-12-310001600033elf:NaturiumLLCMember2023-10-012023-12-310001600033elf:NaturiumLLCMember2023-04-012023-12-310001600033elf:NaturiumLLCMember2022-10-012022-12-310001600033elf:NaturiumLLCMember2022-04-012022-12-310001600033elf:CustomerRelationshipsRetailersMember2023-12-310001600033elf:ElectronicCommerceCustomerRelationshipsMember2023-12-310001600033srt:MinimumMemberus-gaap:TrademarksMember2023-12-310001600033srt:MaximumMemberus-gaap:TrademarksMember2023-12-310001600033us-gaap:TrademarksMember2023-12-310001600033us-gaap:TrademarksMember2023-12-310001600033elf:CustomerRelationshipsRetailersMember2023-03-310001600033elf:ElectronicCommerceCustomerRelationshipsMember2023-03-310001600033us-gaap:TrademarksMember2023-03-310001600033us-gaap:TrademarksMember2023-03-310001600033elf:CustomerRelationshipsRetailersMember2022-12-310001600033elf:ElectronicCommerceCustomerRelationshipsMember2022-12-310001600033us-gaap:TrademarksMember2022-12-310001600033us-gaap:TrademarksMember2022-12-310001600033elf:TermLoanFacilityMember2023-12-310001600033elf:TermLoanFacilityMember2023-03-310001600033elf:TermLoanFacilityMember2022-12-310001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedRevolvingCreditFacilityMember2021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedTermLoanFacilityMember2021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MinimumMember2021-04-302021-04-30xbrli:pure0001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MaximumMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMemberus-gaap:LetterOfCreditMember2021-04-300001600033elf:AmendedCreditAgreementMemberus-gaap:LineOfCreditMember2021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2023-12-310001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMemberelf:MinimumFloorMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMemberelf:MinimumFloorMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMemberelf:LondonInterBankOfferedRateLIBOR1Membersrt:MinimumMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMemberelf:LondonInterBankOfferedRateLIBOR1Membersrt:MinimumMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MaximumMemberelf:LondonInterBankOfferedRateLIBOR1Member2021-04-302021-04-300001600033elf:AmendedCreditAgreementMembersrt:MaximumMemberelf:LondonInterBankOfferedRateLIBOR1Memberelf:TermLoanMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMemberus-gaap:BaseRateMembersrt:MinimumMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMemberus-gaap:BaseRateMembersrt:MinimumMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MaximumMemberus-gaap:BaseRateMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMembersrt:MaximumMemberus-gaap:BaseRateMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:SecuredOvernightFinancingRateSOFRMember2023-03-292023-03-290001600033us-gaap:RevolvingCreditFacilityMember2023-03-292023-03-290001600033us-gaap:RevolvingCreditFacilityMemberelf:SecuredOvernightFinancingRateSOFRMembersrt:MinimumMember2023-03-292023-03-290001600033us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberelf:SecuredOvernightFinancingRateSOFRMember2023-03-292023-03-290001600033elf:AmendedRevolvingCreditFacilityMemberelf:TermLoanMember2023-12-310001600033elf:SecondAmendmentMemberelf:IncrementalTermLoanMember2023-08-280001600033elf:SecondAmendmentMemberelf:SecuredOvernightFinancingRateSOFRMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMemberelf:IncrementalTermLoanMembersrt:MinimumMember2023-08-282023-08-280001600033srt:MaximumMemberelf:SecondAmendmentMemberelf:SecuredOvernightFinancingRateSOFRMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMemberelf:IncrementalTermLoanMember2023-08-282023-08-280001600033elf:SecondAmendmentMemberelf:SecuredOvernightFinancingRateSOFRMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMemberelf:IncrementalTermLoanMember2023-08-282023-08-280001600033us-gaap:BaseRateMemberelf:SecondAmendmentMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMemberelf:IncrementalTermLoanMembersrt:MinimumMember2023-08-282023-08-280001600033srt:MaximumMemberus-gaap:BaseRateMemberelf:SecondAmendmentMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMemberelf:IncrementalTermLoanMember2023-08-282023-08-280001600033us-gaap:BaseRateMemberelf:SecondAmendmentMemberelf:ConsolidatedTotalNetLeverageRatioLevelsMember2023-08-282023-08-280001600033elf:SecondAmendmentMemberelf:IncrementalTermLoanMember2023-12-310001600033elf:ServiceBasedStockOptionsMember2023-10-012023-12-310001600033elf:ServiceBasedStockOptionsMember2022-10-012022-12-310001600033elf:ServiceBasedStockOptionsMember2023-04-012023-12-310001600033elf:ServiceBasedStockOptionsMember2022-04-012022-12-310001600033elf:RestrictedStockUnitsAndRestrictedStockMember2023-10-012023-12-310001600033elf:RestrictedStockUnitsAndRestrictedStockMember2022-10-012022-12-310001600033elf:RestrictedStockUnitsAndRestrictedStockMember2023-04-012023-12-310001600033elf:RestrictedStockUnitsAndRestrictedStockMember2022-04-012022-12-310001600033elf:ServiceBasedStockOptionsMember2023-12-310001600033elf:RestrictedStockUnitsAndRestrictedStockMember2023-12-3100016000332019-05-08elf:renewal_option


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 
_______________________________________________________________   
FORM 10-Q
_______________________________________________________________   
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended December 31, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from ______ to ______

Commission File Number: 001-37873
_______________________________________________________________ 
e.l.f. Beauty, Inc.
(Exact name of registrant as specified in its charter)
_______________________________________________________________
Delaware 46-4464131
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)
570 10th Street
Oakland,
CA94607
 (Address of principal executive offices)(Zip code)
_______________________________________________________________ 
(510)
778-7787
(Registrant’s telephone number, including area code)
_______________________________________________________________ 
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareELFNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non- accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes     No
The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding as of February 1, 2024 was 55,506,934 shares.




CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements within the meaning of the federal securities laws concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business operations and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “aim,” “anticipate,” “assume,” ”believe,” “contemplate,” “continue,” "could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “predict,” “potential,” “positioned,” “seek,” “should,” “target,” “will,” “would” and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements are based on management's current expectations, estimates, forecasts and projections about our business and the industry in which we operate and management’s beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, our actual results and the timing of selected events may differ materially. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under “Risk factors” in Part II, Item 1A of this Quarterly Report and elsewhere in this Quarterly Report. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date of this Quarterly Report. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
SUMMARY OF MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS
The principal risks and uncertainties affecting our business include the following:
The beauty industry is highly competitive, and if we are unable to compete effectively our results will suffer.
Our new product introductions may not be as successful as we anticipate.
Any damage to our reputation or brands may materially and adversely affect our business, financial condition and results of operations.
Our success depends, in part, on the quality, performance and safety of our products.
We may not be able to successfully implement our growth strategy.
Our growth and profitability are dependent on a number of factors, and our historical growth may not be indicative of our future growth.
We may be unable to continue to grow our business effectively or efficiently, which would harm our business, financial condition and results of operations.
Acquisitions or investments, such as our acquisition of Naturium LLC, could disrupt our business and harm our financial condition.
A disruption in our operations, including a disruption in the supply chain for our products, could materially and adversely affect our business.
We rely on a number of third-party suppliers, manufacturers, distributors and other vendors, and they may not continue to produce products or provide services that are consistent with our standards or applicable regulatory requirements, which could harm our brands, cause consumer dissatisfaction, and require us to find alternative suppliers of our products or services.
Adverse economic conditions in the United States or any of the other countries in which we conduct significant business could negatively affect our business, financial condition and results of operations.




We depend on a limited number of retailers for a large portion of our net sales, and the loss of one or more of these retailers, or business challenges at one or more of these retailers, could adversely affect our results of operations.
We have significant operations in China, which exposes us to risks inherent in doing business in that country.
We are subject to international business uncertainties.
If we are unable to protect our intellectual property, the value of our brands and other intangible assets may be diminished, and our business may be adversely affected.
Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of third parties.
The summary risk factors described above should be read together with the text of the full risk factors below in the section titled “Risk factors” and the other information set forth in this Quarterly Report, including our unaudited condensed consolidated financial statements and the related notes, as well as in other documents that we file with the U.S. Securities and Exchange Commission (the “SEC”). The risks summarized above or described in the section titled “Risk factors” are not the only risks that we face. Additional risks and uncertainties not precisely known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations and future growth prospects.




e.l.f. Beauty, Inc.
Table of Contents

4

PART I. FINANCIAL INFORMATION
Item 1. Financial statements (unaudited)
e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated balance sheets
(unaudited)
(in thousands, except share and per share data)
December 31, 2023March 31, 2023December 31, 2022
Assets
Current assets:
Cash and cash equivalents$72,705 $120,778 $87,021 
Accounts receivable, net121,061 67,928 66,237 
Inventory, net204,504 81,323 81,250 
Prepaid expenses and other current assets56,630 33,296 28,382 
Total current assets454,900 303,325 262,890 
Property and equipment, net12,805 7,874 8,726 
Intangible assets, net230,658 78,041 80,071 
Goodwill340,165 171,620 171,620 
Investments1,155 2,875 2,875 
Other assets68,601 31,866 29,743 
Total assets$1,108,284 $595,601 $555,925 
Liabilities and stockholders' equity  
Current liabilities:  
Current portion of long-term debt and finance lease obligations$100,394 $5,575 $5,690 
Accounts payable72,917 31,427 32,049 
Accrued expenses and other current liabilities129,628 70,974 49,798 
Total current liabilities302,939 107,976 87,537 
Long-term debt and finance lease obligations164,403 60,881 62,177 
Deferred tax liabilities4,281 3,742 7,783 
Long-term operating lease obligations21,720 11,201 12,329 
Other long-term liabilities717 784 795 
Total liabilities494,060 184,584 170,621 
Commitments and contingencies (Note 9)
Stockholders' equity:  
Common stock, par value of $0.01 per share; 250,000,000 shares authorized as of December 31, 2023, March 31, 2023 and December 31, 2022; 55,412,234, 53,770,482 and 53,165,462 shares issued and outstanding as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively
553 535 528 
Additional paid-in capital922,592 832,481 823,021 
Accumulated other comprehensive loss(58)  
Accumulated deficit(308,863)(421,999)(438,245)
Total stockholders' equity614,224 411,017 385,304 
Total liabilities and stockholders' equity$1,108,284 $595,601 $555,925 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated statements of operations
(unaudited)
(in thousands, except share and per share data)
 Three months ended December 31,Nine months ended December 31,
 2023202220232022
Net sales$270,943 $146,537 $702,789 $391,487 
Cost of sales78,986 47,812 205,895 130,217 
Gross profit191,957 98,725 496,894 261,270 
Selling, general and administrative expenses160,121 75,434 364,246 201,172 
Operating income 31,836 23,291 132,648 60,098 
Other income (expense), net2,565 730 1,902 (2,195)
Impairment of equity investment  (1,720) 
Interest expense, net(3,985)(463)(3,021)(1,912)
Loss on extinguishment of debt (176) (176)
Income before provision for income taxes30,416 23,382 129,809 55,815 
Income tax provision(3,528)(4,277)(16,673)(10,531)
Net income $26,888 $19,105 $113,136 $45,284 
Net income per share:
Basic$0.49 $0.36 $2.08 $0.87 
Diluted$0.46 $0.34 $1.97 $0.82 
Weighted average shares outstanding:
Basic55,140,887 52,707,406 54,503,518 52,239,761 
Diluted58,030,115 55,840,137 57,550,094 54,906,065 
The accompanying notes are an integral part of these condensed consolidated financial statements.
6

e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated statements of comprehensive income
(unaudited)
(in thousands)
Three months ended December 31,Nine months ended December 31,
2023202220232022
Net income$26,888 $19,105 $113,136 $45,284 
Other comprehensive loss, net of tax
Foreign currency translation adjustment(58) (58) 
Other comprehensive loss, net of tax(58) (58) 
Comprehensive income$26,830 $19,105 $113,078 $45,284 
The accompanying notes are an integral part of these condensed consolidated financial statements.
7

e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated statements of stockholders’ equity
(unaudited)
(in thousands, except share data)
 Common stockAdditional
paid-in
capital
Accumulated other
comprehensive loss
Accumulated
deficit
Total
stockholders'
equity
 SharesAmount
Balance as of March 31, 202353,571,577 $535 $832,481 $ $(421,999)$411,017 
Net income— — — — 52,977 52,977 
Stock-based compensation— — 7,223 — — 7,223 
Exercise of stock options and vesting of restricted stock754,953 8 477 — — 485 
Balance as of June 30, 202354,326,530 $543 $840,181 $ $(369,022)$471,702 
Net income— — — — 33,271 33,271 
Stock-based compensation— — 11,190 — — 11,190 
Exercise of stock options and vesting of restricted stock203,982 2 263 — — 265 
Balance as of September 30, 202354,530,512 $545 $851,634 $ $(335,751)$516,428 
Net income— — — — 26,888 26,888 
Stock-based compensation— — 11,051 — — 11,051 
Exercise of stock options and vesting of restricted stock213,014 2 2,141 — — 2,143 
Issuance of common stock as consideration for acquisition577,659 6 57,766 — — 57,772 
Foreign currency translation adjustment— — — (58)— (58)
Balance as of December 31, 202355,321,185 $553 $922,592 $(58)$(308,863)$614,224 
The accompanying notes are an integral part of these condensed consolidated financial statements.
8

e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated statements of stockholders’ equity
(unaudited)
(in thousands, except share data)
 Common stockAdditional
paid-in
capital
Accumulated
deficit
Total
stockholders'
equity
 SharesAmount
Balance as of March 31, 202251,524,307 $515 $795,443 $(483,529)$312,429 
Net income— — — 14,469 14,469 
Stock-based compensation— — 6,549 — 6,549 
Exercise of stock options and vesting of restricted stock558,336 2 — — 2 
Balance as of June 30, 202252,082,643 $517 $801,992 $(469,060)$333,449 
Net income— — — 11,710 11,710 
Stock-based compensation— — 8,022 — 8,022 
Exercise of stock options and vesting of restricted stock471,966 8 3,771 — 3,779 
Balance as of September 30, 202252,554,609 $525 $813,785 $(457,350)$356,960 
Net income— — — 19,105 19,105 
Stock-based compensation— — 7,239 — 7,239 
Exercise of stock options and vesting of restricted stock269,051 3 1,997 — 2,000 
Balance as of December 31, 202252,823,660 $528 $823,021 $(438,245)$385,304 
The accompanying notes are an integral part of these condensed consolidated financial statements.

9

e.l.f. Beauty, Inc. and subsidiaries
Condensed consolidated statements of cash flows
(unaudited)
(in thousands)
 Nine months ended December 31,
 20232022
Cash flows from operating activities:  
Net income $113,136 $45,284 
Adjustments to reconcile net income to net cash provided by operating activities:
 
Depreciation and amortization24,247 16,496 
Stock-based compensation expense29,459 21,833 
Amortization of debt issuance costs and discount on debt290 271 
Deferred income taxes(1,684)(1,819)
Impairment of equity investment1,720  
Acquisition-related seller expenses(10,549) 
Loss on extinguishment of debt 176 
Other, net27 (1)
Changes in operating assets and liabilities:  
Accounts receivable(45,878)(20,620)
Inventory(106,898)3,248 
Prepaid expenses and other assets(50,696)(15,223)
Accounts payable and accrued expenses84,733 22,610 
Other liabilities(3,768)(3,254)
Net cash provided by operating activities34,139 69,001 
Cash flows from investing activities:  
Acquisition, net of cash acquired(274,973) 
Purchase of property and equipment(5,984)(1,647)
Net cash used in investing activities(280,957)(1,647)
Cash flows from financing activities:  
Proceeds from revolving line of credit89,500  
Proceeds from long-term debt115,000  
Repayment of long-term debt(5,188)(28,750)
Debt issuance costs paid(665) 
Cash received from issuance of common stock2,893 5,652 
Other, net(489)(588)
Net cash provided by (used in) financing activities201,051 (23,686)
Effect of exchange rate changes on cash and cash equivalents(56) 
Net (decrease) increase in cash, cash equivalents and restricted cash
(45,823)43,668 
Cash, cash equivalents and restricted cash - beginning of period120,778 43,353 
Cash, cash equivalents and restricted cash - end of period$74,955 $87,021 
The accompanying notes are an integral part of these condensed consolidated financial statements.
10

e.l.f. Beauty, Inc. and subsidiaries
Notes to condensed consolidated financial statements (unaudited)
Note 1—Nature of operations
e.l.f. Beauty, Inc., a Delaware corporation (“e.l.f. Beauty” and together with its subsidiaries, the “Company”), is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skincare products. The Company's mission is to make the best of beauty accessible to every eye, lip, face and skin concern.
The Company believes its ability to deliver cruelty-free, clean, vegan and premium-quality products at accessible prices with broad appeal differentiates it in the beauty industry. The Company believes the combination of its value proposition, innovation engine, ability to attract and engage consumers, and its world-class team’s ability to execute with speed, has positioned the Company well to navigate the competitive beauty market.
The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. The Company's brands are available online and across leading beauty, mass-market and specialty retailers. The Company has strong relationships with its retail customers such as Target, Walmart, Ulta Beauty and other leading retailers that have enabled the Company to expand distribution both domestically and internationally.
Note 2—Summary of significant accounting policies
Basis of presentation
The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, these interim financial statements contain all adjustments, including normal recurring adjustments, necessary for a fair statement of its financial position as of December 31, 2023, March 31, 2023 and December 31, 2022, and its results of operations and stockholders' equity for the three and nine months ended December 31, 2023 and December 31, 2022 and its cash flows for the nine months ended December 31, 2023 and December 31, 2022. All intercompany balances and transactions have been eliminated in consolidation.
These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Annual Report”). Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.
Use of estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment reporting
Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.
Significant accounting policies
Business combinations
The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases
11

assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.
Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.
The Company made no other material changes in the application of its significant accounting policies that were disclosed in Note 2, “Summary of significant accounting policies,” to the audited consolidated financial statements as of and for the fiscal year ended March 31, 2023 included in the Annual Report.
Revenue recognition
The Company distributes products both through national and international retailers, as well as direct-to-consumers through its e-commerce channel. The marketing and consumer engagement benefits that the direct-to-consumer channel provides are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams.
The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes.
The following table provides disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers (in thousands).
 Three months ended December 31,Nine months ended December 31,
Net sales by geographic region:2023202220232022
United States$229,101 $127,457 $599,552 $343,869 
International41,842 19,080 103,237 47,618 
Total net sales$270,943 $146,537 $702,789 $391,487 
As of December 31, 2023, other than accounts receivable, the Company had no material contract assets, contract liabilities or deferred contract costs recorded on its unaudited condensed consolidated balance sheet.
Recent accounting pronouncements
No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.
Note 3—Restricted cash
Restricted cash amounting to $2.3 million as of December 31, 2023, included in prepaid expenses and other current assets on the accompanying unaudited condensed consolidated balance sheets, represents part of the purchase consideration held in escrow for the settlement of general representation and warranty provisions in connection with the Company’s acquisition of Naturium LLC (“Naturium”). The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.
12

The reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows are as follows (in thousands):
Nine months ended December 31,
 Balance sheet classification20232022
Cash and cash equivalentsCash and cash equivalents$72,705 $87,021 
Restricted cash held in escrowPrepaid expenses and other current assets2,250  
Cash, cash equivalents and restricted cash - end of period$74,955 $87,021 
Note 4—Investment in equity securities
On April 14, 2017, the Company invested $2.9 million in a social media analytics company, which is included in investments on its unaudited condensed consolidated balance sheets. The Company has elected the measurement alternative for equity investments that do not have readily determinable fair values. The Company recorded an impairment charge of $1.7 million on its investment as a separate line under other income (expense), net during the three months ended June 30, 2023, as an identified event or change in circumstances resulted in an indicator of impairment. The Company did not record an additional impairment charge on its investment during the three months ended December 31, 2023.
Note 5—Acquisition
On October 4, 2023, the Company, through its wholly owned subsidiary, e.l.f. Cosmetics, Inc., completed its acquisition of Naturium (including the indirect acquisition of equity interests in Naturium through the purchase of a “tax blocker” holding company) (the “Acquisition”), which furthered the Company’s mission to make the best of beauty accessible to every eye, lip, face and skin concern. Naturium is a skincare company that provides clinically effective products at an affordable price. The Company directly and indirectly acquired all rights, title and interest in and to the outstanding equity securities of Naturium for a purchase price of $333.0 million. The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):
Cash consideration
$275,266 
Equity consideration (common stock issued)(1)
57,772 
Total consideration transferred
333,038 
Less: Net assets acquired
Net assets acquired, excluding liability assumed for acquisition-related seller expenses
$175,042 
Liability assumed for acquisition-related seller expenses(2)
(10,549)
Net assets acquired
(164,493)
Goodwill
$168,545 
(1) The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.
(2) In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.
The Company incurred and expensed acquisition transaction costs of $0.6 million and $3.1 million during the three and nine months ended December 31, 2023, respectively, which are included as a component of selling, general and administrative expenses in the condensed consolidated statements of operations.
The Acquisition has been accounted for as a business combination under the acquisition method and, accordingly, the total purchase price is allocated to the tangible and intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date. The purchase price allocation, deferred tax calculations and residual goodwill are preliminary and pending finalization. Naturium’s results of operations have been included in the Company's condensed consolidated financial statements from the date of acquisition.
13

The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):
Cash$293 
Accounts receivable7,388 
Inventory16,282 
Prepaid expenses and other current assets1,899 
Property and equipment28 
Goodwill(1)
168,545 
Intangible assets 162,800 
Total assets acquired
357,235 
Accounts payable(15,897)
Accrued expenses and other current liabilities(6,077)
Net deferred tax liability(2,223)
Total liabilities assumed(24,197)
Total purchase price
$333,038 
(1) The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skincare products. A substantial amount of the goodwill is expected to be deductible for tax purposes.
Intangible assets
Fair ValueEstimated Useful Life
(in thousands)(in years)
Fair Value Methodology
Customer relationships – retailers$20,000 10
Excess earnings method
Customer relationships – e-commerce18,300 
3
Excess earnings method and with and without method
Trademarks124,500 15
Relief from Royalty method
Total identified intangible assets$162,800 
Certain financial information (unaudited)
The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022), are as follows (in thousands):
 
Amount
Actual Naturium net sales from October 4, 2023 to December 31, 2023
$22,458 
Supplemental pro forma combined net sales for the three months ended December 31, 2023
271,579 
Supplemental pro forma combined net sales for the nine months ended December 31, 2023
744,583 
Supplemental pro forma combined net sales for the three months ended December 31, 2022
159,811 
Supplemental pro forma combined net sales for the nine months ended December 31, 2022
425,423 
The unaudited pro forma financial information shown in the table above are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisition had taken place at April 1, 2022 (the beginning of comparable period presented).
The pro forma earnings of the combined companies are not presented as the effects of the Acquisition in earnings are not material in relation to the overall consolidated financial statements.
14

Note 6—Goodwill and intangible assets
Information regarding the Company’s goodwill and intangible assets as of December 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$97,600 $(72,100)$25,500 
Customer relationships – e-commerce
3 years
22,240 (5,465)16,775 
Trademarks
10 to 15 years
128,000 (3,417)124,583 
Total finite-lived intangibles247,840 (80,982)166,858 
TrademarksIndefinite63,800 — 63,800 
Goodwill340,165 — 340,165 
Total goodwill and other intangibles$651,805 $(80,982)$570,823 
Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(65,780)$11,820 
Customer relationships – e-commerce3 years3,940 (3,940) 
Trademarks10 years3,500 (1,079)2,421 
Total finite-lived intangibles85,040 (70,799)14,241 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(70,799)$249,661 
Information regarding the Company’s goodwill and intangible assets as of December 31, 2022 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(63,840)$13,760 
Customer relationships – e-commerce3 years3,940 (3,938)2 
Trademarks10 years3,500 (991)2,509 
Total finite-lived intangibles85,040 (68,769)16,271 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(68,769)$251,691 
Amortization expenses on finite-lived intangible assets were $6.1 million and $2.0 million in the three months ended December 31, 2023 and December 31, 2022, respectively, and $10.2 million and $6.1 million in the nine months ended December 31, 2023 and December 31, 2022, respectively. Certain trademark assets have been classified as indefinite-lived intangible assets and accordingly, are not subject to amortization. There were no impairments of goodwill or intangible assets recorded in the three and nine months ended December 31, 2023 and December 31, 2022.
15

The estimated future amortization expense related to finite-lived intangible assets, assuming no impairment as of December 31, 2023 is as follows (in thousands):
Remainder of fiscal 2024$4,981 
202517,630 
202617,630 
202714,580 
202811,530 
Thereafter100,507 
Total$166,858 
Note 7—Accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Accrued expenses$44,979 $22,726 $19,298 
Accrued inventory23,562 1,330 468 
Accrued marketing21,241 23,761 7,036 
Current portion of operating lease liabilities7,010 4,510 4,528 
Accrued compensation16,588 13,098 10,591 
Taxes payable9,937 2,851 5,076 
Other current liabilities6,311 2,698 2,801 
Accrued expenses and other current liabilities$129,628 $70,974 $49,798 
Note 8—Debt
The Company’s outstanding debt as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Revolving line of credit(1)
$89,500 $ $ 
Term loan(1)
176,063 66,250 67,500 
Finance lease obligations144 633 832 
Total debt(2)
265,707 66,883 68,332 
Less: debt issuance costs(910)(427)(465)
Total debt, net of issuance costs264,797 66,456 67,867 
Less: current portion(100,394)(5,575)(5,690)
Long-term portion of debt$164,403 $60,881 $62,177 
(1) See further discussion below. As of December 31, 2023, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
(2) The gross carrying amounts of the Company’s long-term debt, before reduction of the debt issuance costs, and finance lease obligations approximate their fair values, based on Level 2 inputs (quoted prices for similar assets and liabilities in active markets or inputs that are observable), as the stated rates approximate market rates for loans with similar terms. The Company did not transfer any liabilities measured at fair value on a recurring basis to or from Level 2 for any of the periods presented.
16

Amended Credit Agreement
On April 30, 2021, the Company amended and restated its prior credit agreement (such amended and restated credit agreement, as further amended, supplemented or modified from time to time, the “Amended Credit Agreement”) and refinanced all loans under the prior credit agreement. The Amended Credit Agreement has a five year term and consists of (i) a $100 million revolving credit facility (the “Amended Revolving Credit Facility”) and (ii) a $100 million term loan facility (the “Amended Term Loan Facility”).
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility is collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on the Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provides for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan; however, all amounts drawn under the Amended Revolving Credit Facility cannot exceed $100 million. The unused balance of the Amended Revolving Credit Facility as of December 31, 2023 was $10.5 million.
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States (“US”) dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR plus 0.10%, subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
The interest rate as of December 31, 2023 for the Amended Revolving Credit Facility and the Amended Term Loan Facility was approximately 6.7%.
Second Amended Credit Agreement
On August 28, 2023, the Company entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, the Company may borrow incremental term loans in a principal amount equal to $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan will bear interest at a rate per annum equal to, at the Company’s election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, to be based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortizes at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ending on December 31, 2023. The Company used the Incremental Term Loan together with cash from its balance sheet and additional borrowings under its Amended Revolving Credit Facility to consummate the Acquisition (as defined in Note 5 hereto) and to pay related fees and expenses in connection with the Acquisition and Second Amendment.
The interest rate as of December 31, 2023 for the Incremental Term Loan was approximately 6.9%.
The Amended Credit Agreement contains a number of covenants that, among other things and subject to certain exceptions, restrict the Company’s ability to pay dividends and distributions or repurchase capital stock, incur additional indebtedness, create liens on assets, engage in mergers or consolidations and sell or otherwise dispose of assets. The Amended Credit Agreement also includes reporting, financial and maintenance covenants that require the Company to, among other things, comply with certain consolidated total net leverage ratios and consolidated fixed charge coverage ratios.
17

Note 9—Commitments and contingencies
Legal contingencies
The Company is from time to time subject to, and is currently involved in legal proceedings, claims and litigation arising in the ordinary course of business. The Company is not currently a party to any matters that management expects will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
Note 10—Income taxes
The Company’s quarterly tax provision is based upon an estimated annual effective tax rate as adjusted for any discrete items. The Company’s provision for income taxes were $3.5 million and $4.3 million for the three months ended December 31, 2023 and December 31, 2022, respectively, and $16.7 million and $10.5 million for the nine months ended December 31, 2023 and December 31, 2022, respectively, with an effective tax rate of 11.6% and 18.3% for the three months ended December 31, 2023 and December 31, 2022, respectively, and an effective tax rate of 12.8% and 18.9% for the nine months ended December 31, 2023 and December 31, 2022, respectively. The effective tax rate differs from the U.S. statutory tax rate primarily due to discrete tax benefit related to stock-based compensation.
Note 11—Stock-based compensation
Stock based compensation expense is recognized on a straight-line basis over the requisite service period. Total stock-based compensation is shown in the table below (in thousands):
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Service-based vesting options$41 $89 $128 $266 
Restricted stock and RSUs11,001 7,168 29,331 21,567 
Total stock compensation expense$11,042 $7,257 $29,459 $21,833 
As of December 31, 2023, there was $0.1 million and $88.3 million of total unrecognized stock-based compensation cost related to unvested service-based stock options and shares subject to RSAs and RSUs, respectively. The unrecognized stock-based compensation is expected to be recognized over the remaining weighted-average period of 1.8 years for service-based stock options and 2.0 years for shares subject to RSAs and RSUs, respectively.
Note 12—Repurchase of common stock
On May 8, 2019, the Company announced that its board of directors authorized a share repurchase program to acquire up to $25.0 million of the Company’s common stock (the “Share Repurchase Program”). Purchases under the Share Repurchase Program may be made from time to time, in such amounts as management deems appropriate, through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program does not have an expiration date, does not require the Company to repurchase any specific number of shares of its common stock, and may be modified, suspended or terminated at any time without notice. There is no guarantee that any additional shares will be purchased under the Share Repurchase Program and such shares are intended to be retired after purchase.
The covenants in the Amended Credit Agreement require the Company to be in compliance with certain leverage ratios to make repurchases under the Share Repurchase Program.
The Company did not repurchase any shares during the three and nine months ended December 31, 2023. A total of $17.1 million remains available for future share repurchases under the Share Repurchase Program as of December 31, 2023.
18

Note 13—Net income per share
The Company computes basic net income per share using the weighted-average number of shares of common stock outstanding. Diluted net income per share amounts are calculated using the treasury stock method for equity-based compensation awards. The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):
 Three months ended December 31,Nine months ended December 31,
 2023202220232022
Numerator:    
Net income $26,888 $19,105 $113,136 $45,284 
Denominator:    
Weighted-average common shares outstanding – basic55,140,887 52,707,406 54,503,518 52,239,761 
Dilutive common equivalent shares from equity awards2,889,228 3,132,731 3,046,576 2,666,304 
Weighted-average common shares outstanding – diluted58,030,115 55,840,137 57,550,094 54,906,065 
Net income per share:    
Basic$0.49 $0.36 $2.08 $0.87 
Diluted$0.46 $0.34 $1.97 $0.82 
Weighted-average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share31,021 9,215 58,792 257,292 
Note 14—Leases
The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company's equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.
Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.
19

Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):
 ClassificationDecember 31, 2023March 31, 2023December 31, 2022
Assets
Operating lease assets Other assets$27,224 $14,071 $15,120 
Finance lease assets (a)
Other assets 245 350 
Total leased assets$27,224 $14,316 $15,470 
Liabilities
Current
Operating Accrued expenses and other current liabilities$7,010 $4,510 $4,528 
FinanceCurrent portion of long-term debt and finance lease obligations144 575 690 
Noncurrent
Operating Long-term operating lease obligations21,720 11,201 12,329 
FinanceLong-term debt and finance lease obligations 58 142 
Total lease liabilities$28,874 $16,344 $17,689 
_____________________
(a) Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.
For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands):
Three months ended December 31,Nine months ended December 31,
 Classification2023202220232022
Operating lease cost Selling, general and administrative (“SG&A”) expenses$2,203 $1,149 $4,905 $3,458 
Finance lease cost
Amortization of leased assetsSG&A expenses 105 210 315 
Interest on lease liabilitiesInterest expense, net3 7 10 25 
Total lease cost $2,206 $1,261 $5,125 $3,798 
As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):
Operating
leases
Finance
leases
Total
Remainder of fiscal 2024$1,985 $87 $2,072 
20258,434 58 8,492 
20268,424  8,424 
20275,060  5,060 
20281,921  1,921 
Thereafter6,994  6,994 
Total lease payments32,818 145 32,963 
Less: Interest4,088 1 4,089 
Present value of lease liabilities$28,730 $144 $28,874 
20

For leases commencing prior to January 1, 2019, minimum lease payments exclude payments to landlords for real estate taxes and common area maintenance. These payments can be either fixed or variable, depending on the lease.
As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows:
 December 31, 2023December 31, 2022
Weighted-average remaining lease term
Operating leases4.8 years4.7 years
Finance leases0.4 years1.1 years
Weighted-average discount rate
Operating leases4.9 %2.6 %
Finance leases1.6 %2.8 %
Operating cash outflows from operating leases for the nine months ended December 31, 2023 and December 31, 2022 were $3.2 million and $3.6 million, respectively.

21

Item 2. Management’s discussion and analysis of financial condition and results of operations.
Management’s discussion and analysis of financial condition and results of operations (“MD&A”) should be read together with the MD&A presented in the Annual Report on Form 10-K for the year ended March 31, 2023 (the “Annual Report”) and the unaudited condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q (this “Quarterly Report”), which include additional information about our accounting policies, practices and the transactions underlying our financial results.
Overview and Business Trends
e.l.f. Beauty, Inc., a Delaware corporation (“e.l.f. Beauty” and together with its subsidiaries, the “Company,” or “we”), is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skincare products. Our mission is to make the best of beauty accessible to every eye, lip, face and skin concern.
We believe our ability to deliver cruelty-free, clean, vegan and premium-quality products at accessible prices with broad appeal differentiates us in the beauty industry. We believe the combination of our value proposition, innovation engine, ability to attract and engage consumers, and our world-class team’s ability to execute with speed has positioned us well to navigate the competitive beauty market.
Our family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. Our brands are available online and across leading beauty, mass-market, and specialty retailers. We have strong relationships with our retail customers such as Target, Walmart, Ulta Beauty and other leading retailers that have enabled us to expand distribution both domestically and internationally.
Our Acquisition of Naturium
On October 4, 2023, we consummated our acquisition of Naturium LLC, a Delaware limited liability company (“Naturium”), and TCB-N Prelude Blocker Corp., a Delaware corporation (“Blocker”), pursuant to a Securities Purchase Agreement, dated August 28, 2023 (the "Purchase Agreement"), by and among the Company, e.l.f. Cosmetics, Inc., Naturium, Blocker and various sellers. Pursuant to the Purchase Agreement, we acquired all rights, title and interest in and to the outstanding equity securities of Naturium and Blocker for a purchase price of $333.0 million paid in cash and shares of our common stock (the "Acquisition"). See Note 5, “Acquisition,” in our unaudited condensed consolidated financial statements for further details.
Seasonality
Our results of operations are subject to seasonal fluctuations, with net sales in the third and fourth fiscal quarters typically being higher than in the first and second fiscal quarters. The higher net sales in our third and fourth fiscal quarters are largely attributable to the increased levels of purchasing by retailers for the holiday season and customer shelf reset activities, respectively. Lower inventory builds from our retailers in preparation for the holiday season or shifts in customer shelf reset activity could have a disproportionate effect on our results of operations for the entire fiscal year. To support anticipated higher sales during the third and fourth fiscal quarters, we make investments in working capital to ensure inventory levels can support demand. Fluctuations throughout the year are also driven by the timing of product restocking or rearrangement by our major retail customers as well as expansion into new retail customers. Because a limited number of our retail customers account for a large percentage of our net sales, a change in the order pattern of one or more of our large retail customers could cause a significant fluctuation of our quarterly results or impact our liquidity.
22

Results of operations
The following table sets forth our consolidated statements of operations data in dollars and as a percentage of net sales for the periods presented:
 Three months ended December 31,Nine months ended December 31,
(in thousands)2023202220232022
Net sales$270,943 $146,537 $702,789 $391,487 
Cost of sales78,986 47,812 205,895 130,217 
Gross profit191,957 98,725 496,894 261,270 
Selling, general and administrative expenses160,121 75,434 364,246 201,172 
Operating income 31,836 23,291 132,648 60,098 
Other income (expense), net2,565 730 1,902 (2,195)
Impairment of equity investment— — (1,720)— 
Interest expense, net(3,985)(463)(3,021)(1,912)
Loss on extinguishment of debt— (176)— (176)
Income before provision for income taxes30,416 23,382 129,809 55,815 
Income tax provision(3,528)(4,277)(16,673)(10,531)
Net income $26,888 $19,105 $113,136 $45,284 
 Three months ended December 31,Nine months ended December 31,
(percentage of net sales)2023202220232022
Net sales100 %100 %100 %100 %
Cost of sales29 %33 %29 %33 %
Gross margin71 %67 %71 %67 %
Selling, general and administrative expenses59 %51 %52 %51 %
Operating income 12 %16 %19 %15 %
Other income (expense), net%— %— %(1)%
Impairment of equity investment— %— %— %— %
Interest expense, net(1)%— %— %— %
Income before provision for income taxes11 %16 %18 %14 %
Income tax provision(1)%(3)%(2)%(3)%
Net income 10 %13 %16 %12 %
Comparison of the three months ended December 31, 2023 to the three months ended December 31, 2022
Net sales
Net sales increased $124.4 million, or 85%, to $270.9 million for the three months ended December 31, 2023, from $146.5 million for the three months ended December 31, 2022. The increase was driven by strength across both our retailer and e-commerce channels. Net sales increased $86.8 million, or 67%, in our retailer channels and $37.6 million, or 216%, in our e-commerce channels. From a price and volume perspective, a higher volume of units sold drove $81.9 million of the increase in net sales and a higher average item price within retailer and e-commerce orders drove the remaining $42.5 million increase in net sales as compared to the three months ended December 31, 2022.
Gross profit
Gross profit increased $93.2 million, or 94%, to $192.0 million for the three months ended December 31, 2023, compared to $98.7 million for the three months ended December 31, 2022. Higher unit volume drove $55.2 million of the increase in gross profit, with the remaining increase of $38.0 million driven by higher average item price and mix. Gross margin increased to 71% from 67% when compared to the three months ended December 31, 2022. The increase in gross margin rate was primarily driven by favorable foreign exchange impacts, improved transportation costs, cost savings and mix in the three months ended December 31, 2023.
23

Selling, general and administrative expenses
Selling, general and administrative (“SG&A”) expenses were $160.1 million for the three months ended December 31, 2023, an increase of $84.7 million, or 112%, from $75.4 million for the three months ended December 31, 2022. SG&A expenses as a percentage of net sales increased to 59% for the three months ended December 31, 2023 from 51% for the three months ended December 31, 2022. The $84.7 million increase was primarily related to an increase in marketing and digital spend of $44.0 million, increased compensation and benefits of $10.5 million, increased operations costs of $8.8 million, increased retail fixturing and visual merchandising costs of $7.4 million, increased depreciation and amortization of $5.9 million and increased professional fees of $2.3 million.
Other income, net
Other income, net totaled $2.6 million for the three months ended December 31, 2023, as compared to $0.7 million for the three months ended December 31, 2022. The year-over-year variance is primarily due to an increase in unrealized gain in the quarter attributable to favorable foreign currency rate fluctuation.
Interest expense, net
Interest expense, net was $4.0 million for the three months ended December 31, 2023, as compared to $0.5 million for the three months ended December 31, 2022. The change compared to last year was primarily due to additional borrowings for the three months ended December 31, 2023 as well as higher interest costs. See Note 8, “Debt,” in our unaudited condensed consolidated financial statements for further details on our debt.
Income tax provision
The provision for income taxes was $3.5 million, or an effective rate of 11.6%, for the three months ended December 31, 2023, as compared to a provision of $4.3 million, or an effective rate of 18.3%, for the three months ended December 31, 2022. The change in the provision for income taxes was primarily driven by an increase in discrete tax benefits of $3.7 million, primarily related to stock-based compensation, partially offset by an increase in income before taxes of $7.0 million.
Comparison of the nine months ended December 31, 2023 to the nine months ended December 31, 2022
Net sales
Net sales increased $311.3 million, or 80%, to $702.8 million for the nine months ended December 31, 2023, compared to $391.5 million for the nine months ended December 31, 2022. The increase was driven primarily by strength in both our retailer and e-commerce channels. Net sales increased $249.2 million, or 72%, in our retailer channels and $62.1 million, or 142%, in our e-commerce channels. From a price and volume perspective, a higher volume of units sold drove $220.2 million of the increase in net sales and a higher average item price within retailer and e-commerce orders drove the remaining $91.1 million increase in net sales as compared to the nine months ended December 31, 2022.
Gross profit
Gross profit increased $235.6 million, or 90%, to $496.9 million for the nine months ended December 31, 2023, compared to $261.3 million for the nine months ended December 31, 2022. Higher unit volume drove $147.0 million of the increase in gross profit, with the remaining increase of $88.6 million driven by higher average item price and mix. Gross margin increased to 71% from 67% when compared to the nine months ended December 31, 2022. The increase in gross margin rate in the nine months ended December 31, 2023 was primarily driven by favorable foreign exchange impacts, cost savings and mix, improved transportation costs, and lower inventory adjustments, partially offset by costs associated with retailer activity and space expansion.
Selling, general and administrative expenses
SG&A expenses were $364.2 million for the nine months ended December 31, 2023, an increase of $163.1 million, or 81%, from $201.2 million for the nine months ended December 31, 2022. SG&A expenses as a percentage of net sales increased to 52% for the nine months ended December 31, 2023 from 51% for the nine months ended December 31, 2022. The $163.1 million increase was primarily related to an increase in marketing and digital spend of $84.6 million, increased compensation and benefits of $22.3 million, increased operations costs of $17.6 million, increased retail fixturing and visual merchandising costs of $13.5 million, increased depreciation and amortization of $7.0 million and increased professional fees of $6.9 million.
24

Other income (expense), net
Other income, net totaled $1.9 million for the nine months ended December 31, 2023, as compared to other expense, net of $2.2 million for the nine months ended December 31, 2022. The year-over-year variance is primarily due to an increase in unrealized gain in the period attributable to favorable foreign currency rate fluctuation.
Impairment of equity investment
Impairment of equity investment was $1.7 million for the nine months ended December 31, 2023. See Note 4, “Investment in equity securities,” in our unaudited condensed consolidated financial statements for further details.
Interest expense, net
Interest expense, net was $3.0 million for the nine months ended December 31, 2023, as compared to $1.9 million for the nine months ended December 31, 2022. The year-over-year variance was primarily due to additional borrowings for the three months ended December 31, 2023 as well as higher interest costs, partially offset by increased interest earned on our cash balances. See Note 8, “Debt,” in our unaudited condensed consolidated financial statements for further details on our debt.
Income tax provision
The provision for income taxes was $16.7 million, or an effective rate of 12.8%, for the nine months ended December 31, 2023, as compared to a provision of $10.5 million, or an effective rate of 18.9%, for the nine months ended December 31, 2022. The change in the provision for income taxes was primarily driven by an increase in income before taxes of $74.0 million, partially offset by an increase in discrete tax benefits of $16.9 million, primarily related to stock-based compensation.
Financial condition, liquidity and capital resources
Overview
As of December 31, 2023, we had $72.7 million of cash and cash equivalents and $2.3 million of restricted cash. In addition, as of December 31, 2023, we had borrowing capacity of $10.5 million under our Amended Revolving Credit Facility.
Our primary cash needs are for working capital, fixturing, retail product displays and digital investments. Cash needs typically vary depending on strategic initiatives selected for the fiscal year, including investments in infrastructure, digital capabilities and expansion within or to additional retailer store locations.
We expect to fund ongoing cash needs from existing cash and cash equivalents, cash generated from operations and, if necessary, draws on our Amended Revolving Credit Facility.
Our primary working capital requirements are for product and product-related costs, compensation and benefits, distribution costs, advertising and marketing. Fluctuations in working capital are primarily driven by the timing of when a retailer rearranges or restocks its products, expansion of space within our existing retailer base or to new retailers and the general seasonality of our business. As of December 31, 2023, we had working capital, excluding cash and cash equivalents and restricted cash, of $77.0 million, compared to $74.6 million as of March 31, 2023. Working capital, excluding cash and cash equivalents, restricted cash and debt, was $177.4 million and $80.1 million as of December 31, 2023 and March 31, 2023, respectively.
We believe that our operating cash flow, existing cash and cash equivalents and available financing under the Amended Revolving Credit Facility will be adequate to meet our planned operating, investing and financing needs for the next twelve months. The unused balance of the Amended Revolving Credit Facility as of December 31, 2023 was $10.5 million. If necessary, we can borrow funds under our Amended Revolving Credit Facility to finance our liquidity requirements, subject to customary borrowing conditions. To the extent additional funds are necessary to meet our long-term liquidity needs as we continue to execute our business strategy, we anticipate that they will be obtained through the incurrence of additional indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing may not be available on favorable terms, or at all. Our ability to meet our operating, investing and financing needs depends to a significant extent on our future financial performance, which will be subject in part to general economic, competitive, financial, regulatory and other factors that are beyond our control, including those described elsewhere in Part II, Item 1A “Risk factors.” In addition to these general economic and industry factors, the principal factors in determining whether our cash flows will be sufficient to meet our liquidity requirements will be based on our ability to provide innovative products to our customers, manage production and our supply chain.
25

Cash flows
 Nine months ended December 31,
(in thousands)20232022
Net cash provided by (used in):  
Operating activities$34,139 $69,001 
Investing activities(280,957)(1,647)
Financing activities201,051 (23,686)
Cash provided by operating activities
For the nine months ended December 31, 2023, net cash provided by operating activities was $34.1 million. This included net income as adjusted for depreciation, amortization and other non-cash items of $167.2 million, and payment of acquisition-related seller expenses of $10.5 million in connection with the Acquisition, partially offset by an increase in operating assets and liabilities as shown on the statement of cash flows of $122.5 million. The increase in operating assets and liabilities was primarily driven by a $106.9 million increase in inventory. The increase was reflective of building inventory to support net sales growth, as well as $8.7 million related to Naturium inventory, and $27.7 million related to a change in certain vendor arrangements where we now take ownership of inventory at shipment from China versus when it enters our U.S. distribution center. Additional changes to assets and liabilities include a $50.7 million increase in prepaid expense and other assets, a $45.9 million increase in accounts receivable and a $3.8 million decrease related to other liabilities, partially offset by an $84.7 million increase in accounts payable and accrued expenses.
For the nine months ended December 31, 2022, net cash provided by operating activities was $69.0 million. This included net income as adjusted for depreciation, amortization and other non-cash items of $82.2 million and an increase in operating assets and liabilities as shown on the statement of cash flows of $13.2 million. The increase in operating assets and liabilities was primarily driven by a $15.2 million increase of prepaid expense and other assets, a $20.6 million increase in accounts receivable and a $3.3 million decrease related to other liabilities. This was partially offset by a $22.6 million increase in accounts payable and accrued expenses and a $3.2 million decrease in inventory.
Cash used in investing activities
For the nine months ended December 31, 2023, net cash used in investing activities was $281.0 million. This includes $275.0 million paid for the Acquisition, and capital expenditures related to fixturing, equipment and software of $6.0 million.
For the nine months ended December 31, 2022, net cash used in investing activities was $1.6 million consisting of capital expenditures related to fixturing, equipment and software.
Cash provided by (used in) financing activities
For the nine months ended December 31, 2023, net cash provided by financing activities was $201.1 million and was primarily driven by proceeds from the Amended Term Loan Facility of $115.0 million and Revolving Credit Facility of $89.5 million and cash received from the exercise of stock options of $2.9 million. This was partially offset by repayment on the Amended Term Loan Facility of $5.2 million and payment of debt issuance costs of $0.7 million associated with the Second Amendment.
For the nine months ended December 31, 2022, net cash used in financing activities was $23.7 million and was primarily driven by repayment on the Amended Term Loan Facility of $28.8 million, partially offset by cash received from the exercise of stock options of $5.7 million.

Description of indebtedness
Amended Credit Agreement
On April 30, 2021, we entered into the Amended Credit Agreement and refinanced all loans under the prior credit agreement. The Amended Credit Agreement has a five year term and consists of the Amended Revolving Credit Facility and the Amended Term Loan Facility.
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility is collateralized by substantially all of our assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on our consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provides for sub-facilities in the form of a $7 million letter of credit and a $5 million
26

swing line loan; however, all amounts drawn under the Amended Revolving Credit Facility cannot exceed $100 million. The unused balance of the Amended Revolving Credit Facility as of December 31, 2023 was $10.5 million.
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bear interest, at borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the US dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, we amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR, subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
The interest rate as of December 31, 2023 for the Amended Revolving Credit Facility and the Amended Term Loan Facility was approximately 6.7%.
Second Amended Credit Agreement
On August 28, 2023, we entered into the Second Amendment to the Amended Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, we may borrow incremental term loans in a principal amount equal to $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan will bear interest at a rate per annum equal to, at our election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, to be based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortizes at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ending on December 31, 2023. We used the Incremental Term Loan together with cash from our balance sheet and additional borrowings under our Amended Revolving Credit Facility to consummate the Acquisition and to pay related fees and expenses in connection with the Acquisition and Second Amendment.
The interest rate as of December 31, 2023 for the Incremental Term Loan was approximately 6.9%.
The Amended Credit Agreement contains a number of covenants that, among other things and subject to certain exceptions, restrict our ability to pay dividends and distributions or repurchase our capital stock, incur additional indebtedness, create liens on assets, engage in mergers or consolidations and sell or otherwise dispose of assets. The Amended Credit Agreement also includes reporting, financial and maintenance covenants that require us to, among other things, comply with certain consolidated total net leverage ratios and consolidated fixed charge coverage ratios. As of December 31, 2023, we were in compliance with all financial covenants under the Amended Credit Agreement.

Contractual obligations and commitments
There have been no material changes to our contractual obligations and commitments as included in the Annual Report.
Off-balance sheet arrangements
We are not party to any off-balance sheet arrangements.
Critical accounting policies and estimates
The MD&A is based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these unaudited condensed consolidated financial statements required the use of estimates and judgments that affect the reported amounts of our assets, liabilities, revenues and expenses. Management bases estimates on historical experience and other assumptions it believes to be reasonable under the circumstances and evaluates these estimates on an on-going basis. Actual results may differ from these estimates. There have been no significant changes to the critical accounting policies and estimates included in the Annual Report.
27

Recent accounting pronouncements
Recent accounting pronouncements are disclosed in Note 2 to our unaudited condensed consolidated financial statements.
Item 3. Quantitative and qualitative disclosures about market risk.
There have been no material changes to our primary risk exposures or management of market risks from those disclosed in the Annual Report.
Item 4. Controls and procedures.
Evaluation of disclosure controls and procedures over financial reporting
As of December 31, 2023, our management conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2023, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to the officers who certify our financial reports and to the members of the Company’s senior management and board of directors as appropriate to allow timely decisions regarding required disclosure.
Changes in internal control over financial reporting
We have assessed the impact on changes to our internal controls over financial reporting and concluded that there have been no changes to our internal control over financial reporting that occurred during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
28

PART II. OTHER INFORMATION
Item 1. Legal proceedings.
We are from time to time subject to, and are presently involved in, legal proceedings, claims and litigation arising in the ordinary course of business. We are not currently a party to any matters that management expects will have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Item 1A. Risk factors.
Certain risks may have a material and/or adverse effect on our business, financial condition and results of operations. These risks include those described below and may include additional risks and uncertainties not presently known to us or that we currently deem immaterial. These risks should be read in conjunction with the other information in this Quarterly Report, including our unaudited condensed consolidated financial statements and related notes thereto and “Management’s discussion and analysis of financial condition and results of operations” in Part I, Item 2 of this Quarterly Report.
Risk factors related to the beauty industry
The beauty industry is highly competitive, and if we are unable to compete effectively our results will suffer.
We face vigorous competition from companies throughout the world, including large multinational consumer products companies that have many beauty brands under ownership and independent beauty and skincare brands, including those that may target the latest trends or specific distribution channels. Competition in the beauty industry is based on the introduction of new products, pricing of products, quality of products and packaging, brand awareness, perceived value and quality, innovation, in-store presence and visibility, promotional activities, advertising, editorials, e-commerce and mobile-commerce initiatives and other activities. We must compete with a high volume of new product introductions and existing products by diverse companies across several different distribution channels.
Many multinational consumer companies have greater financial, technical or marketing resources, longer operating histories, greater brand recognition or larger customer bases than we do and may be able to respond more effectively to changing business and economic conditions than we can. Many of these competitors’ products are sold in a wider selection or greater number of retail stores and possess a larger presence in these stores, typically having significantly more inline shelf space than we do. Given the finite space allocated to beauty products by retail stores, our ability to grow the number of retail stores in which our products are sold and expand our space allocation once in these retail stores may require the removal or reduction of the shelf space of these competitors. We may be unsuccessful in our growth strategy in the event retailers do not reallocate shelf space from our competitors to us. Increasing shelf space allocated to our products may be especially challenging in instances when a retailer has its own brand. In addition, our competitors may attempt to gain market share by offering products at prices at or below the prices at which our products are typically offered, including through the use of large percentage discounts and “buy one and get one free” offers. Competitive pricing may require us to reduce our prices, which would decrease our profitability or result in lost sales. Our competitors, many of whom have greater resources than we do, may be better able to withstand these price reductions and lost sales.
It is difficult for us to predict the timing and scale of our competitors’ activities in these areas or whether new competitors will emerge in the beauty industry. In recent years, numerous online, “indie,” celebrity and influencer-backed beauty companies have emerged and garnered significant followings. In addition, further technological breakthroughs, including new and enhanced technologies which increase competition in the online retail market, new product offerings by competitors and the strength and success of our competitors’ marketing programs may impede our growth and the implementation of our business strategy.
Our ability to compete also depends on the continued strength of our brands and products, the success of our marketing, innovation and execution strategies, the continued diversity of our product offerings, the successful management of new product introductions and innovations, strong operational execution, including in order fulfillment, our ability to adapt to changes in technology, including the successful utilization of data analytics, artificial intelligence and machine learning, and our success in entering new markets and expanding our business in existing geographies. If we are unable to continue to compete effectively, it could have a material adverse effect on our business, financial condition and results of operations.
29

Our new product introductions may not be as successful as we anticipate.
The beauty industry is driven in part by fashion and beauty trends, which may shift quickly. Our continued success depends on our ability to anticipate, gauge and react in a timely and cost-effective manner to changes in consumer preferences for beauty products, consumer attitudes toward our industry and brands and where and how consumers shop for those products. We must continually work to develop, produce and market new products, maintain and enhance the recognition of our brands, maintain a favorable mix of products and develop our approach as to how and where we market and sell our products.
We have a process for the development, evaluation and validation of our new product concepts. Nonetheless, each new product launch involves risks, as well as the possibility of unexpected consequences. For example, the acceptance of new product launches and sales to our retail customers may not be as high as we anticipate due to lack of acceptance of the products themselves or their price or limited effectiveness of our marketing strategies. In addition, our ability to launch new products may be limited by delays or difficulties affecting the ability of our suppliers or manufacturers to timely manufacture, distribute and ship new products or displays for new products. Sales of new products may be affected by inventory management by our retail customers, and we may experience product shortages or limitations in retail display space by our retail customers. We may also experience a decrease in sales of certain existing products as a result of newly-launched products, the impact of which could be exacerbated by shelf space limitations or any shelf space loss. Any of these occurrences could delay or impede our ability to achieve our sales objectives, which could have a material adverse effect on our business, financial condition and results of operations.
As part of our ongoing business strategy, we expect that we will need to continue to introduce new products in the color cosmetics and skincare categories, while also expanding our product launches into adjacent categories in which we may have little to no operating experience. The success of product launches in adjacent product categories could be hampered by our relative inexperience operating in such categories, the strength of our competitors or any of the other risks referred to above. Furthermore, any expansion into new product categories may prove to be an operational and financial constraint which inhibits our ability to successfully accomplish such expansion. Our inability to introduce successful products in our traditional categories or in adjacent categories could limit our future growth and have a material adverse effect on our business, financial condition and results of operations.
Any damage to our reputation or brands may materially and adversely affect our business, financial condition and results of operations.
We believe that developing and maintaining our brands is critical and that our financial success is directly dependent on consumer perception of our brands. Furthermore, the importance of brand recognition may become even greater as competitors offer more products similar to ours.
We have relatively low brand awareness among consumers when compared to legacy beauty brands, and maintaining and enhancing the recognition and reputation of our brands is critical to our business and future growth. Many factors, some of which are beyond our control, are important to maintaining our reputation and brands. These factors include our ability to comply with ethical, social, product, labor and environmental standards. Any actual or perceived failure in compliance with such standards could damage our reputation and brands.
The growth of our brands depends largely on our ability to provide a high-quality consumer experience, which in turn depends on our ability to bring innovative products to the market at competitive prices that respond to consumer demands and preferences. Additional factors affecting our consumer experience include our ability to provide appealing store sets in retail stores, the maintenance and stocking of those sets by our retail customers, the overall shopping experience provided by our retail customers, a reliable and user-friendly website interface and mobile applications for our consumers to browse and purchase products on our e-commerce websites and mobile applications. If we are unable to preserve our reputation, enhance our brand recognition or increase positive awareness of our products and in-store and Internet platforms, it may be difficult for us to maintain and grow our consumer base, and our business, financial condition and results of operations may be materially and adversely affected.
The success of our brands may also suffer if our marketing plans or product initiatives do not have the desired impact on our brands' image or our ability to attract consumers. Further, our brand value could diminish significantly due to a number of factors, including consumer perception that we have acted in an irresponsible manner, adverse publicity about our products, our failure to maintain the quality of our products, product contamination, the failure of our products to deliver consistently positive consumer experiences, or our products becoming unavailable to consumers.
30

Our success depends, in part, on the quality, performance and safety of our products.
Any loss of confidence on the part of consumers in the ingredients used in our products, whether related to product contamination or product safety or quality failures, actual or perceived, or inclusion of prohibited ingredients, could tarnish the image of our brands and could cause consumers to choose other products. Allegations of contamination or other adverse effects on product safety or suitability for use by a particular consumer, even if untrue, may require us to expend significant time and resources responding to such allegations and could, from time to time, result in a recall of a product from any or all of the markets in which the affected product was distributed. Any such issues or recalls could negatively affect our profitability and image of our brands.
If our products are found to be, or perceived to be, defective or unsafe, or if they otherwise fail to meet our consumers’ expectations, our relationships with consumers could suffer, the appeal of our brands could be diminished, we may need to recall some of our products and/or become subject to regulatory action, and we could lose sales or market share or become subject to boycotts or liability claims. In addition, safety or other defects in our competitors’ products could reduce consumer demand for our own products if consumers view them to be similar. Any of these outcomes could result in a material adverse effect on our business, financial condition and results of operations.
Risk factors related to our growth and profitability
We may not be able to successfully implement our growth strategy.
Our future growth, profitability and cash flows depend upon our ability to successfully implement our business strategy, which, in turn, is dependent upon a number of key initiatives, including our ability to:
build demand in our brands;
invest in digital capabilities;
lead innovation by providing prestige quality products at an extraordinary value;
drive productivity and space expansion with our retailers;
deliver profitable growth; and
pursue strategic extensions that can leverage our strengths and bring new capabilities.
There can be no assurance that we can successfully achieve any or all of the above initiatives in the manner or time period that we expect. Further, achieving these objectives will require investments which may result in short-term cost increases with net sales materializing on a longer-term horizon and, therefore, may be dilutive to our earnings. We cannot provide any assurance that we will realize, in full or in part, the anticipated benefits we expect our strategy will achieve. The failure to realize those benefits could have a material adverse effect on our business, financial condition and results of operations.
Our growth and profitability are dependent on a number of factors, and our historical growth may not be indicative of our future growth.
Our historical growth may not be indicative of our future performance as we may not be successful in executing our growth strategy, and, even if we achieve our strategic imperatives, we may not be able to sustain profitability. In future periods, our revenue could decline or grow more slowly than we expect. We also may incur significant losses in the future for a number of reasons, including the following risks and the other risks described in this report, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors:
we may lose one or more significant retail customers, or sales of our products through these retail customers may decrease;
the ability of our third-party suppliers and manufacturers to produce our products and of our distributors to distribute our products could be disrupted;
because substantially all of our products are sourced and manufactured in China, our operations are susceptible to risks inherent in doing business there;
31

our products may be the subject of regulatory actions, including, but not limited to, actions by the US Food and Drug Administration (the “FDA”), the Federal Trade Commission (the “FTC”) and the Consumer Product Safety Commission (the “CPSC”) in the United States and comparable foreign authorities outside the United States;
we may be unable to introduce new products that appeal to consumers or otherwise successfully compete with our competitors in the beauty industry;
we may be unsuccessful in enhancing the recognition and reputation of our brands, and our brands may be damaged as a result of, among other reasons, our failure, or alleged failure, to comply with applicable ethical, social, product, labor or environmental standards;
we may experience service interruptions, data corruption, cyber-based attacks or network security breaches which result in the disruption of our operating systems or the loss of confidential information of our consumers;
we may be unable to retain key members of our senior management team or attract and retain other qualified personnel; and
we may be affected by adverse economic conditions in the United States or internationally.
We may be unable to continue to grow our business effectively or efficiently, which would harm our business, financial condition and results of operations.
Since our formation, we have experienced significant growth in our business, customer base, employee headcount and operations, and we expect to continue to grow our business. Growing our business has placed, and we expect that it will continue to place, strain on our management team, personnel, financial and information systems, supply chain and distribution capacity and other resources. To manage our growth effectively, we must continue to enhance our operational, financial and management systems, including our warehouse management and inventory control; maintain and improve our internal controls and disclosure controls and procedures; maintain and improve our information technology systems and procedures; and expand, train and manage our employee base while maintaining close coordination among our executive, accounting, finance, legal, human resources, marketing, regulatory, sales and operations functions.
We may not be able to continue to effectively manage our expansion in any one or more of these areas, and any failure to do so could significantly harm our business, financial condition and results of operations. Growing our business may make it difficult for us to adequately predict the expenditures we will need to make in the future. If we do not make the necessary overhead expenditures to accommodate our future growth, we may not be successful in executing our growth strategy, and our results of operations would suffer.
Acquisitions or investments, such as our acquisition of Naturium, could disrupt our business and harm our financial condition.
We frequently review acquisition and strategic investment opportunities that would expand our current product offerings, our distribution channels, increase the size and geographic scope of our operations or otherwise offer growth and operating efficiency opportunities. There can be no assurance that we will be able to identify suitable candidates or consummate these transactions on favorable terms. The process of integrating an acquired business, product or technology can create unforeseen operating difficulties, expenditures and other challenges such as:
potentially increased regulatory and compliance requirements;
implementation or remediation of controls, procedures and policies at the acquired business;
diversion of management time and focus from operation of our then-existing business to acquisition integration challenges;
coordination of product, sales, marketing and program and systems management functions;
transition of the users and customers of the acquired business, product, or technology onto our system;
retention of employees from the acquired business;
32

integration of employees from the acquired business into our organization;
integration of the acquired business’ accounting, information management, human resources and other administrative systems and operations into our systems and operations;
liability for activities of the acquired business, product or technology prior to the acquisition, including violations of law, commercial disputes and tax and other known and unknown liabilities; and
litigation or other claims in connection with the acquired business, product or technology, including claims brought by terminated employees, customers, former stockholders or other third parties.
If we are unable to address these difficulties and challenges or other problems encountered in connection with any acquisition or investment, we might not realize the anticipated benefits of that acquisition or investment, and we might incur unanticipated liabilities or otherwise suffer harm to our business generally. For example, if the integration of Naturium's business with our business is more difficult, costly or time-consuming than expected, we may not fully realize the expected benefits of our acquisition of Naturium, which may adversely affect our business, financial condition and results of operations. See also “Risk factors related to our acquisition of Naturium.”
To the extent that we pay the consideration for any acquisitions or investments in cash, it reduces the amount of cash available to us for other purposes. Acquisitions or investments can also result in dilutive issuances of our equity securities or the incurrence of debt, contingent liabilities, amortization expenses, increased interest expenses or impairment charges against goodwill on our consolidated balance sheet, any of which could have a material adverse effect on our business, financial condition and results of operations. For example, in connection with our acquisition of Naturium, we paid total consideration of approximately $333 million using an incremental term loan under the Company’s existing credit facility, borrowings on the Company’s existing revolving facility, cash on the balance sheet and approximately $58 million of Company stock.
Risk factors related to our acquisition of Naturium
We have made certain assumptions relating to our acquisition of Naturium that may prove to be materially inaccurate.
We have made certain assumptions relating to our acquisition of Naturium that may prove to be inaccurate, including as the result of the failure to realize the expected benefits of the acquisition, failure to realize expected revenue growth rates and higher than expected operating, transaction and integration costs, as well as general economic and business conditions that adversely affect the Company. If the assumptions are incorrect, our business, financial condition and results of operations may be materially adversely affected.
Naturium may have liabilities that are not known to us.
Naturium may have liabilities that we failed, or were unable, to discover in the course of performing our due diligence investigations in connection with our acquisition of Naturium. We may learn additional information about Naturium that materially and adversely affects us and Naturium, such as unknown or contingent liabilities and liabilities related to compliance with applicable laws. Moreover, Naturium may be subject to audits, reviews, inquiries, investigations and claims of non-compliance and litigation by federal and state regulatory agencies which could result in liabilities or other sanctions. Any such liabilities or sanctions, individually or in the aggregate, could have an adverse effect on our business, financial condition and results of operations.
Risk factors related to our business operations and macroeconomic conditions
A disruption in our operations, including a disruption in the supply chains for our products, could materially and adversely affect our business.
As a company engaged in distribution on a global scale, our operations, including those of our third-party manufacturers, suppliers, brokers and delivery service providers, are subject to the risks inherent in such activities, including industrial accidents, environmental events, strikes and other labor disputes, disruptions or delays in shipments, disruptions in information systems, product quality control, safety, licensing requirements and other regulatory issues, as well as natural disasters, pandemics (such as the coronavirus pandemic), border disputes, international conflict (such as the Israel-Hamas war
33

or the ongoing military conflict in Ukraine), acts of terrorism and other external factors over which we and our third-party manufacturers, suppliers, brokers and delivery service providers have no control. The loss of, or damage to, the manufacturing facilities or distribution centers of our third-party manufacturers, suppliers, brokers and delivery service providers could materially and adversely affect our business, financial condition and results of operations.
We depend heavily on ocean container delivery, as well as fast boats, rail and air freight, to receive shipments of our products from our third-party manufacturers located in China and contracted third-party delivery service providers to deliver our products to our distribution facilities and logistics providers, and from there to our retail customers. Further, we rely on postal and parcel carriers for the delivery of products sold directly to consumers through our e-commerce websites and mobile applications. Interruptions, to or failures in, these delivery services could prevent the timely or successful delivery of our products. These interruptions or failures may be due to unforeseen events that are beyond our control or the control of our third-party delivery service providers, such as port congestion, container shortages, inclement weather, natural disasters, international conflict, labor unrest or other transportation disruptions. In addition, port congestion, container shortages, inclement weather, natural disasters, international conflict, labor unrest or other transportation disruptions may increase the costs to supply or transport our products or the components of our products. If our products are not delivered on time or are delivered in a damaged state, retail customers and consumers may refuse to accept our products and have less confidence in our services. In addition, a vessel and container shortage globally could delay future inventory receipts and, in turn, could delay deliveries to our retailer customers and availability of products in our direct-to-consumer e-commerce channel. Such potential delays, additional transportation expenses and shipping disruptions could negatively impact our results of operations through higher inventory costs and reduced sales. Furthermore, the delivery personnel of contracted third-party delivery service providers act on our behalf and interact with our consumers personally. Any failure to provide high-quality delivery services to our consumers may negatively affect the shopping experience of our consumers, damage our reputation and cause us to lose consumers.
Our ability to meet the needs of our consumers and retail customers depends on the proper operation of our distribution facilities, where most of our inventory that is not in transit is housed. Although we currently insure our inventory, our insurance coverage may not be sufficient to cover the full extent of any loss or damage to our inventory or distribution facilities, and any loss, damage or disruption of the facilities, or loss or damage of the inventory stored there, could materially and adversely affect our business, financial condition and results of operations.
Our success depends, in part, on our retention of key members of our senior management team and ability to attract and retain qualified personnel.
Our success depends, in part, on our ability to attract and retain key employees, including our executive officers, senior management team and operations, finance, sales and marketing personnel. The labor markets in the United States and China, where most of our employees are located, are hyper competitive, and attracting and retaining top talent requires significant organizational costs and attention. We are a relatively small company that relies on a few key employees, any one of whom would be difficult to replace, and because we are a small company, we believe that the loss of key employees may be more disruptive to us than it would be to a larger company. Our success also depends, in part, on our continuing ability to identify, hire, train and retain other highly qualified personnel. In addition, we may be unable to effectively plan for the succession of senior management, including our Chief Executive Officer. The loss of key personnel or the failure to attract and retain qualified personnel may have a material adverse effect on our business, financial condition and results of operations.
We rely on a number of third-party suppliers, manufacturers, distributors and other vendors, and they may not continue to produce products or provide services that are consistent with our standards or applicable regulatory requirements, which could harm our brands, cause consumer dissatisfaction, and require us to find alternative suppliers of our products or services.
We use multiple third-party suppliers and manufacturers, primarily based in China, to source and manufacture substantially all of our products. We engage our third-party suppliers and manufacturers on a purchase order basis and are not party to long-term contracts with any of them. The ability of these third parties to supply and manufacture our products may be affected by competing orders placed by other persons and the demands of those persons. Further, we are subject to risks associated with disruptions or delays in shipments whether due to port congestion, container shortages, labor disputes, product regulations and/or inspections or other factors, natural disasters or health pandemics, or other transportation disruptions. If we experience significant increases in demand or need to replace a significant number of existing suppliers or manufacturers, there can be no assurance that additional supply and manufacturing capacity will be available when required on terms that are acceptable to us, or at all, or that any supplier or manufacturer will allocate sufficient capacity to us in order to meet our requirements.
34

In addition, quality control problems, such as the use of ingredients and delivery of products that do not meet our quality control standards and specifications or comply with applicable laws or regulations could harm our business. These quality control problems could result in regulatory action, such as restrictions on importation, products of inferior quality or product stock outages or shortages, harming our sales and creating inventory write-downs for unusable products.
We have also outsourced significant portions of our distribution process, as well as certain technology-related functions, to third-party service providers. Specifically, we rely on third-party distributors to sell our products in a number of foreign countries, our warehouses and distribution facilities are managed and staffed by third-party service providers, we are dependent on a single third-party vendor for credit card processing, and we utilize a third-party hosting and networking provider to host our e-commerce websites and mobile applications. The failure of one or more of these entities to provide the expected services on a timely basis, or at all, or at the prices we expect, or the costs and disruption incurred in changing these outsourced functions to being performed under our management and direct control or that of a third-party, may have a material adverse effect on our business, financial condition and results of operations. We are not party to long-term contracts with some of our distributors, and upon expiration of these existing agreements, we may not be able to renegotiate the terms on a commercially reasonable basis, or at all.
Further, our third-party manufacturers, suppliers and distributors may:
have economic or business interests or goals that are inconsistent with ours;
take actions contrary to our instructions, requests, policies or objectives;
be unable or unwilling to fulfill their obligations under relevant purchase orders, including obligations to meet our production deadlines, quality standards, pricing guidelines and product specifications, or to comply with applicable regulations, including those regarding the safety and quality of products and ingredients and good manufacturing practices;
have financial difficulties;
encounter raw material or labor shortages;
encounter increases in raw material or labor costs which may affect our procurement costs;
disclose our confidential information or intellectual property to competitors or third parties;
engage in activities or employment practices that may harm our reputation; and
work with, be acquired by, or come under control of, our competitors.
The occurrence of any of these events, alone or together, could have a material adverse effect on our business, financial condition and results of operations. In addition, such problems may require us to find new third-party suppliers, manufacturers or distributors, and there can be no assurance that we would be successful in finding third-party suppliers, manufacturers or distributors meeting our standards of innovation and quality.
The management and oversight of the engagement and activities of our third-party suppliers, manufacturers and distributors requires substantial time, effort and expense of our employees, and we may be unable to successfully manage and oversee the activities of our third-party manufacturers, suppliers and distributors. If we experience any supply chain disruptions caused by our manufacturing process or by our inability to locate suitable third-party manufacturers or suppliers, or if our manufacturers or raw material suppliers experience problems with product quality or disruptions or delays in the manufacturing process or delivery of the finished products or the raw materials or components used to make such products, our business, financial condition and results of operations could be materially and adversely affected.
If we fail to manage our inventory effectively, our results of operations, financial condition and liquidity may be materially and adversely affected.
Our business requires us to manage a large volume of inventory effectively. We depend on our forecasts to estimate demand for and popularity of various products to make purchasing decisions and to manage our inventory of stock-keeping units. Demand for products, however, can change significantly between the time inventory or components are ordered and the date of sale. Demand may be affected by seasonality, new product launches, rapid changes in product cycles and pricing, product
35

defects, promotions, changes in consumer spending patterns, changes in consumer tastes with respect to our products and other factors, and our consumers may not purchase products in the quantities that we expect. It may be difficult to accurately forecast demand and determine appropriate levels of product or components. We generally do not have the right to return unsold products to our suppliers.
If we fail to manage our inventory effectively or negotiate favorable credit terms with third-party suppliers, we may be subject to a heightened risk of inventory obsolescence, a decline in inventory values, and significant inventory write-downs or write-offs. In addition, if we are required to lower sale prices in order to reduce inventory level or to pay higher prices to our suppliers, our profit margins might be negatively affected. Any of the above may materially and adversely affect our business, financial condition and results of operations. See also “Risk factors related to our retail customers, consumers and the seasonality of our businessOur quarterly results of operations fluctuate due to seasonality, order patterns from key retail customers and other factors, and we may not have sufficient liquidity to meet our seasonal working capital requirements.”
Public health crises could adversely affect our business, financial condition and results of operations.
The COVID-19 pandemic and government and private sector responsive measures taken to contain or mitigate the effects of the pandemic, as well as related changes in consumer shopping behaviors, adversely affected our business, financial condition and results of operations. The emergence of another pandemic, epidemic or infectious disease outbreak could have a similar effect. The potential impacts of such public health crises include, but are not limited to:
the possibility of closures, reduced operating hours and/or decreased retail traffic for our retail customers, resulting in a decrease in sales of our products;
disruption to our distribution centers and our third-party suppliers and manufacturers, including the effects of facility closures as a result of disease outbreaks or other illnesses, or measures taken by federal, state or local governments to reduce its spread, reductions in operations hours, labor shortages and real-time changes in operating procedures, including for additional cleaning and disinfection procedures; and
significant disruption of global financial markets, which could have a negative impact on our ability to access capital in the future.
The COVID-19 pandemic contributed significantly to global supply chain constraints, with restrictions and limitations on related activities causing disruption and delay. These disruptions and delays strained domestic and international supply chains, resulting in port congestion, transportation delays as well as labor and container shortages, and affected the flow or availability of certain products.
The emergence of another pandemic, epidemic or infectious disease outbreak, and any required or voluntary actions to help limit the spread of illness, could impact our ability to carry out our business and may materially adversely impact global economic conditions, our business, financial condition and results of operations. There is a risk that our suppliers and distribution centers may become less productive or encounter disruptions as a result of the emergence and spread of another disease, and/or these facilities may no longer be allowed to operate based on directives from public health officials or government authorities in the United States, China or other jurisdictions. Such events could materially increase our costs, negatively impact our sales and damage our results of operations and liquidity, possibly to a significant degree.
The full extent of the impact of a pandemic, such as the COVID-19 pandemic, an epidemic or an infectious disease outbreak on our business, financial condition and results of operations will depend on future developments that are highly uncertain and unpredictable, including the timing, acceptance and efficacy of vaccinations and possible achievement of herd immunity in various locations, the occurrence of virus mutations and variants, infection rates increasing or returning in various geographic areas, actions by government authorities to contain outbreaks or treat their impact, and any related impact on capital and financial markets and consumer behavior, including the impacts of any recession or inflationary pressures, all of which may vary across regions.
Adverse economic conditions in the United States or any of the other countries in which we conduct significant business could negatively affect our business, financial condition and results of operations.
Many of our products may be considered discretionary items for consumers. Consumer spending on beauty products is influenced by general economic conditions and the availability of discretionary income. Adverse economic conditions in the United States, Canada, the United Kingdom (the “UK”), China or any of the other countries in which we conduct significant business, such as the current inflationary economic environment, rising interest rates, financial distress caused by recent or
36

potential bank failures and the associated banking crisis, an economic recession, depression or downturn, a tightening of the credit markets, high energy prices or higher unemployment levels, may lead to decreased consumer spending, reduced credit availability and a decline in consumer confidence and demand, each of which poses a risk to our business. As global economic conditions continue to be volatile and economic uncertainty remains, trends in consumer discretionary spending also remain unpredictable and subject to reductions due to credit constraints and uncertainties about the future.
A decrease in consumer spending or in retailer and consumer confidence and demand for our products could have a significant negative impact on our net sales and profitability, including our operating margins and return on invested capital. These economic conditions could cause some of our retail customers or suppliers to experience cash flow or credit problems and impair their financial condition, which could disrupt our business and adversely affect product orders, payment patterns and default rates and increase our bad debt expense.
Volatility in the financial markets could have a material adverse effect on our business, financial condition and results of operations.
While we currently generate cash flows from our ongoing operations and have had access to credit markets through our various financing activities, credit markets may experience significant disruptions. Deterioration in global financial markets, rising interest rates and concerns over potential recessions could make future financing difficult or more expensive. If any financial institution party to our credit facilities or other financing arrangements were to declare bankruptcy or become insolvent, they may be unable to perform under their agreements with us. This could leave us with reduced borrowing capacity, which could have a material adverse effect on our business, financial condition and results of operations.
We regularly maintain cash balances at third-party financial institutions in excess of the Federal Deposit Insurance Corporation (the “FDIC”) insurance limit. In 2023, the FDIC took control and was appointed receiver of Silicon Valley Bank (“SVB”), Signature Bank and First Republic Bank, after each bank was unable to continue its operations. Although the Company did not have any cash or cash equivalent balances on deposit with SVB, Signature Bank or First Republic Bank and, therefore, did not experience any direct risk of loss, we are unable to predict the extent or nature of the impacts of the failures of these banks and related circumstances at this time. Similarly, we cannot predict the impact that the high market volatility and instability of the banking sector more broadly could have on economic activity and our business in particular. The failure of other banks and financial institutions and measures taken, or not taken, by governments, businesses and other organizations in response to these events could adversely impact our business, financial condition and results of operations.
If the financial institutions with which we do business enter receivership or become insolvent in the future, there is no guarantee that the Department of the Treasury, the Federal Reserve and the FDIC will intercede to provide us and other depositors with access to balances in excess of the $250,000 FDIC insurance limit or that we would be able to: (i) access our existing cash, cash equivalents and investments; (ii) maintain any required letters of credit or other credit support arrangements; or (iii) adequately fund our business for a prolonged period of time or at all. Any of such events could have a material adverse effect on our current or projected business operations and results of operations and financial condition. In addition, if any parties with which we conduct business are unable to access funds pursuant to such instruments or lending arrangements with such a financial institution, such parties’ ability to continue to fund their business and perform their obligations to us could be adversely affected, which, in turn, could have a material adverse effect on our business, financial condition and results of operations.
Risk factors related to our financial condition
Our indebtedness may have a material adverse effect on our business, financial condition and results of operations.
As of December 31, 2023, we had a total of $265.7 million of indebtedness, consisting of amounts outstanding under our credit facilities and finance lease obligations, and a total availability of $10.5 million under our Amended Revolving Credit Facility. Our primary cash needs are for working capital, fixturing, retail product displays and digital investments. Cash needs typically vary depending on strategic initiatives selected for the fiscal year, including investments in infrastructure, digital capabilities expansion within or to additional retailer store locations, and acquisitions. On August 28, 2023, we entered into the Second Amendment to the Amended and Restated Credit Agreement, pursuant to which we borrowed an incremental term loan in a principal amount equal to $115.0 million (the “Incremental Term Loan”), together with available cash from our balance sheet and additional borrowings under our Amended Revolving Credit Facility, to consummate and pay related fees and expenses in connection with our acquisition of Naturium.
37

Our indebtedness could have significant consequences, including:
requiring a substantial portion of our cash flows to be dedicated to debt service payments instead of funding growth, working capital, capital expenditures, investments or other cash requirements;
reducing our flexibility to adjust to changing business conditions or obtain additional financing;
exposing us to the risk of increased interest rates as our borrowings are at variable rates;
making it more difficult for us to make payments on our indebtedness;
subjecting us to restrictive covenants that may limit our flexibility in operating our business, including our ability to take certain actions with respect to indebtedness, liens, sales of assets, consolidations and mergers, affiliate transactions, dividends and other distributions and changes of control;
subjecting us to maintenance covenants which require us to maintain specific financial ratios; and
limiting our ability to obtain additional financing for working capital, capital expenditures, debt service requirements and general corporate or other purposes.
If our cash from operations is not sufficient to meet our current or future operating needs, expenditures and debt service obligations, our business, financial condition and results of operations may be materially and adversely affected.
We may require additional cash resources due to changed business conditions or other future developments, including any marketing initiatives, investments or additional acquisitions we may decide to pursue. To the extent we are unable to generate sufficient cash flow, we may be forced to cancel, reduce or delay these activities. Alternatively, if our sources of funding are insufficient to satisfy our cash requirements, we may seek to obtain an additional credit facility or sell equity or debt securities. The sale of equity securities would result in dilution of our existing stockholders. The incurrence of additional indebtedness would result in increased debt service obligations and operating and financing covenants that could restrict our operations.
Our ability to generate cash to meet our operating needs, expenditures and debt service obligations will depend on our future performance and financial condition, which will be affected by financial, business, economic, legislative, regulatory and other factors, including potential changes in costs, pricing, the success of product innovation and marketing, competitive pressure and consumer preferences. If our cash flows and capital resources are insufficient to fund our debt service obligations and other cash needs, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional debt or equity capital or restructure or refinance our indebtedness. Our credit facilities may restrict our ability to take these actions, and we may not be able to affect any such alternative measures on commercially reasonable terms, or at all. If we cannot make scheduled payments on our debt, the lenders under the Amended Credit Agreement can terminate their commitments to loan money under the Amended Revolving Credit Facility, and our lenders under the Amended Credit Agreement can declare all outstanding principal and interest to be due and payable and foreclose against the assets securing their borrowings, and we could be forced into bankruptcy or liquidation.
Furthermore, it is uncertain whether financing will be available in amounts or on terms acceptable to us, if at all, which could materially and adversely affect our business, financial condition and results of operations.
Changes in tax law, in our tax rates or in exposure to additional income tax liabilities or assessments could materially and adversely affect our business, financial condition and results of operations.
We are subject to the income tax laws of the United States and several international jurisdictions. Changes in law and policy relating to taxes, including changes in administrative interpretations and legal precedence, could materially and adversely affect our business, financial condition and results of operations.
In addition, as we continue to expand our business internationally, the application and implementation of existing, new or future international laws could materially and adversely affect our business, financial condition and results of operations. Current economic and political conditions make tax rules in any jurisdiction, including those in which we operate, subject to significant change.
38

Fluctuations in currency exchange rates may negatively affect our financial condition and results of operations.
Exchange rate fluctuations may affect the costs that we incur in our operations. The main currencies to which we are exposed are the Euro, British pound, Chinese Renminbi and Canadian dollar. The exchange rates between these currencies and the US dollar in recent years have fluctuated significantly and may continue to do so in the future. A depreciation of these currencies against the US dollar will decrease the US dollar equivalent of the amounts derived from foreign operations reported in our consolidated financial statements, and an appreciation of these currencies will result in a corresponding increase in such amounts. The cost of certain items, such as raw materials, manufacturing, employee compensation and benefits and transportation and freight, required by our operations may be affected by changes in the value of the relevant currencies.
To the extent that we are required to pay for goods or services in foreign currencies, the appreciation of such currencies against the US dollar will tend to negatively affect our business. There can be no assurance that foreign currency fluctuations will not have a material adverse effect on our business, financial condition and results of operations.
Risk factors related to our retail customers, consumers and the seasonality of our business
We depend on a limited number of retailers for a large portion of our net sales, and the loss of one or more of these retailers, or business challenges at one or more of these retailers, could adversely affect our results of operations.
A limited number of our retail customers account for a large percentage of our net sales. We expect a small number of retailers will, in the aggregate, continue to account for the majority of our net sales for foreseeable future periods. Any changes in the policies or our ability to meet the demands of our retail customers relating to service levels, inventory de-stocking, pricing and promotional strategies or limitations on access to display space could have a material adverse effect on our business, financial condition and results of operations.
As is typical in our industry, our business with retailers is based primarily upon discrete sales orders, and we do not have contracts requiring retailers to make firm purchases from us. Accordingly, retailers could reduce their purchasing levels or cease buying products from us at any time and for any reason. If we lose a significant retail customer or if sales of our products to a significant retailer materially decrease, it could have a material adverse effect on our business, financial condition and results of operations.
Because a high percentage of our sales are made through our retail customers, our results are subject to risks relating to the general business performance of our key retail customers. Factors that adversely affect our retail customers’ businesses may also have a material adverse effect on our business, financial condition and results of operations. These factors may include:
any reduction in consumer traffic and demand at our retail customers as a result of economic downturns, pandemics or other health crises, changes in consumer preferences or reputational damage as a result of, among other developments, data privacy breaches, regulatory investigations or employee misconduct;
any credit risks associated with the financial condition of our retail customers;
the effect of consolidation or weakness in the retail industry or at certain retail customers, including store closures and the resulting uncertainty; and
inventory reduction initiatives and other factors affecting retail customer buying patterns, including any reduction in retail space committed to beauty products and retailer practices used to control inventory shrinkage.
Our quarterly results of operations fluctuate due to seasonality, order patterns from key retail customers and other factors, and we may not have sufficient liquidity to meet our seasonal working capital requirements.
Our results of operations are subject to seasonal fluctuations, with net sales in the third and fourth fiscal quarters typically being higher than in the first and second fiscal quarters. The higher net sales in our third and fourth fiscal quarters are largely attributable to the increased levels of purchasing by retailers for the holiday season and customer shelf reset activity, respectively. Adverse events that occur during either the third or fourth fiscal quarter could have a disproportionate effect on our results of operations for the entire fiscal year. To support anticipated higher sales during the third and fourth fiscal quarters, we make investments in working capital to ensure inventory levels can support demand.
Fluctuations throughout the year are also driven by the timing of product restocking or rearrangement by our major customers as well as our expansion into new customers. Because a limited number of our retail customers account for a large
39

percentage of our net sales, a change in the order pattern of one or more of our large retail customers could cause a significant fluctuation of our quarterly results or reduce our liquidity.
Furthermore, product orders from our large retail customers may vary over time due to changes in their inventory or out-of-stock policies. If we were to experience a significant shortfall in sales or profitability, we may not have sufficient liquidity to fund our business. As a result of quarterly fluctuations caused by these and other factors, comparisons of our operating results across different fiscal quarters may not be accurate indicators of our future performance. Any quarterly fluctuations that we report in the future may differ from the expectations of market analysts and investors, which could cause the price of our common stock to fluctuate significantly.
Risk factors related to information technology and cybersecurity
We are increasingly dependent on information technology, and if we are unable to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, our operations could be disrupted.
We rely on information technology networks and systems to market and sell our products, to process electronic and financial information, to assist with sales tracking and reporting, to manage a variety of business processes and activities and to comply with regulatory, legal and tax requirements. We are increasingly dependent on a variety of secure information systems to effectively process retail customer orders and fulfill consumer orders from our e-commerce business. We depend on our information technology infrastructure for digital marketing activities and for electronic communications among our personnel, retail customers, consumers, manufacturers and suppliers around the world. These information technology systems, some of which are managed by third parties, may be susceptible to damage, disruptions or shutdowns due to failures during the process of upgrading or replacing software, databases or components, power outages, hardware failures, computer viruses, telecommunication failures, user errors, catastrophic events and data security and privacy threats, cyber and otherwise. If our information technology systems suffer damage, disruption or shutdown, we may incur substantial cost in repairing or replacing these systems, and if we do not effectively resolve the issues in a timely manner, our business, financial condition and results of operations may be materially and adversely affected, and we could experience delays in reporting our financial results.
Data security and privacy threats are becoming increasingly difficult to detect and come from a variety of sources, including traditional computer “hackers,” threat actors, “hacktivists,” personnel (such as through theft or misuse), organized criminal threat actors, sophisticated nation states and nation-state supported actors. Some threat actors now engage and are expected to continue to engage in cyberattacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyberattacks that could materially disrupt our systems and operations. Any material disruption of our systems, or the systems of our third-party service providers, could disrupt our ability to track, record and analyze the products that we sell and could negatively impact our operations, shipment of goods, ability to process financial information and transactions and our ability to receive and process retail customer and e-commerce orders or engage in normal business activities.
Our e-commerce operations are important to our business. Our e-commerce websites and mobile applications serve as an extension of our marketing strategies by introducing potential new consumers to our brand, product offerings and enhanced content. Due to the importance of our e-commerce operations, we are vulnerable to website downtime and other technical failures. Our failure to successfully respond to these risks in a timely manner could reduce e-commerce sales and damage our brands' reputation.
The risks described here are heightened due to the increase in remote working. A portion of our personnel is currently working under our hybrid model of three days in the office and two days remote, while others work remote entirely. It is possible with this model that the execution of our business plans and operations could be negatively impacted. If a natural disaster, power outage, connectivity issue, or other event occurs that impacts our employees’ ability to work remotely, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The increase in remote working may also result in heightened consumer privacy, IT security and fraud concerns, potentially disrupting our operations.
We must continue to maintain and make requisite or critical upgrades to our information technology systems, and our failure to do so could have a material adverse effect on our business, financial condition and results of operations.
We conduct annual penetration testing and vulnerability assessments to identify and address potential security weaknesses in our systems and third-party vendor environments to support expected future growth. As such, we will continue to invest in
40

and implement modifications and upgrades to our information technology systems and procedures, including replacing legacy systems with successor systems, making changes to legacy systems or acquiring new systems with new functionality, hiring employees with information technology expertise and building new policies, procedures, training programs and monitoring tools. We are currently undertaking various technology upgrades and enhancements to support our business growth, including an implementation of SAP software to upgrade our platforms and systems worldwide. These types of activities subject us to inherent costs and risks associated with replacing and changing these systems, including impairment of our ability to leverage our e-commerce channels, fulfill customer orders, potential disruption of our internal control structure, substantial capital expenditures, additional administration and operating expenses, acquisition and retention of sufficiently skilled personnel to implement and operate the new systems, demands on management time and other risks and costs of delays or difficulties in transitioning to or integrating new systems into our current systems.
The implementation of new information technology systems, such as our implementation of SAP software, or any modification of our key information systems may not result in productivity improvements at a level that outweighs the costs of implementation, or at all. In addition, difficulties with implementing new technology systems, delays in our timeline for planned improvements, significant system failures, or our inability to successfully modify our information systems to respond to changes in our business needs may cause disruptions in our business operations and have a material adverse effect on our business, financial condition and results of operations.
If we fail to adopt new technologies or adapt our e-commerce websites and systems to changing consumer requirements or emerging industry standards, our business may be materially and adversely affected.
To remain competitive, we must continue to enhance and improve the responsiveness, functionality and features of our information technology, including our e-commerce websites and mobile applications. Our competitors are continually innovating and introducing new products to increase their consumer base and enhance user experience. As a result, in order to attract and retain consumers and compete against our competitors, we must continue to invest resources to enhance our information technology and improve our existing products and services for our consumers. The Internet and the online retail industry are characterized by rapid technological evolution, changes in consumer requirements and preferences, frequent introductions of new products and services embodying new technologies and the emergence of new industry standards and practices, any of which could render our existing technologies and systems obsolete. Our success will depend, in part, on our ability to identify, develop, acquire or license leading technologies useful in our business, and respond to technological advances and emerging industry standards and practices in a cost-effective and timely way. The development of our e-commerce websites, mobile applications and other proprietary technology entails significant technical and business risks. There can be no assurance that we will be able to properly implement or use new technologies effectively or adapt our e-commerce websites, mobile applications and systems to meet consumer requirements or emerging industry standards. If we are unable to adapt in a cost-effective and timely manner in response to changing market conditions or consumer requirements, whether for technical, legal, financial or other reasons, our business, financial condition and results of operations may be materially and adversely affected.
Failure to protect sensitive information of our consumers and information technology systems against security breaches could damage our reputation and brand and substantially harm our business, financial condition and results of operations.
We collect, maintain, transmit, store and otherwise process data about our consumers, suppliers, prospective and current employees and others, including personal data, financial information, including consumer payment information, as well as other confidential and proprietary information important to our business. We also employ third-party service providers that collect, store, process and transmit personal data, and confidential, proprietary and financial information on our behalf.
We have in place technical and organizational measures to maintain the security and safety of critical proprietary, personal, employee, customer and financial data which we continue to maintain and upgrade to industry standards. However, advances in technology, the pernicious ingenuity of criminals, new exposures via cryptography, acts or omissions by our employees, contractors or service providers or other events or developments could result in a compromise or breach in the security of confidential or personal data. We and our service providers may not be able to prevent third parties, including criminals, competitors or others, from breaking into or altering our systems, disrupting business operations or communications infrastructure through denial-of-service attacks, attempting to gain access to our systems, information or monetary funds through phishing or social engineering campaigns, installing viruses or malicious software on our e-commerce websites or mobile applications or devices used by our employees or contractors, or carrying out other activity intended to disrupt our systems or gain access to confidential or sensitive information in our or our service providers’ systems.
41

We are not aware of any material breach or compromise of the personal data of consumers, but we have been subject to attacks (e.g., phishing, denial of service) in the past and cannot guarantee that our security measures will be sufficient to prevent a material breach or compromise in the future.
Furthermore, such third parties may engage in various other illegal activities using such information, including credit card fraud or identity theft, which may cause additional harm to us, our consumers and our brands. We also may be vulnerable to error or malfeasance by our own employees or other insiders. Third parties may attempt to fraudulently induce our or our service providers’ employees to misdirect funds or to disclose information in order to gain access to personal data we maintain about our consumers or website users. In addition, we have limited control or influence over the security policies or measures adopted by third-party providers of online payment services through which some of our consumers may elect to make payment for purchases at our e-commerce websites and mobile applications. Contracted third-party delivery service providers may also violate their confidentiality or data processing obligations and disclose or use information about our consumers inadvertently or illegally.
If a material security breach were to occur, our reputation and brands could be damaged, and we could be required to expend significant capital and other resources to alleviate problems caused by such breaches including exposure of litigation or regulatory action and a risk of loss and possible liability. Actual or anticipated attacks may cause us to incur increasing costs, including costs to deploy additional personnel and protection technologies, train employees and engage third-party experts and consultants. In addition, any party who is able to illicitly obtain a subscriber’s password could access the subscriber’s financial, transaction or personal information. Any compromise or breach of our security measures, or those of our third-party service providers, may violate applicable privacy, data security, financial, cyber and other laws and cause significant legal and financial exposure, adverse publicity and a loss of confidence in our security measures, all of which could have a material adverse effect on our business, financial condition and results of operations. We may be subject to post-breach review of the adequacy of our privacy and security controls by regulators and other third parties, which could result in post-breach regulatory investigation, fines and consumer litigation as well as regulatory oversight, at significant expense and risking reputational harm.
Furthermore, we are subject to diverse laws and regulations in the United States, the European Union (the “EU”) and other international jurisdictions that require notification to affected individuals in the event of a breach involving personal information. These required notifications can be time-consuming and costly. Furthermore, failure to comply with these laws and regulations could subject us to regulatory scrutiny and additional liability. Although we maintain relevant insurance, we cannot be certain that our insurance coverage will be adequate for all breach related liabilities, that insurance will continue to be available to us on economically reasonable terms, or at all, or that the insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition and results of operations. We may need to devote significant resources to protect against security breaches or to address problems caused by breaches, diverting resources from the growth and expansion of our business.
Payment methods used on our e-commerce websites subject us to third-party payment processing-related risks.
We accept payments from our consumers using a variety of methods, including online payments with credit cards and debit cards issued by major banks, payments made with gift cards processed by third-party providers and payment through third-party online payment platforms such as PayPal, Afterpay and Apple Pay. We also rely on third parties to provide payment processing services. For certain payment methods, including credit and debit cards, we pay interchange and other fees, which may increase over time and raise our operating costs and lower our profit margins. We may also be subject to fraud and other illegal activities in connection with the various payment methods we offer, including online payment options and gift cards. Transactions on our e-commerce websites and mobile applications are card-not-present transactions, so they present a greater risk of fraud. Criminals are using increasingly sophisticated methods to engage in illegal activities such as unauthorized use of credit or debit cards and bank account information. Requirements relating to consumer authentication and fraud detection with respect to online sales are complex. We may ultimately be held liable for the unauthorized use of a cardholder’s card number in an illegal activity and be required by card issuers to pay charge-back fees. Charge-backs result not only in our loss of fees earned with respect to the payment, but also leave us liable for the underlying money transfer amount. If our charge-back rate becomes excessive, card associations also may require us to pay fines or refuse to process our transactions. In addition, we may be subject to additional fraud risk if third-party service providers or our employees
42

fraudulently use consumer information for their own gain or facilitate the fraudulent use of such information. Overall, we may have little recourse if we process a criminally fraudulent transaction.
We are subject to payment card association operating rules, certification requirements and various rules, regulations and requirements governing electronic funds transfers, which could change or be reinterpreted to make it difficult or impossible for us to comply. As our business changes, we may also be subject to different rules under existing standards, which may require new assessments that involve costs above what we currently pay for compliance. If we fail to comply with the rules or requirements of any provider of a payment method we accept, or if the volume of fraud in our transactions limits or terminates our rights to use payment methods we currently accept, or if a data breach occurs relating to our payment systems, among other things, we may be subject to fines and higher transaction fees and lose our ability to accept credit and debit card payments from our consumers, process electronic funds transfers or facilitate other types of online payments, and our reputation and our business, financial condition and results of operations could be materially and adversely affected.
Risk factors related to conducting business internationally
We have significant operations in China, which exposes us to risks inherent in doing business in that country.
We currently source and manufacture a substantial number of our products from third-party suppliers and manufacturers in China. As of December 31, 2023, we had 94 employees in China. With the rapid development of the Chinese economy, the cost of labor has increased and may continue to increase in the future. Our results of operations will be materially and adversely affected if our labor costs, or the labor costs of our suppliers and manufacturers, increase significantly. In addition, we and our manufacturers and suppliers may not be able to find a sufficient number of qualified workers due to the intensely competitive and fluid market for skilled labor in China. Furthermore, pursuant to Chinese labor laws, employers in China are subject to various requirements when signing labor contracts, paying remuneration, determining the term of employees’ probation and unilaterally terminating labor contracts. These labor laws and related regulations impose liabilities on employers and may significantly increase the costs of workforce reductions. If we decide to change or reduce our workforce, these labor laws could limit or restrict our ability to make such changes in a timely, favorable and effective manner. Any of these events may materially and adversely affect our business, financial condition and results of operations.
Operating in China exposes us to political, legal and economic risks. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to operate in China may be adversely affected by changes in the United States and Chinese laws and regulations such as those related to, among other things, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property, currency controls, network security, employee benefits, privacy, hygiene supervision and other matters. For example, in December 2021, the US Congress enacted the Uyghur Forced Labor Prevention Act in an effort to prevent what it views as forced labor and human rights abuses in the Xinjiang Uyghur Autonomous Region (“XUAR”). If it is determined that our third-party suppliers and manufacturers mine, produce or manufacture our products wholly or in part from the XUAR, then we could be prohibited from importing such products into the United States. In addition, we may not obtain or retain the requisite legal permits to continue to operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits. In addition, Chinese trade regulations are in a state of flux, and we may become subject to other forms of taxation, tariffs and duties in China. Furthermore, the third parties we rely on in China may disclose our confidential information or intellectual property to competitors or third parties, which could result in the illegal distribution and sale of counterfeit versions of our products. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.
We are subject to international business uncertainties.
We sell many of our products to customers located outside the United States. In addition, substantially all of our third-party suppliers and manufacturers are located in China and certain other foreign countries. We intend to continue to sell to customers outside the United States and maintain our relationships in China and other foreign countries where we have suppliers and manufacturers. Further, we recently opened an office in the UK and hired a team of employees to support our international expansion, and we are establishing additional relationships in other countries to grow our operations. The substantial up-front investment required, the lack of consumer awareness of our products in jurisdictions outside of the United States, differences in consumer preferences and trends between the United States and other jurisdictions, the risk of inadequate intellectual property protections and differences in packaging, labeling and related laws, rules and regulations are all substantial matters that need to be evaluated prior to doing business in new territories. We cannot be assured that our international efforts will be successful.
43

International sales and increased international operations may be subject to risks such as:
difficulties in staffing and managing foreign operations;
burdens of complying with a wide variety of laws and regulations, including more stringent regulations relating to data privacy and security, particularly in the UK and the EU;
adverse tax effects and foreign exchange controls making it difficult to repatriate earnings and cash;
political and economic instability;
terrorist activities and natural disasters;
trade restrictions;
disruptions or delays in shipments whether due to port congestion, container shortages, labor disputes, product regulations and/or inspections or other factors, natural disasters or health pandemics, or other transportation disruptions;
differing employment practices and laws and labor disruptions;
the imposition of government controls;
an inability to use or to obtain adequate intellectual property protection for our key brands and products;
tariffs and customs duties and the classifications of our goods by applicable governmental bodies;
a legal system subject to undue influence or corruption;
a business culture in which illegal sales practices may be prevalent;
logistics and sourcing; and
military conflicts.
The occurrence of any of these risks could negatively affect our international business and consequently our overall business, financial condition and results of operations.
In addition, the ultimate effects of the UK's withdrawal from the EU (“Brexit”) are still difficult to predict as there remains considerable uncertainty around the impact of post-Brexit regulations as the various agencies interpret the regulations and develop enforcement practices. Changes related to Brexit could subject us to heightened risks in that region, including disruptions to trade and free movement of goods, services and people to and from the UK, disruptions to our employees in the UK and the workforce of our business partners, increased foreign exchange volatility with respect to the British pound and additional legal, political and economic uncertainty. If these actions impacting our international distribution and sales channels result in increased costs for us or our international partners, such changes could result in higher costs to us, adversely affecting our operations, particularly as we expand our international presence in the UK.
The ongoing conflict between Russia and Ukraine has caused, and may continue to cause, negative effects on geopolitical conditions and the global economy, including financial markets, inflation and the global supply chain, which could have an adverse impact on our business, financial condition and results of operations.
In February 2022, Russian military forces launched a full-scale military invasion of Ukraine that has resulted in an ongoing military conflict between the two countries. The length, impact and outcome of the ongoing military conflict in Ukraine is highly unpredictable, and the conflict has caused, and may continue to cause, global political, economic and social instability, and disruptions to the global economy, financial systems, international trade, the global supply chain and the transportation and energy sectors, among others.
Russia’s recognition of two separatist republics in the Donetsk and Luhansk regions of Ukraine and subsequent military action against Ukraine have led to an unprecedented expansion of sanction programs imposed by the United States, the EU, the UK,
44

Canada, Switzerland, Japan and other countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People’s Republic and the so-called Luhansk People’s Republic. In retaliation against new international sanctions and as part of measures to stabilize and support the volatile Russian financial and currency markets, Russian authorities imposed significant currency control measures aimed at restricting the outflow of foreign currency and capital from Russia, imposed various restrictions on transacting with non-Russian parties, banned exports of various products and other economic and financial restrictions. The situation is rapidly evolving as a result of the conflict in Ukraine, and the United States, the EU, the UK and other countries may implement additional sanctions, export controls or other measures against Russia, Belarus and other countries, regions, officials, individuals or industries in the respective territories. Such sanctions and other measures, as well as the existing and potential further responses from Russia or other countries to such sanctions, tensions and military actions, could adversely affect the global economy and financial markets and could adversely affect our business, financial condition and results of operations. In addition, it is possible that the conflict could expand beyond its current scope and involve additional countries and regions.
We continue to monitor the situation in Ukraine and are assessing its impact on our business, including our business partners and customers. We do not sell our products in Russia and, to date, we have not experienced any material interruptions in our infrastructure, supplies, technology systems or networks needed to support our operations. We have no way to predict the progress or outcome of the conflict in Ukraine, whether it will expand or its impacts in Ukraine, Russia, Europe, the United States or the rest of the world as the conflict, and any resulting government reactions, are rapidly developing and beyond our control. The extent and duration of the military action, sanctions and resulting market disruptions could be significant and could potentially have substantial impact on the global economy and our business for an unknown period of time. Any of the above-mentioned factors could affect our business, financial condition and results of operations.
Risk factors related to evolving laws and regulations and compliance with laws and regulations
New laws, regulations, enforcement trends or changes in existing regulations governing the introduction, marketing and sale of our products to consumers could harm our business.
There has been an increase in regulatory activity and activism in the United States and abroad, and the regulatory landscape is becoming more complex with increasingly strict requirements. If this trend continues, we may find it necessary to alter some of the ways we have traditionally manufactured and marketed our products in order to stay in compliance with a changing regulatory landscape, and this could add to the costs of our operations and have an adverse impact on our business. To the extent federal, state, local or foreign regulatory changes regarding consumer protection, or the ingredients, claims or safety of our products occur in the future, they could require us to reformulate or discontinue certain of our products, revise the product packaging or labeling, or adjust operations and systems, any of which could result in, among other things, increased costs, delays in product launches, product returns or recalls and lower net sales, and therefore could have a material adverse effect on our business, financial condition and results of operations. Noncompliance with applicable regulations could result in enforcement action by the FDA or other regulatory authorities within or outside the United States, including but not limited to product seizures, injunctions, product recalls and criminal or civil monetary penalties, all of which could have a material adverse effect on our business, financial condition and results of operations.
In the United States, with the exception of color additives, the FDA does not currently require pre-market approval for products intended to be sold as cosmetics. However, the FDA may in the future require pre-market authorization for certain cosmetic products, establishments or manufacturing facilities. Moreover, such products could also be regulated as both drugs and cosmetics simultaneously, as the categories are not mutually exclusive. The statutory and regulatory requirements applicable to drugs are extensive and require significant resources and time to ensure compliance. For example, if any of our products intended to be sold as cosmetics were to be regulated as drugs, we might be required to conduct, among other things, clinical trials to demonstrate the safety and efficacy of these products. We may not have sufficient resources to conduct any required clinical trials or to ensure compliance with the manufacturing requirements applicable to drugs. If the FDA determines that any of our products intended to be sold as cosmetics should be classified and regulated as drug products and we are unable to comply with applicable drug requirements, we may be unable to continue to market those products. Any inquiry into the regulatory status of our cosmetics and any related interruption in the marketing and sale of these products could damage our reputation and image in the marketplace.
In recent years, the FDA has issued warning letters to several cosmetic companies alleging improper claims regarding their cosmetic products. If the FDA determines that we have disseminated inappropriate drug claims for our products intended to be sold as cosmetics, we could receive a warning or untitled letter, be required to modify our product claims or take other actions to satisfy the FDA. In addition, plaintiffs’ lawyers have filed class action lawsuits against cosmetic companies after receipt of these types of FDA warning letters. There can be no assurance that we will not be subject to state and federal government actions or class action lawsuits, which could harm our business, financial condition and results of operations.
45

Additional state and federal requirements may be imposed on consumer products as well as cosmetics, cosmetic ingredients, or the labeling and packaging of products intended for use as cosmetics. For example, on December 29, 2022, Congress enacted the Modernization of Cosmetics Regulation Act of 2022 (“MoCRA”). MoCRA created new compliance requirements for manufacturers of cosmetic products in the United States and also significantly expanded the FDA's authority to oversee and regulate cosmetics. Under MoCRA, companies must comply with new requirements for cosmetics, such as new labeling requirements for certain products, safety substantiation, facility registration, product listing, adverse event reporting, good manufacturing practice (“GMP”) requirements and mandatory recalls. In addition, MoCRA provided FDA with new enforcement authorities over cosmetics, such as the ability to initiate mandatory recalls and to obtain access certain product records. Many of the requirements were scheduled to become applicable on December 29, 2023, with some of the requirements, such as those relating to labeling, scheduled to become applicable later in 2024 and 2025; however, on November 8, 2023, the FDA advised that it does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing until July 1, 2024 to provide regulated industry additional time to comply with the requirements.
In either case, although the FDA is required under MoCRA to propose mandatory GMPs for cosmetics by July 1, 2024, and although parties that operate facilities engaged in the manufacturing or processing of cosmetic products are required to register such facilities and submit product listing information to FDA by the same deadline, the FDA has yet to propose implementing regulations for MoCRA. As such, we are unable to ascertain at this time the full impact that complying with MoCRA will have on our business. Compliance with the new requirements may further increase the cost of manufacturing certain of our products and could have a material adverse effect on our business, financial condition and results of operations.
We also sell a number of products as over-the-counter (“OTC”) drug products, which are subject to the FDA OTC drug regulatory requirements because they are intended to be used as sunscreen or to treat acne. The FDA regulates the formulation, manufacturing, packaging and labeling of OTC drug products. Our sunscreen and acne drug products are regulated pursuant to FDA OTC drug monographs that specify acceptable active drug ingredients and acceptable product claims that are generally recognized as safe and effective for particular uses. If any of these products that are marketed as OTC drugs are not in compliance with the applicable FDA monograph, we may be required to reformulate the product, stop making claims relating to such product or stop selling the product until we are able to obtain costly and time-consuming FDA approvals. We are also required to submit adverse event reports to the FDA for our OTC drug products, and failure to comply with this requirement may subject us to FDA regulatory action.
We also sell a number of consumer products, which are subject to regulation by the CPSC in the United States under the provisions of the Consumer Product Safety Act, as amended by the Consumer Product Safety Improvement Act of 2008. These statutes and the related regulations ban from the market consumer products that fail to comply with applicable product safety laws, regulations and standards. The CPSC has the authority to require the recall, repair, replacement or refund of any such banned products or products that otherwise create a substantial risk of injury and may seek penalties for regulatory noncompliance under certain circumstances. The CPSC also requires manufacturers of consumer products to report certain types of information to the CPSC regarding products that fail to comply with applicable regulations. Certain state laws also address the safety of consumer products, and mandate reporting requirements, and noncompliance may result in penalties or other regulatory action.
Our products are also subject to state laws and regulations, such as the California Safe Drinking Water and Toxic Enforcement Act, also known as “Prop 65,” and failure to comply with such laws may also result in lawsuits and regulatory enforcement that could have a material adverse effect on our business, financial condition and results of operations. We are, and may in the future be, involved in litigation related to such state laws and regulations.
Our facilities and those of our third-party manufacturers are subject to regulation under the Federal Food, Drug and Cosmetic Act (“FDCA”) and FDA implementing regulations.
Our facilities and those of our third-party manufacturers are subject to regulation under the FDCA and FDA implementing regulations. The FDA may inspect all of our facilities and those of our third-party manufacturers periodically to determine if we and our third-party manufacturers are complying with provisions of the FDCA and FDA regulations. In addition, third-party manufacturer’s facilities for manufacturing OTC drug products must comply with the FDA’s current GMP (“cGMP”) requirements for drug products that require us and our manufacturers to maintain, among other things, good manufacturing processes, including stringent vendor qualifications, ingredient identification, manufacturing controls and record keeping.
Our operations could be harmed if regulatory authorities make determinations that we, or our vendors, are not in compliance with these regulations. If the FDA finds a violation of cGMPs, it may enjoin our manufacturer’s operations, seize product, restrict importation of goods, and impose administrative, civil or criminal penalties. If we or our third-party manufacturers fail
46

to comply with applicable regulatory requirements, we could be required to take costly corrective actions, including suspending manufacturing operations, changing product formulations, suspending sales, or initiating product recalls. In addition, compliance with these regulations has increased and may further increase the cost of manufacturing certain of our products as we work with our vendors to ensure they are qualified and in compliance. For example, under MoCRA, manufacturers of cosmetic products in the United States will become subject to mandatory GMP requirements. Although the FDA has yet to establish or implement regulations for such GMP requirements, third-party manufacturers of our cosmetic products may be slow or unable to adapt to these forthcoming regulations, which may require us to find alternative suppliers for our products. Any of these outcomes could have a material adverse effect on our business, financial condition and results of operations.
Government regulations and private party actions relating to the marketing and advertising of our products and services may restrict, inhibit or delay our ability to sell our products and harm our business, financial condition and results of operations.
Government authorities regulate advertising and product claims regarding the performance and benefits of our products. These regulatory authorities typically require a reasonable basis to support any marketing claims. What constitutes a reasonable basis for substantiation can vary widely from market to market, and there is no assurance that the efforts that we undertake to support our claims will be deemed adequate for any particular product or claim. A significant area of risk for such activities relates to improper or unsubstantiated claims about our products and their use or safety. If we are unable to show adequate substantiation for our product claims, or our promotional materials make claims that exceed the scope of allowed claims for the classification of the specific product, whether cosmetics, OTC drug products or other consumer products that we offer, the FDA, the FTC or other regulatory authorities could take enforcement action or impose penalties, such as monetary consumer redress, requiring us to revise our marketing materials, amend our claims or stop selling certain products, all of which could harm our business, financial condition and results of operations. Any regulatory action or penalty could lead to private party actions, or private parties could seek to challenge our claims even in the absence of formal regulatory actions which could harm our business, financial condition and results of operations.
Our business is subject to complex and evolving US and foreign laws and regulations regarding privacy and data protection. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased costs of operations or otherwise harm our business, financial condition and results of operations.
We are subject to a variety of laws and regulations in the United States and abroad regarding privacy and data protection, some of which can be enforced by private parties or government entities and some of which provide for significant penalties for non-compliance. Such laws and regulations restrict how personal information is collected, processed, stored, used and disclosed, as well as set standards for its security, implement notice requirements regarding privacy practices, and provide individuals with certain rights regarding the use, disclosure, and sale of their protected personal information.
For example, the California Consumer Privacy Act (the “CCPA”) requires certain disclosures to California residents regarding a business’s data processing activities, affords California consumers rights with respect to their personal information (including the rights related to access to and deletion of personal information, and the right to opt out of certain disclosures of their personal information), and establishes significant penalties for noncompliance. The California Privacy Rights Act (the “CPRA”), which took effect on January 1, 2023, significantly expands the CCPA, including by introducing additional obligations such as data minimization and retention requirements, granting additional rights to California residents such as correction of personal information and additional opt-out rights, and creating a new regulatory authority, the California Privacy Protection Agency, to implement and enforce the law. Comprehensive privacy legislation imposing similar obligations have been passed in several states and took effect in Virginia, Colorado, Connecticut and Utah in 2023. Following this trend, several other states are considering enacting data protection legislation that may impose significant obligations and restrictions. Additionally, there is discussion in Congress of a new comprehensive federal data protection law. The enactment of such laws could create conflicting requirements, compliance with which could result in additional compliance costs. The effects of these laws are potentially significant and may require us to modify our data collection or processing practices and policies and to incur substantial costs and expenses in an effort to comply, and increase our potential exposure to regulatory enforcement and/or litigation.
In addition, the UK General Data Protection Regulation and Data Protection Act 2018 (collectively, the “UK GDPR”) and the EU’s General Data Protection Regulation (the “EU GDPR”) (the EU GDPR and UK GDPR together referred to as the “GDPR”) impose comprehensive data privacy compliance obligations in relation to the collection, processing, sharing, disclosure, transfer and other use of data relating to an identifiable living individual, including a principle of accountability and the obligation to demonstrate compliance through policies, procedures, training and audits. Failure to comply with the UK GDPR
47

or the GDPR could result in penalties for noncompliance of up to the greater of GBP 17.5 million/EUR 20 million (as applicable) or 4% of our global annual turnover, and companies can be fined under each of these regimes independently with respect to the same violation. In addition to fines, a violation of the UK GDPR or the GDPR may result in regulatory investigations, reputational damage, orders to cease/change data processing activities, enforcement notices, assessment notices (for a compulsory audit) and/or civil claims (including class actions).
We are also subject, under the GDPR, to restrictions on cross-border transfers of personal data out of the European Economic Area (the “EEA”) where recent legal developments have created complexity and uncertainty regarding transfers of personal data outside the EEA and the UK, including to the United States. We rely on the standard contractual clauses (“SCCs”) to transfer data outside of the EEA/ UK in some situations; however, the Court of Justice of the European Union (“CJEU”) has stated that reliance on the SCCs alone may not be sufficient. On October 7, 2022, President Biden signed an Executive Order on ‘Enhancing Safeguards for United States Intelligence Activities’ which introduced new redress mechanisms and binding safeguards to address some of the concerns raised by the CJEU. We expect the existing legal complexity and uncertainty regarding international personal data transfers to continue. Some European regulators have prevented companies from transferring personal data out of the EEA for allegedly violating the EU GDPR’s cross—border transfer rules. As supervisory authorities issue further guidance on personal data export mechanisms, including circumstances where the SCCs cannot be used, and/or continue to take enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results.
Data privacy continues to remain a matter of interest to lawmakers and regulators. In the United States, a number of privacy-related proposals (including proposed comprehensive privacy legislation) are pending before federal and state legislative and regulatory bodies and additional laws and regulations have been passed but are not yet effective, all of which could significantly affect our business. The same may be true outside the United States, where various jurisdictions have enacted or are considering comprehensive data protection legislation. Additionally, at the federal level in the United States, various bills have been introduced to enact comprehensive federal privacy legislation, though to date none of these efforts have been successful. If comprehensive privacy legislation is enacted at the federal level in the United States, this could lead to additional costs and increase our overall risk exposure.
We are also subject to evolving privacy laws on cookies, tracking technologies and e-marketing. Regulation of cookies and similar technologies may lead to broader restrictions on our marketing and personalization activities and may negatively impact our efforts to understand consumers’ Internet usage, online shopping and other relevant online behaviors, as well as the effectiveness of our marketing and our business generally. Such regulations, including uncertainties about how well the advertising technology ecosystem can adapt to legal changes around the use of tracking technologies, may have a negative effect on businesses, including ours, that collect and use online usage information for consumer acquisition and marketing. We may also be subject to fines and penalties for non-compliance with any such laws and regulations. The decline of cookies or other online tracking technologies as a means to identify and target potential purchasers may increase the cost of operating our business and lead to a decline in revenues. In addition, legal uncertainties about the legality of cookies and other tracking technologies may increase regulatory scrutiny and increase potential civil liability under data protection or consumer protection laws.
Compliance with existing, forthcoming, and proposed privacy and data protection laws and regulations can be costly and can delay or impede our ability to market and sell our products, impede our ability to conduct business through websites and mobile applications we and our partners may operate, require us to modify or amend our information practices and policies, change and limit the way we use consumer information in operating our business, cause us to have difficulty maintaining a single operating model, result in negative publicity, increase our operating costs, require significant management time and attention, or subject us to inquiries or investigations, claims or other remedies, including significant fines and penalties, or demands that we modify or cease existing business practices. In addition, if our privacy or data security measures fail to comply with applicable current or future laws and regulations, we may be subject to litigation, regulatory investigations, enforcement notices requiring us to change the way we use personal data or our marketing practices, fines or other liabilities, as well as negative publicity and a potential loss of business. We may also face civil claims including representative actions and other class action type litigation (where individuals have suffered harm), potentially amounting to significant compensation or damages liabilities, as well as associated costs, and diversion of internal resources. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.
48

Failure to comply with the US Foreign Corrupt Practices Act, other applicable anti-corruption and anti-bribery laws, and applicable trade control laws could subject us to penalties and other adverse consequences.
We currently source and manufacture a substantial number of our products from third-party suppliers and manufacturers located outside of the United States, and we have an office in China from which we manage our international supply chain. We sell our products in several countries outside of the United States, including through distributors. Our operations are subject to the US Foreign Corrupt Practices Act (the “FCPA”), as well as the anti-corruption and anti-bribery laws in the countries where we do business. The FCPA prohibits covered parties from offering, promising, authorizing or giving anything of value, directly or indirectly, to a “foreign government official” with the intent of improperly influencing the official’s act or decision, inducing the official to act or refrain from acting in violation of lawful duty, or obtaining or retaining an improper business advantage. The FCPA also requires publicly traded companies to maintain records that accurately and fairly represent their transactions, and to have an adequate system of internal accounting controls. In addition, other applicable anti-corruption laws prohibit bribery of domestic government officials, and some laws that may apply to our operations prohibit commercial bribery, including giving or receiving improper payments to or from non-government parties, as well as so-called “facilitation” payments. In addition, we are subject to United States and other applicable trade control regulations that restrict with whom we may transact business, including the trade sanctions enforced by the US Treasury, Office of Foreign Assets Control.
While we have implemented policies, internal controls and other measures reasonably designed to promote compliance with applicable anti-corruption and anti-bribery laws and regulations, and certain safeguards designed to ensure compliance with US trade control laws, our employees or agents may engage in improper conduct for which we might be held responsible. Any violations of these anti-corruption or trade controls laws, or even allegations of such violations, can lead to an investigation and/or enforcement action, which could disrupt our operations, involve significant management distraction, and lead to significant costs and expenses, including legal fees. If we, or our employees or agents acting on our behalf, are found to have engaged in practices that violate these laws and regulations, we could suffer severe fines and penalties, profit disgorgement, injunctions on future conduct, securities litigation, bans on transacting government business, delisting from securities exchanges and other consequences that may have a material adverse effect on our business, financial condition and results of operations. In addition, our brands and reputation, our sales activities or our stock price could be adversely affected if we become the subject of any negative publicity related to actual or potential violations of anti-corruption, anti-bribery or trade control laws and regulations.
Government regulation of the Internet and e-commerce is evolving, and unfavorable changes or failure by us to comply with these regulations could substantially harm our business, financial condition and results of operations.
We are subject to general business regulations and laws as well as regulations and laws specifically governing the Internet and e-commerce. Existing and future regulations and laws could impede the growth of the Internet, e-commerce or mobile commerce. These regulations and laws may involve taxes, tariffs, privacy and data security, anti-spam, content protection, electronic contracts and communications, consumer protection, social media marketing, third-party cookies, web beacons and similar technology for online behavioral advertising and gift cards. It is not clear how existing laws governing issues such as property ownership, sales taxes and other taxes and consumer privacy apply to the Internet as the vast majority of these laws were adopted prior to the advent of the Internet and do not contemplate or address the unique issues raised by the Internet or e-commerce. It is possible that general business regulations and laws, or those specifically governing the Internet or e-commerce, may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules or our practices. We cannot be sure that our practices have complied, comply or will comply fully with all such laws and regulations. Any failure, or perceived failure, by us to comply with any of these laws or regulations could result in damage to our reputation, a loss in business and proceedings or actions against us by governmental entities or others. Any such proceeding or action could hurt our reputation, force us to spend significant amounts in defense of these proceedings, distract our management, increase our costs of doing business and decrease the use of our sites by consumers and suppliers and may result in the imposition of monetary liability. We may also be contractually liable to indemnify and hold harmless third parties from the costs or consequences of non-compliance with any such laws or regulations. In addition, it is possible that governments of one or more countries may seek to censor content available on our sites or may even attempt to completely block access to our sites. Adverse legal or regulatory developments could substantially harm our business. In particular, in the event that we are restricted, in whole or in part, from operating in one or more countries, our ability to retain or increase our consumer base may be adversely affected, and we may not be able to maintain or grow our net sales and expand our business as anticipated.
49

Risk factors related to legal and regulatory proceedings
We are involved, and may become involved in the future, in disputes and other legal or regulatory proceedings that, if adversely decided or settled, could materially and adversely affect our business, financial condition and results of operations.
We are, and may in the future become, party to litigation, regulatory proceedings or other disputes. In general, claims made by or against us in disputes and other legal or regulatory proceedings can be expensive and time consuming to bring or defend against, requiring us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. These potential claims include, but are not limited to, personal injury claims, class action lawsuits, intellectual property claims, privacy claims, employment litigation and regulatory investigations and causes of action relating to the advertising and promotional claims about our products. Any adverse determination against us in these proceedings, or even the allegations contained in the claims, regardless of whether they are ultimately found to be without merit, may also result in settlements, injunctions or damages that could have a material adverse effect on our business, financial condition and results of operations.
We may be required to recall products and may face product liability claims, either of which could result in unexpected costs and damage our reputation.
We sell products for human use. Our products intended for use as cosmetics or skincare are not generally subject to pre-market approval or registration processes, so we cannot rely upon a government safety panel to qualify or approve our products for use. A product may be safe for the general population when used as directed but could cause an adverse reaction for a person who has a health condition or allergies, or who is taking a prescription medication. While we include what we believe are adequate instructions and warnings and we have historically had low numbers of reported adverse reactions, previously unknown adverse reactions could occur. If we discover that any of our products are causing adverse reactions, we could suffer adverse publicity or regulatory/government sanctions.
Potential product liability risks may arise from the testing, manufacture and sale of our products, including that the products fail to meet quality or manufacturing specifications, contain contaminants, include inadequate instructions as to their proper use, include inadequate warnings concerning side effects and interactions with other substances or for persons with health conditions or allergies, or cause adverse reactions or side effects. Product liability claims could increase our costs, and adversely affect our business, financial condition and results of operations. As we continue to offer an increasing number of new products, our product liability risk may increase. It may be necessary for us to recall products that do not meet approved specifications or because of the side effects resulting from the use of our products, which would result in adverse publicity, potentially significant costs in connection with the recall and could have a material adverse effect on our business, financial condition and results of operations.
In addition, plaintiffs in the past have received substantial damage awards from other cosmetic and drug companies based upon claims for injuries allegedly caused by the use of their products. Although we currently maintain general liability insurance, any claims brought against us may be subject to policy exclusions or exceed our existing or future insurance policy coverage or limits. Any judgment against us that is not covered or in excess of our policy coverage or limits would have to be paid from our cash reserves, which would reduce our capital resources. In addition, we may be required to pay higher premiums and accept higher deductibles in order to secure adequate insurance coverage in the future. Further, we may not have sufficient capital resources to pay a judgment, in which case our creditors could levy against our assets. Any product liability claim or series of claims brought against us could harm our business significantly, particularly if a claim were to result in adverse publicity or damage awards outside or in excess of our insurance policy limits.
Risk factors related to intellectual property
If we are unable to protect our intellectual property, the value of our brands and other intangible assets may be diminished, and our business may be adversely affected.
We rely on trademark, copyright, trade secret, patent and other laws protecting proprietary rights, nondisclosure and confidentiality agreements and other practices, to protect our brands and proprietary information, technologies and processes. Our primary trademarks include “e.l.f.,” "e.l.f. SKIN," “Naturium,” “e.l.f. eyes lips face,” “Well People,” and “Keys Soulcare,” all of which are registered or have registrations pending in the United States and in many other countries or registries. Our trademarks are valuable assets that support our brands and consumers’ perception of our products. Although we have existing and pending trademark registrations for our brands in the United States and in many of the foreign countries in which we operate, we may not be successful in asserting trademark or trade name protection in all jurisdictions.
50

We also have not applied for trademark protection in all relevant foreign jurisdictions and cannot assure you that our pending trademark applications will be approved. Third parties may also attempt to register our trademarks abroad in jurisdictions where we have not yet applied for trademark protection, oppose our trademark applications domestically or abroad, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products in some parts of the world, which could result in the loss of brand recognition and could require us to devote resources to advertising and marketing new brands.
We have limited patent protection, which limits our ability to protect our products from competition. We primarily rely on know-how to protect our products. It is possible that others will independently develop the same or similar know-how, which may allow them to sell products similar to ours. If others obtain access to our know-how, our confidentiality agreements may not effectively prevent disclosure of our proprietary information, technologies and processes and may not provide an adequate remedy in the event of unauthorized use of such information, which could harm our competitive position. Furthermore, advances in artificial intelligence technology may generate intellectual property developments, which existing intellectual property laws may not adequately protect and which may also give rise to a proliferation of infringement which we may not be able to address effectively.
The efforts we have taken to protect our proprietary rights may not be sufficient or effective. In addition, effective trademark, copyright, patent and trade secret protection may be unavailable or limited for certain of our intellectual property in some foreign countries. Other parties may infringe our intellectual property rights and may dilute our brands in the marketplace. We may need to engage in litigation or other activities to enforce our intellectual property rights, to protect our trade secrets or to determine the validity and scope of proprietary rights of others. Any such activities could require us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. If we fail to protect our intellectual property or other proprietary rights, our business, financial condition and results of operations may be materially and adversely affected.
Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of third parties.
Our commercial success depends in part on our ability to operate without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights, trade secrets and other proprietary rights of others. We cannot be certain that the conduct of our business does not and will not infringe, misappropriate or otherwise violate such rights. From time to time we receive allegations of intellectual property infringement and third parties have filed claims against us with allegations of intellectual property infringement. We are, and may in the future be, subject to third-party claims of intellectual property infringement. In addition, third parties may involve us in intellectual property disputes as part of a business model or strategy to gain competitive advantage.
As we gain greater visibility and market exposure as a public company and otherwise, we also face a greater risk of being the subject of such claims and litigation. For these and other reasons, third parties may allege that our products or activities infringe, misappropriate, dilute or otherwise violate their trademark, patent, copyright or other proprietary rights. Defending against allegations and litigation could be expensive, occupy significant amounts of time, divert management’s attention from other business concerns and have an adverse impact on our ability to bring products to market. In addition, if we are found to infringe, misappropriate, dilute or otherwise violate third-party trademark, patent, copyright or other proprietary rights, our ability to use brands to the fullest extent we plan may be limited, we may need to obtain a license, which may not be available on commercially reasonable terms, or at all, or we may need to redesign or rebrand our marketing strategies or products, which may not be possible.
We may also be required to pay substantial damages or be subject to an order prohibiting us and our retail customers from importing or selling certain products or engaging in certain activities. Our inability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and proprietary rights of others could have a material adverse effect on our business, financial condition and results of operations.
Our agreement with Alicia Keys for our Keys Soulcare brand may be terminated if specified conditions are not met.
We have an agreement with Alicia Keys regarding our Keys Soulcare brand, which, among other things, includes a license for her likeness and imposes various obligations on us. If we breach our obligations, our rights under the agreement could be terminated by Alicia Keys and we could, among other things, have to pay damages, lose our ability to associate the Keys Soulcare brand with her, lose our ability to sell products branded as Keys Soulcare, lose any upfront investments made in connection with the Keys Soulcare brand, and sustain reputational damage. Each of these risks could have an adverse effect on our business, results of operations and financial condition.
51

Risk factors related to marketing activities
Use of social media may materially and adversely affect our reputation or subject us to fines or other penalties, and any failure in our marketing efforts through our social media presence could materially and adversely affect our business, financial condition and results of operations.
We rely to a large extent on our online presence to reach consumers, and we offer consumers the opportunity to rate and comment on our products on our e-commerce websites and mobile applications. Negative commentary or false statements regarding us or our products may be posted on our e-commerce websites, mobile applications, or social media platforms and may be harmful to our reputation or business. Our target consumers often value readily available information and may act on such information without further investigation and without regard to its accuracy. The harm may be immediate without affording us an opportunity for redress or correction. In addition, we may face claims relating to information that is published or made available through the interactive features of our e-commerce websites and mobile applications. For example, we may receive third-party complaints that the comments or other content posted by users on our platforms infringe third-party intellectual property rights or otherwise infringe the legal rights of others. While the Communications Decency Act and Digital Millennium Copyright Act generally protect online service providers from claims of copyright infringement or other legal liability for the self-directed activities of its users, if it were determined that we did not meet the relevant safe harbor requirements under either law, we could be exposed to claims related to advertising practices, defamation, intellectual property rights, rights of publicity and privacy, and personal injury torts. We could incur significant costs investigating and defending such claims and, if we are found liable, significant damages. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.
We also use third-party social media platforms as marketing tools. For example, we maintain Snapchat, Facebook, TikTok, X (formerly Twitter), Roblox, Twitch, Pinterest, Instagram and YouTube accounts. As e-commerce and social media platforms continue to rapidly evolve, we must continue to maintain a presence on these platforms and establish presences on new or emerging popular social media platforms. If we are unable to cost-effectively use social media platforms as marketing tools, our ability to acquire new consumers and our financial condition may suffer. Generally, the opportunities in and sophistication of newer advertising channels are relatively undeveloped and unproven, and there can be no assurance that we will be able to continue to appropriately manage and fine-tune our marketing efforts in response to these and other trends in the advertising industry. Furthermore, these newer advertising channels often change rapidly and can be subject to disruptions for reasons beyond our control. For example, lawmakers in the United States, Europe and Canada have recently escalated efforts to restrict access to TikTok. While a US judge in November 2023 blocked Montana’s first-of-its-kind proposed state ban of TikTok, other states, governmental bodies and institutions have voiced concerns that TikTok poses a national security threat and may pursue similar prohibitions. As laws and regulations rapidly evolve to govern the use of these platforms and devices, the failure by us, our employees or third parties acting at our direction to abide by applicable laws and regulations in the use of these platforms and devices could subject us to regulatory investigations, class action lawsuits, liability, fines or other penalties and have a material adverse effect on our business, financial condition and result of operations. Any failure to successfully manage our marketing efforts on, or disruptions to, social media channels that we have come to depend on for marketing could materially adversely affect our business, financial condition and results of operations.
In addition, an increase in the use of social media for product promotion and marketing may cause an increase in the burden on us to monitor compliance of such materials and increase the risk that such materials could contain problematic product or marketing claims in violation of applicable regulations.
Our business relies heavily on email and other messaging services, and any restrictions on the sending of emails or messages or an inability to timely deliver such communications could materially adversely affect our net revenue and business.
Our business is highly dependent upon email and other messaging services for promoting our brands, products and e-commerce platforms. We provide emails, text messages and “push” communications to inform consumers of new products, shipping specials and other promotions. We believe these messages are an important part of our consumer experience. If we are unable to successfully deliver emails or other messages to our subscribers, or if subscribers decline to open or read our messages, our business, financial condition and results of operations may be materially adversely affected. Changes in how web and mail services block, organize and prioritize email may reduce the number of subscribers who receive or open our emails. For example, Google’s Gmail service has a feature that organizes incoming emails into categories (for example, primary, social and promotions).
52

Such categorization or similar inbox organizational features may result in our emails being delivered in a less prominent location in a subscriber’s inbox or viewed as “spam” by our subscribers and may reduce the likelihood of that subscriber reading our emails. Actions by third parties to block, impose restrictions on or charge for the delivery of emails or other messages could also adversely impact our business. From time to time, Internet service providers or other third parties may block bulk email transmissions or otherwise experience technical difficulties that result in our inability to successfully deliver emails or other messages to consumers.
Changes in the laws or regulations that limit our ability to send such communications or impose additional requirements upon us in connection with sending such communications would also materially adversely impact our business. For example, electronic marketing and privacy requirements in the EU and the UK are highly restrictive and differ greatly from those in the United States, which could cause fewer of individuals in the EU or the UK to subscribe to our marketing messages and drive up our costs and risk of regulatory oversight and fines if we are found to be non-compliant.
Our use of email and other messaging services to send communications to consumers may also result in legal claims against us, which may cause us increased expenses, and if successful might result in fines and orders with costly reporting and compliance obligations or might limit or prohibit our ability to send emails or other messages. We also rely on social networking messaging services to send communications and to encourage consumers to send communications. Changes to the terms of these social networking services to limit promotional communications, any restrictions that would limit our ability or our consumers’ ability to send communications through their services, disruptions or downtime experienced by these social networking services or decline in the use of or engagement with social networking services by consumers could materially and adversely affect our business, financial condition and results of operations.
Risk factors relating to our stockholders and ownership of our common stock
Our business could be negatively impacted by corporate citizenship and sustainability matters.
There is an increased focus from certain investors, customers, consumers, employees, and other stakeholders concerning corporate citizenship and sustainability matters. From time to time, we may announce certain initiatives, including goals, regarding our focus areas, which include environmental matters, packaging, responsible sourcing and social investments. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in accurately reporting our progress on such initiatives and goals. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Any such matters, or related corporate citizenship and sustainability matters, could have a material adverse effect on our business, financial condition and results of operations.
In addition, a variety of organizations measure the performance of companies on environmental, social, and governance (“ESG”) topics, and the results of these assessments are widely publicized. Investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the company’s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the company’s board of directors in supervising various sustainability issues.
Furthermore, ESG-related legislation and regulation is being implemented across the world, including in the United States, and any such legislation or regulation, including the SEC’s proposed climate-related reporting requirements, may impose additional compliance burdens on us and on third parties in our value chain, which could potentially result in increased administrative costs, decreased demand in the marketplace for our products, and/or increased costs for our supplies and products. The SEC has proposed rule changes that would require registrants to include certain climate-related disclosures in their registration statements and periodic reports, including information about climate-related risks that are reasonably likely to have a material impact on their business, results of operations, or financial condition, and certain climate-related financial statement metrics in a note to their audited financial statements. If approved, these new disclosure requirements will likely increase our costs of compliance, which would then increase our operating expenses.
We take into consideration the expected impact of ESG matters on the sustainability of our business over time and the potential impact of our business on society and the environment. However, in light of investors’ increased focus on ESG matters, and in light of increased and evolving legislation and regulation regarding ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet our customers’ or society’s expectations as to our proper role. If we fail to meet the ESG values, standards and metrics that we set for ourselves, or our articulated public benefit purposes, or fail to align to regulatory or market expectations or standards regarding such matters, we may experience negative publicity and a loss of customers as a result, which will adversely affect our business, financial condition, and results of operations.
53

Actions of activist stockholders could be costly and time-consuming, divert management’s attention and resources, and have an adverse effect on our business.
While we value open dialogue and input from our stockholders, activist stockholders could take actions that could be costly and time-consuming to us, disrupt our operations, and divert the attention of our board of directors, management, and employees, such as public proposals and requests for potential nominations of candidates for election to our board of directors, requests to pursue a strategic combination or other transaction, or other special requests. As a result, we have retained, and may in the future retain additional services of various professionals to advise us in these matters, including legal, financial and communications advisers, the costs of which may negatively impact our future financial results. In addition, perceived uncertainties as to our future direction, strategy, or leadership created as a consequence of activist stockholder initiatives may result in the loss of potential business opportunities, harm our ability to attract new or retain existing investors, customers, directors, employees or other partners, and cause our stock price to experience periods of volatility or stagnation.
Because we have no current plans to pay cash dividends on our common stock, stockholders may not receive any return on investment unless they sell our common stock for a price greater than that which they paid for it.
We have no current plans to pay cash dividends on our common stock. The declaration, amount and payment of any future dividends will be at the sole discretion of our board of directors. Our board of directors may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and implications on the payment of dividends by us to our stockholders or by our subsidiaries to us, including restrictions under the Amended Credit Agreement and other indebtedness we may incur, and such other factors as our board of directors may deem relevant.
Stockholders may be diluted by the future issuance of additional common stock in connection with our incentive plans, acquisitions or otherwise.
We had approximately 194.5 million shares of common stock authorized but unissued and 55.5 million shares of common stock outstanding as of February 1, 2024. Our amended and restated certificate of incorporation authorizes us to issue these shares of common stock and stock options exercisable for common stock (and other equity awards) for the consideration and on the terms and conditions established by our board of directors in its sole discretion, whether in connection with acquisitions or otherwise. Any common stock that we issue, including under our existing equity incentive plans or any additional equity incentive plans that we may adopt in the future, would dilute the percentage ownership held by existing investors. In connection with our acquisition of Naturium, we issued 577,659 shares of the Company’s common stock, with a fair market value of $57.8 million as of the date of the Acquisition.
Anti-takeover provisions in our organizational documents and Delaware law might discourage or delay acquisition attempts for us that stockholders might consider favorable.
Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our company more difficult without the approval of our board of directors. Among other things:
although we do not have a stockholder rights plan, these provisions allow us to authorize the issuance of undesignated preferred stock in connection with a stockholder rights plan or otherwise, the terms of which may be established and the shares of which may be issued without stockholder approval, and which may include super voting, special approval, dividend or other rights or preferences superior to the rights of the holders of common stock;
these provisions provide for a classified board of directors with staggered three-year terms;
these provisions require advance notice for nominations of directors by stockholders and for stockholders to include matters to be considered at our annual meetings;
these provisions prohibit stockholder action by written consent;
these provisions provide for the removal of directors only for cause and only upon affirmative vote of holders of at least 75% of the shares of common stock entitled to vote generally in the election of directors; and
these provisions require the amendment of certain provisions only by the affirmative vote of at least 75% of the shares of common stock entitled to vote generally in the election of directors.
54

Further, as a Delaware corporation, we are also subject to provisions of Delaware law, which may impair a takeover attempt that our stockholders may find beneficial. These anti-takeover provisions and other provisions under Delaware law could discourage, delay or prevent a transaction involving a change in control of our company, including actions that our stockholders may deem advantageous, or negatively affect the trading price of our common stock. These provisions could also discourage proxy contests and make it more difficult for other stockholders to elect directors of their choosing and to cause us to take other corporate actions they may desire.
Our board of directors is authorized to issue and designate shares of our preferred stock in additional series without stockholder approval.
Our amended and restated certificate of incorporation authorizes our board of directors, without the approval of our stockholders, to issue up to 30 million shares of our preferred stock, subject to limitations prescribed by applicable law, rules and regulations and the provisions of our amended and restated certificate of incorporation, as shares of preferred stock in series, to establish from time to time the number of shares to be included in each such series and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. The powers, preferences and rights of these additional series of preferred stock may be senior to or on parity with our common stock, which may reduce its value.
Our amended and restated certificate of incorporation and amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
Our amended and restated certificate of incorporation and amended and restated bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine. This provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find this provision in our amended and restated certificate of incorporation and amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business, financial condition and results of operations.
General risk factors
An active trading market for our common stock may not be sustained, and the market price of shares of our common stock may be volatile, which could cause the value of your investment to decline.
Although our common stock is listed on the NYSE, there can be no assurances that an active trading market for our common stock will be sustained. In the absence of an active trading market for our common stock, stockholders may not be able to sell their common stock at the time or price they would like to sell.
Even if an active trading market is sustained, the market price of our common stock may be highly volatile and could be subject to wide fluctuations. Securities markets often experience significant price and volume fluctuations. This market volatility, as well as general economic, market or political conditions, could reduce the market price of shares of our common stock in spite of our operating performance. In addition, our results of operations could be below the expectations of public market analysts and investors due to a number of potential factors, including variations in our quarterly results of operations, additions or departures of key management personnel, changes in consumer preferences or beauty trends, announcements of new products or significant price reductions by our competitors, failure to meet analysts’ earnings estimates, publication of research reports about our industry, litigation and government investigations, changes or proposed changes in laws or regulations or differing interpretations or enforcement thereof affecting our business, adverse market reaction to any indebtedness we may incur or securities we may issue in the future, changes in market valuations of similar companies or speculation in the press or investment community, announcements by our competitors of significant contracts, acquisitions, dispositions, strategic partnerships, joint ventures or capital commitments, adverse publicity about our industry, the level of success of releases of new products and in response the market price of shares of our common stock could decrease significantly.
55

In addition, in May 2019, we announced that our board of directors authorized a share repurchase program allowing us to repurchase up to $25.0 million of our outstanding shares of common stock (“Share Repurchase Program”), of which approximately $17.1 million remains available for future share repurchases as of December 31, 2023. Purchases under the Share Repurchase Program may be made from time to time in the open market, in privately negotiated transactions or otherwise. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program may be suspended or discontinued at any time and there is no guarantee that any shares will be purchased under the Share Repurchase Program.
In the past, following periods of volatility in the overall market and the market price of a company’s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources.
Future sales, or the perception of future sales, by us or our stockholders in the public market could cause the market price for our common stock to decline.
The sale of substantial amounts of shares of our common stock in the public market, or the perception that such sales could occur could harm the prevailing market price of shares of our common stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates. We intend to file one or more registration statements on Form S-8 to cover additional shares of our common stock or securities convertible into or exchangeable for shares of our common stock pursuant to automatic increases in the number of shares reserved under our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan. Accordingly, shares registered under these registration statements on Form S-8 will be available for sale in the open market.
As restrictions on resale end, the market price of shares of our common stock could drop significantly if the holders of these restricted shares sell them or are perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of shares of our common stock or other securities.
If securities analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.

Item 2. Unregistered sales of equity securities and use of proceeds.
Issuer Purchases of Equity Securities
In May 2019, we announced that our board of directors authorized the Share Repurchase Program, which authorizes us to repurchase up to $25 million of our outstanding shares of common stock. The Share Repurchase Program remains in effect through the earlier of (i) the date that $25 million of our outstanding common stock has been purchased under the Share Repurchase Program or (ii) the date that our board of directors cancels the Share Repurchase Program.
Subject to certain exceptions, the covenants in the Amended Credit Agreement require us to be in compliance with certain leverage ratios to make repurchases under the Share Repurchase Program.
We did not repurchase any shares during the three months ended December 31, 2023, including pursuant to the Share Repurchase Program. A total of $17.1 million remains available for future share repurchases under the Share Repurchase Program as of December 31, 2023.
56


Item 3. Defaults upon senior securities.
None.
Item 4. Mine safety disclosures.
None.
Item 5. Other information.
Rule 10b5-1 Trading Plans
During the three months ended December 31, 2023, no director or officer of the Company adopted, terminated or modified a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits.
   Incorporated by Reference
Exhibit
Number
Exhibit DescriptionFiled
Herewith
FormExhibit
Number
File NumberFiling Date
3.18-K3.1001-378739/27/2016
3.28-K3.2001-378739/27/2016
31.1X    
31.2X    
32.1*X    
101.INSXBRL Instance Document - Instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X    
101.SCHInline XBRL Taxonomy Extension Schema Document.X
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.X
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.X
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).X
*This certification is deemed furnished, and not filed, with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Quarterly Report, irrespective of any general incorporation language contained in such filing.

57

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  e.l.f. Beauty, Inc.
   
February 7, 2024 By:/s/ Tarang P. Amin
Date  
Tarang P. Amin
Chief Executive Officer
(Principal Executive Officer)
   
February 7, 2024 By:/s/ Mandy Fields
Date  
Mandy Fields
Chief Financial Officer
(Principal Financial and Accounting Officer)
58
EX-31.1 2 q324exhibit311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tarang P. Amin, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of e.l.f. Beauty, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 7, 2024
/s/ Tarang P. Amin
Tarang P. Amin
Chief Executive Officer
(Principal Executive Officer)

EX-31.2 3 q324exhibit312.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mandy Fields, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of e.l.f. Beauty, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 7, 2024
/s/ Mandy Fields
Mandy Fields
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

EX-32.1 4 q324exhibit321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of e.l.f. Beauty, Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), Tarang P. Amin, Chief Executive Officer of the Company, and Mandy Fields, Chief Financial Officer of the Company, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 7, 2024
 
/s/ Tarang P. Amin
Tarang P. Amin
Chief Executive Officer
(Principal Executive Officer)
 
/s/ Mandy Fields
Mandy Fields
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

EX-101.SCH 5 elf-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed consolidated balance sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed consolidated balance sheets (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed consolidated statements of operations (unaudited) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Statement of comprehensive income (Statement) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed consolidated statements of stockholders' equity (unaudited) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed consolidated statements of cash flows (unaudited) link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Nature of operations link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Summary of significant accounting policies link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Restricted cash link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Investment in equity securities link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Goodwill and intangible assets link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Accrued expenses and other current liabilities link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Commitments and contingencies link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Stock-based compensation link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Repurchase of common stock link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Net income per share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Summary of significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Summary of significant accounting policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Restricted cash (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Goodwill and intangible assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Accrued expenses and other current liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Stock-based compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Net income per share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Summary of significant accounting policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Summary of significant accounting policies - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Restricted cash - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Investment in equity securities - (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Acquisition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Acquisition - Schedule of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Acquisition - Schedule of Purchase Price Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Acquisition - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Acquisition - Schedule of Acquisition Net Sales (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Goodwill and intangible assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Debt - Schedule of Outstanding Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Debt - Schedule of Outstanding Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Income taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Stock-based compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Repurchase of common stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Leases - Balance Sheet Line Items (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Leases - Components of Lease Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Leases - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Leases - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Leases - Weighted Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 elf-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 elf-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 elf-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Deferred income taxes Deferred Income Taxes and Tax Credits Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Pay vs Performance Disclosure [Line Items] 2028 Lease Liability, Payments, Due Year Four Lease Liability, Payments, Due Year Four Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Variable Rate Components [Domain] Variable Rate Components [Domain] Variable Rate Components [Domain] Equity Award Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Interest rate at period end Line of Credit Facility, Interest Rate at Period End Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash consideration Payments to Acquire Businesses, Gross Schedule of Purchase Price Allocation and Intangible Assets and Liabilities Acquired Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Revolving Credit Facility Revolving Credit Facility [Member] Impairment of finite-lived intangible assets Impairment of Intangible Assets, Finite-Lived Deferred tax liabilities Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Accounts payable Accounts Payable, Current Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Commitments and contingencies (Note 9) Commitments and Contingencies Operating leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Thereafter Lease Liability, Payments, Due After Year Four Lease Liability, Payments, Due After Year Four Number of options to renew Lessee Operating Lease, Number Of Options To Renew Lessee Operating Lease, Number Of Options To Renew Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Repurchase of common stock Equity [Text Block] Weighted-average remaining lease term Weighted Average Remaining Lease Term [Abstract] Weighted Average Remaining Lease Term [Abstract] Cash received from issuance of common stock Proceeds from Issuance of Common Stock Net assets acquired, excluding liability assumed for acquisition-related seller expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Excluding Liability For Acquisition Related Seller Expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Excluding Liability For Acquisition Related Seller Expenses Geographical [Axis] Geographical [Axis] Income taxes Income Tax Disclosure [Text Block] Current Lease Liability, Current [Abstract] Lease Liability, Current [Abstract] Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Current liabilities: Liabilities, Current [Abstract] Business Acquisition [Line Items] Business Acquisition [Line Items] Diluted (in USD per share) Diluted (in USD per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Business acquisition, share price (in usd per share) Business Acquisition, Share Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Line of Credit Line of Credit [Member] Exercise of stock options and vesting of restricted stock Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net income Net income Net Income (Loss) Total current liabilities Liabilities, Current 2026 Finance Lease, Liability, to be Paid, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Indefinite-lived Intangible Assets, Major Class Name Indefinite-Lived Intangible Assets, Major Class Name [Domain] Leases Lessee, Operating Leases [Text Block] Liabilities and stockholders' equity Liabilities and Equity [Abstract] Investment in equity securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Stockholders' equity: Equity, Attributable to Parent [Abstract] Exercise of stock options and vesting of restricted stock (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Impairment of equity investment Impairment of equity investment Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Schedule of Reconciliation of Numerator and Denominator in Basic and Diluted Net Income Per Common Share Computations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Total Lease, Liabilities, Payments, Due [Abstract] Lease, Liabilities, Payments, Due [Abstract] Executive Category: Executive Category [Axis] Total lease payments Lease Liability, Payments, Due Lease Liability, Payments, Due Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Summary of significant accounting policies Significant Accounting Policies [Text Block] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] 2027 Lease Liability, Payments, Due Year Three Lease Liability, Payments, Due Year Three Underlying Securities Award Underlying Securities Amount Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Entity Small Business Entity Small Business 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Letter of Credit Letter of Credit [Member] Long-term operating lease obligations Operating Operating Lease, Liability, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt instrument, term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Less: Interest Lease Liability, Undiscounted Excess Amount Lease Liability, Undiscounted Excess Amount Trademarks Trademarks Trademarks [Member] Debt issuance costs paid Payments of Debt Issuance Costs Goodwill and other intangibles, Net carrying amount Intangible Assets, Net (Including Goodwill) Schedule of Maturities of Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Term Loan Term Loan Facility [Member] Term loan member. Schedule of Consideration Transferred Schedule of Business Acquisitions, by Acquisition [Table Text Block] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Amended Credit Agreement Amended Credit Agreement [Member] Amended Credit Agreement Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of Components of Lease Expense Lease, Cost [Table Text Block] Inventory Increase (Decrease) in Inventories Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Weighted average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type Award Type [Axis] Document Quarterly Report Document Quarterly Report Unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Customer relationships – e-commerce Electronic Commerce Customer Relationships [Member] Electronic commerce customer relationships. Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Number of distribution channels Number Of Distribution Channels Number Of Distribution Channels Remainder of fiscal 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Use of estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Leases Lessee, Finance Leases [Text Block] Entity File Number Entity File Number Current portion of operating lease liabilities Operating Operating Lease, Liability, Current Interest on lease liabilities Finance Lease, Interest Expense Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Depreciation and amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Minimum Floor Minimum Floor [Member] Minimum Floor [Member] Finite-lived intangibles, Net carrying amount Finite-Lived Intangible Assets, Net Recent accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Other liabilities Increase (Decrease) in Other Operating Liabilities Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash - beginning of period Cash, cash equivalents and restricted cash - end of period Cash, cash equivalents, restricted cash and restricted cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Finite-lived intangibles, Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Operating lease cost Operating Lease, Cost Common stock, shares issued (in shares) Common Stock, Shares, Issued Total consideration transferred Total consideration transferred Business Combination, Consideration Transferred Gross profit Gross Profit Current portion of long-term debt and finance lease obligations Less: current portion Long-Term Debt and Lease Obligation, Current Security Exchange Name Security Exchange Name Selling, general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Total leased assets Lease, Right-Of-Use Asset Lease, Right-Of-Use Asset Unrecognized stock-based compensation cost, expected weighted-average period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other, net Proceeds from (Payments for) Other Financing Activities Maximum Maximum [Member] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Assets Lease, Right-Of-Use Asset [Abstract] Issuance of common stock as consideration for acquisition Stock Issued During Period, Value, Acquisitions Entity Address, Address Line One Entity Address, Address Line One 2027 Finance Lease, Liability, to be Paid, Year Three Amended Term Loan Facility Amended Term Loan Facility [Member] Amended Term Loan Facility Accrued expenses Accrued Expenses Accrued expenses. Stock-based compensation Share-Based Payment Arrangement [Text Block] Basis of presentation Basis of Accounting, Policy [Policy Text Block] 2025 Finance Lease, Liability, to be Paid, Year One Taxes payable Taxes Payable, Current Business Acquisition [Axis] Business Acquisition [Axis] Weighted-average discount rate Leases, Weighted Average Discount Rate [Abstract] Leases, Weighted Average Discount Rate [Abstract] Variable Rate [Axis] Variable Rate [Axis] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Acquisition Business Combination Disclosure [Text Block] Indefinite lived intangibles, Net carrying amount Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Schedule Of Intangible Assets And Goodwill [Table] Schedule Of Intangible Assets And Goodwill [Table] Schedule of intangible assets and goodwill. Income Tax Disclosure [Abstract] Amended Revolving Credit Facility Amended Revolving Credit Facility [Member] Amended Revolving Credit Facility Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Total debt Long-Term Debt, Gross And Lease Obligation Long-Term Debt, Gross And Lease Obligation Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Service-based vesting options Service Based Stock Options [Member] Service-based stock options. Inventory, net Inventory, Net Total lease cost Lease, Cost Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue recognition Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Total lease payments Finance Lease, Liability, to be Paid 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows from operating leases Operating Lease, Payments Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Term Loan Term Loan [Member] Term Loan PEO PEO [Member] Other, net Other Operating Activities, Cash Flow Statement Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate (percentage) Effective Income Tax Rate Reconciliation, Percent Present value of lease liabilities Operating Lease, Liability Remainder of fiscal 2024 Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Credit Facility [Axis] Credit Facility [Axis] Total liabilities Liabilities Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Liability assumed for acquisition-related seller expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liability Assumed For Acquisition Seller Related Expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liability Assumed For Acquisition Seller Related Expenses Debt Disclosure [Abstract] Debt Disclosure [Abstract] Number of reporting segments Number of Reportable Segments Earnings Per Share [Abstract] Earnings Per Share [Abstract] Common stock, par value of $0.01 per share; 250,000,000 shares authorized as of December 31, 2023, March 31, 2023 and December 31, 2022; 55,412,234, 53,770,482 and 53,165,462 shares issued and outstanding as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Lessee operating lease, option to extend Lessee, Operating Lease, Option to Extend, Term Lessee, Operating Lease, Option to Extend, Term Social Media Analytics Company Social Media Analytics Company [Member] Social Media Analytics Company [Member] Anti-dilutive securities excluded from diluted EPS: Earnings Per Share, Diluted, Other Disclosure [Abstract] Consolidated Total Net Leverage Ratio Levels Consolidated Total Net Leverage Ratio Levels [Member] Consolidated Total Net Leverage Ratio Levels Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Goodwill and other intangibles, Accumulated amortization Intangible Assets Including Goodwill, Accumulated Amortization Intangible assets including goodwill accumulated amortization. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Remainder of fiscal 2024 Lease Liability, Payments, Remainder Of Fiscal Year Lease Liability, Payments, Remainder Of Fiscal Year Segment reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Schedule of Maturities of Finance Lease Liabilities Finance Lease, Liability, to be Paid, Maturity [Table Text Block] All Individuals All Individuals [Member] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other income (expense), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Amount authorized under share repurchase program Stock Repurchase Program, Authorized Amount Total debt, net of issuance costs Long-Term Debt and Lease Obligation, Including Current Maturities Goodwill and intangible assets Goodwill and Intangible Assets Disclosure [Text Block] Repurchase of common stock (in shares) Stock Repurchased During Period, Shares PEO Name PEO Name Base Rate Base Rate [Member] 2028 Finance Lease, Liability, to be Paid, Year Four Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Future Amortization Expense for Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Total lease liabilities Lease, Liability Lease, Liability Other current liabilities Other Accrued Liabilities, Current Nature of operations Nature of Operations [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] LIBOR London Inter Bank Offered Rate (LIBOR) 1 [Member] London Inter Bank Offered Rate (LIBOR) 1 Business Combination and Asset Acquisition [Abstract] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Pro forma revenue Business Acquisition, Pro Forma Revenue Thereafter Finance Lease, Liability, To Be Paid, After Year Four Finance Lease, Liability, To Be Paid, After Year Four Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Finance leases Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Finance lease accumulated amortization Finance Lease, Right-of-Use Asset, Accumulated Amortization Finite-Lived Intangible Assets, Major Class Name Finite-Lived Intangible Assets, Major Class Name [Domain] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Income before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Long-term debt and finance lease obligations Long-term portion of debt Long-Term Debt and Lease Obligation Net deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Investments Equity Securities without Readily Determinable Fair Value, Amount Net income per share: Net income per share: Earnings Per Share Reconciliation [Abstract] Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Entity Emerging Growth Company Entity Emerging Growth Company Less: debt issuance costs Debt Issuance Costs, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Total purchase price Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Document Fiscal Period Focus Document Fiscal Period Focus 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Estimated useful life Finite-Lived Intangible Asset, Useful Life Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Common stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Second Amendment Second Amendment [Member] Second Amendment Net income per share Earnings Per Share [Text Block] Investments, All Other Investments [Abstract] Investments, All Other Investments [Abstract] SOFR Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate (SOFR) Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Accrued marketing Accrued Marketing Costs, Current Minimum Minimum [Member] Weighted average shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property and equipment, net Property, Plant and Equipment, Net Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Commitments and contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Liabilities Lease, Liability [Abstract] Lease, Liability [Abstract] Total liabilities and stockholders' equity Liabilities and Equity Customer relationships – retailers Customer Relationships Retailers [Member] Customer relationships retailers. Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Operating lease assets Operating Lease, Right-of-Use Asset Basic (in USD per share) Basic (in USD per share) Earnings Per Share, Basic Unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Remainder of fiscal 2024 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Arrangement Duration Trading Arrangement Duration Incremental Term Loan Incremental Term Loan [Member] Incremental Term Loan Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Cash, Cash Equivalents, and Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Impairment charge Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount Remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Accrued expenses and other current liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Indefinite-lived Intangible Assets Indefinite-Lived Intangible Assets [Axis] Term loan Long-Term Debt, Gross Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Naturium LLC Naturium LLC [Member] Naturium LLC Statement of Comprehensive Income [Abstract] Finance lease obligations Present value of lease liabilities Finance Lease, Liability Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Common stock issued (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Insider Trading Arrangements [Line Items] Acquisition-related seller expenses Acquisition Related, Seller Expenses Acquisition Related, Seller Expenses Schedule of Information Regarding Company's Goodwill and Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Acquisition transaction cost Asset Acquisition, Consideration Transferred, Transaction Cost Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive common equivalent shares from equity awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Issuance of common stock as consideration for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Adjustment to Compensation, Amount Adjustment to Compensation Amount Customer relationships – retailers Retail [Member] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Acquired Document Period End Date Document Period End Date Proceeds from revolving line of credit Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Repayment of long-term debt Repayments of Long-Term Debt Finance leases Finance Lease, Weighted Average Discount Rate, Percent Finance Finance Lease, Liability, Noncurrent Schedule of Acquisition Net Sales Business Acquisition, Pro Forma Information [Table Text Block] Entity Central Index Key Entity Central Index Key Noncurrent Lease, Liability, Noncurrent [Abstract] Lease, Liability, Noncurrent [Abstract] Amortization of debt issuance costs and discount on debt Amortization of Debt Issuance Costs and Discounts Accrued inventory Accrued Inventory, Current Accrued Inventory, Current Total stock compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Finite-lived intangibles, Gross carrying amount Finite-Lived Intangible Assets, Gross Income tax provision Income tax provision Income Tax Expense (Benefit) International Non-US [Member] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Quarterly installment rate Debt Instrument, Quarterly Installment Rate Debt Instrument, Quarterly Installment Rate Finance lease assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Accrued compensation Employee-related Liabilities, Current Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Cash and Cash Equivalents [Abstract] Schedule of Balance Sheet Information Assets And Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee [Table Text Block] Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Equity [Abstract] Equity [Abstract] Operating leases Operating Lease, Weighted Average Remaining Lease Term Net sales Total net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Acquisition, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Operating leases Operating Lease, Weighted Average Discount Rate, Percent Restricted stock and RSUs Restricted Stock Units And Restricted Stock [Member] Restricted Stock Units and Restricted Stock [Member] Variable Rate Components [Axis] Variable Rate Components [Axis] Variable Rate Components Credit Facility [Domain] Credit Facility [Domain] Schedule Of Intangible Assets And Goodwill [Line Items] Schedule Of Intangible Assets And Goodwill [Line Items] Schedule of intangible assets and goodwill. Business combinations Business Combinations Policy [Policy Text Block] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Finance leases Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Diluted (in shares) Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Interest expense, net Interest Income (Expense), Nonoperating, Net Less: Interest Finance Lease, Liability, Undiscounted Excess Amount Interest rate, amortization Debt Instrument, Annual Principal Amortization Rate Debt Instrument, Annual Principal Amortization Rate Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid-in Capital [Member] Finance lease cost Lease, Cost [Abstract] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Cover [Abstract] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition United States UNITED STATES Other long-term liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Total lease payments Lessee, Operating Lease, Liability, to be Paid Accrued expenses and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses And Other Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses And Other Current Liabilities Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Amortization of leased assets Finance Lease, Right-of-Use Asset, Amortization Restricted cash Cash and Cash Equivalents Disclosure [Text Block] 2026 Lease Liability, Payments, Due Year Two Lease Liability, Payments, Due Year Two Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Non-PEO NEO Non-PEO NEO [Member] Goodwill and intangible asset impairment Goodwill and Intangible Asset Impairment Equity Component [Domain] Equity Component [Domain] Finance Finance Lease, Liability, Current Adjustment to Compensation: Adjustment to Compensation [Axis] Equity consideration (common stock issued) Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Operating income Operating Income (Loss) Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Cash and cash equivalents Cash and Cash Equivalents [Member] Goodwill and other intangibles, Gross carrying amount Intangible Assets Gross Including Goodwill Intangible assets gross including goodwill. Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Unused fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Statement [Line Items] Statement [Line Items] Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of Outstanding Debt Schedule of Debt [Table Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Revolving line of credit Long-Term Line of Credit 2025 Lease Liability, Payments, Due Year One Lease Liability, Payments, Due Year One EX-101.PRE 9 elf-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover page - shares
9 Months Ended
Dec. 31, 2023
Feb. 01, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2023  
Document Transition Report false  
Entity File Number 001-37873  
Entity Registrant Name e.l.f. Beauty, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-4464131  
Entity Address, Address Line One 570 10th Street  
Entity Address, City or Town Oakland,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94607  
City Area Code (510)  
Local Phone Number 778-7787  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol ELF  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   55,506,934
Amendment Flag false  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001600033  
Current Fiscal Year End Date --03-31  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed consolidated balance sheets (unaudited) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Current assets:      
Cash and cash equivalents $ 72,705 $ 120,778 $ 87,021
Accounts receivable, net 121,061 67,928 66,237
Inventory, net 204,504 81,323 81,250
Prepaid expenses and other current assets 56,630 33,296 28,382
Total current assets 454,900 303,325 262,890
Property and equipment, net 12,805 7,874 8,726
Intangible assets, net 230,658 78,041 80,071
Goodwill 340,165 171,620 171,620
Investments 1,155 2,875 2,875
Other assets 68,601 31,866 29,743
Total assets 1,108,284 595,601 555,925
Current liabilities:      
Current portion of long-term debt and finance lease obligations 100,394 5,575 5,690
Accounts payable 72,917 31,427 32,049
Accrued expenses and other current liabilities 129,628 70,974 49,798
Total current liabilities 302,939 107,976 87,537
Long-term debt and finance lease obligations 164,403 60,881 62,177
Deferred tax liabilities 4,281 3,742 7,783
Long-term operating lease obligations 21,720 11,201 12,329
Other long-term liabilities 717 784 795
Total liabilities 494,060 184,584 170,621
Commitments and contingencies (Note 9)
Stockholders' equity:      
Common stock, par value of $0.01 per share; 250,000,000 shares authorized as of December 31, 2023, March 31, 2023 and December 31, 2022; 55,412,234, 53,770,482 and 53,165,462 shares issued and outstanding as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively 553 535 528
Additional paid-in capital 922,592 832,481 823,021
Accumulated other comprehensive loss (58) 0 0
Accumulated deficit (308,863) (421,999) (438,245)
Total stockholders' equity 614,224 411,017 385,304
Total liabilities and stockholders' equity $ 1,108,284 $ 595,601 $ 555,925
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed consolidated balance sheets (unaudited) (Parenthetical) - $ / shares
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]      
Common stock, par value (in USD per share) $ 0.01 $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 250,000,000 250,000,000 250,000,000
Common stock, shares issued (in shares) 55,412,234 53,770,482 53,165,462
Common stock, shares outstanding (in shares) 55,412,234 53,770,482 53,165,462
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed consolidated statements of operations (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Net sales $ 270,943 $ 146,537 $ 702,789 $ 391,487
Cost of sales 78,986 47,812 205,895 130,217
Gross profit 191,957 98,725 496,894 261,270
Selling, general and administrative expenses 160,121 75,434 364,246 201,172
Operating income 31,836 23,291 132,648 60,098
Other income (expense), net 2,565 730 1,902 (2,195)
Impairment of equity investment 0 0 (1,720) 0
Interest expense, net (3,985) (463) (3,021) (1,912)
Loss on extinguishment of debt 0 (176) 0 (176)
Income before provision for income taxes 30,416 23,382 129,809 55,815
Income tax provision (3,528) (4,277) (16,673) (10,531)
Net income $ 26,888 $ 19,105 $ 113,136 $ 45,284
Net income per share:        
Basic (in USD per share) $ 0.49 $ 0.36 $ 2.08 $ 0.87
Diluted (in USD per share) $ 0.46 $ 0.34 $ 1.97 $ 0.82
Weighted average shares outstanding:        
Basic (in shares) 55,140,887 52,707,406 54,503,518 52,239,761
Diluted (in shares) 58,030,115 55,840,137 57,550,094 54,906,065
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Statement of comprehensive income (Statement) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]        
Net income $ 26,888 $ 19,105 $ 113,136 $ 45,284
Other comprehensive loss, net of tax        
Foreign currency translation adjustment (58) 0 (58) 0
Other comprehensive loss, net of tax (58) 0 (58) 0
Comprehensive income $ 26,830 $ 19,105 $ 113,078 $ 45,284
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed consolidated statements of stockholders' equity (unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2022   51,524,307      
Beginning balance at Mar. 31, 2022 $ 312,429 $ 515 $ 795,443   $ (483,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 14,469       14,469
Stock-based compensation 6,549   6,549    
Exercise of stock options and vesting of restricted stock (in shares)   558,336      
Exercise of stock options and vesting of restricted stock 2 $ 2      
Ending balance (in shares) at Jun. 30, 2022   52,082,643      
Ending balance at Jun. 30, 2022 333,449 $ 517 801,992   (469,060)
Beginning balance (in shares) at Mar. 31, 2022   51,524,307      
Beginning balance at Mar. 31, 2022 312,429 $ 515 795,443   (483,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 45,284        
Foreign currency translation adjustment $ 0        
Ending balance (in shares) at Dec. 31, 2022 53,165,462 52,823,660      
Ending balance at Dec. 31, 2022 $ 385,304 $ 528 823,021   (438,245)
Beginning balance (in shares) at Jun. 30, 2022   52,082,643      
Beginning balance at Jun. 30, 2022 333,449 $ 517 801,992   (469,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,710       11,710
Stock-based compensation 8,022   8,022    
Exercise of stock options and vesting of restricted stock (in shares)   471,966      
Exercise of stock options and vesting of restricted stock 3,779 $ 8 3,771    
Ending balance (in shares) at Sep. 30, 2022   52,554,609      
Ending balance at Sep. 30, 2022 356,960 $ 525 813,785   (457,350)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 19,105       19,105
Stock-based compensation 7,239   7,239    
Exercise of stock options and vesting of restricted stock (in shares)   269,051      
Exercise of stock options and vesting of restricted stock 2,000 $ 3 1,997    
Foreign currency translation adjustment $ 0        
Ending balance (in shares) at Dec. 31, 2022 53,165,462 52,823,660      
Ending balance at Dec. 31, 2022 $ 385,304 $ 528 823,021   (438,245)
Beginning balance (in shares) at Mar. 31, 2023 53,770,482 53,571,577      
Beginning balance at Mar. 31, 2023 $ 411,017 $ 535 832,481 $ 0 (421,999)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 52,977       52,977
Stock-based compensation 7,223   7,223    
Exercise of stock options and vesting of restricted stock (in shares)   754,953      
Exercise of stock options and vesting of restricted stock 485 $ 8 477    
Ending balance (in shares) at Jun. 30, 2023   54,326,530      
Ending balance at Jun. 30, 2023 $ 471,702 $ 543 840,181 0 (369,022)
Beginning balance (in shares) at Mar. 31, 2023 53,770,482 53,571,577      
Beginning balance at Mar. 31, 2023 $ 411,017 $ 535 832,481 0 (421,999)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 113,136        
Foreign currency translation adjustment $ (58)        
Ending balance (in shares) at Dec. 31, 2023 55,412,234 55,321,185      
Ending balance at Dec. 31, 2023 $ 614,224 $ 553 922,592 (58) (308,863)
Beginning balance (in shares) at Jun. 30, 2023   54,326,530      
Beginning balance at Jun. 30, 2023 471,702 $ 543 840,181 0 (369,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 33,271       33,271
Stock-based compensation 11,190   11,190    
Exercise of stock options and vesting of restricted stock (in shares)   203,982      
Exercise of stock options and vesting of restricted stock 265 $ 2 263    
Ending balance (in shares) at Sep. 30, 2023   54,530,512      
Ending balance at Sep. 30, 2023 516,428 $ 545 851,634 0 (335,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 26,888       26,888
Stock-based compensation 11,051   11,051    
Exercise of stock options and vesting of restricted stock (in shares)   213,014      
Exercise of stock options and vesting of restricted stock 2,143 $ 2 2,141    
Issuance of common stock as consideration for acquisition (in shares)   577,659      
Issuance of common stock as consideration for acquisition 57,772 $ 6 57,766    
Foreign currency translation adjustment $ (58)     (58)  
Ending balance (in shares) at Dec. 31, 2023 55,412,234 55,321,185      
Ending balance at Dec. 31, 2023 $ 614,224 $ 553 $ 922,592 $ (58) $ (308,863)
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed consolidated statements of cash flows (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income $ 113,136 $ 45,284
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 24,247 16,496
Stock-based compensation expense 29,459 21,833
Amortization of debt issuance costs and discount on debt 290 271
Deferred income taxes (1,684) (1,819)
Impairment of equity investment 1,720 0
Acquisition-related seller expenses (10,549) 0
Loss on extinguishment of debt 0 176
Other, net 27 (1)
Changes in operating assets and liabilities:    
Accounts receivable (45,878) (20,620)
Inventory (106,898) 3,248
Prepaid expenses and other assets (50,696) (15,223)
Accounts payable and accrued expenses 84,733 22,610
Other liabilities (3,768) (3,254)
Net cash provided by operating activities 34,139 69,001
Cash flows from investing activities:    
Acquisition, net of cash acquired (274,973) 0
Purchase of property and equipment (5,984) (1,647)
Net cash used in investing activities (280,957) (1,647)
Cash flows from financing activities:    
Proceeds from revolving line of credit 89,500 0
Proceeds from long-term debt 115,000 0
Repayment of long-term debt (5,188) (28,750)
Debt issuance costs paid (665) 0
Cash received from issuance of common stock 2,893 5,652
Other, net (489) (588)
Net cash provided by (used in) financing activities 201,051 (23,686)
Effect of exchange rate changes on cash and cash equivalents (56) 0
Net (decrease) increase in cash, cash equivalents and restricted cash (45,823) 43,668
Cash, cash equivalents and restricted cash - beginning of period 120,778 43,353
Cash, cash equivalents and restricted cash - end of period $ 74,955 $ 87,021
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Nature of operations
9 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of operations Nature of operations
e.l.f. Beauty, Inc., a Delaware corporation (“e.l.f. Beauty” and together with its subsidiaries, the “Company”), is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skincare products. The Company's mission is to make the best of beauty accessible to every eye, lip, face and skin concern.
The Company believes its ability to deliver cruelty-free, clean, vegan and premium-quality products at accessible prices with broad appeal differentiates it in the beauty industry. The Company believes the combination of its value proposition, innovation engine, ability to attract and engage consumers, and its world-class team’s ability to execute with speed, has positioned the Company well to navigate the competitive beauty market.
The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. The Company's brands are available online and across leading beauty, mass-market and specialty retailers. The Company has strong relationships with its retail customers such as Target, Walmart, Ulta Beauty and other leading retailers that have enabled the Company to expand distribution both domestically and internationally.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies
9 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Summary of significant accounting policies Summary of significant accounting policies
Basis of presentation
The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, these interim financial statements contain all adjustments, including normal recurring adjustments, necessary for a fair statement of its financial position as of December 31, 2023, March 31, 2023 and December 31, 2022, and its results of operations and stockholders' equity for the three and nine months ended December 31, 2023 and December 31, 2022 and its cash flows for the nine months ended December 31, 2023 and December 31, 2022. All intercompany balances and transactions have been eliminated in consolidation.
These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Annual Report”). Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.
Use of estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment reporting
Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.
Significant accounting policies
Business combinations
The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases
assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.
Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.
The Company made no other material changes in the application of its significant accounting policies that were disclosed in Note 2, “Summary of significant accounting policies,” to the audited consolidated financial statements as of and for the fiscal year ended March 31, 2023 included in the Annual Report.
Revenue recognition
The Company distributes products both through national and international retailers, as well as direct-to-consumers through its e-commerce channel. The marketing and consumer engagement benefits that the direct-to-consumer channel provides are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams.
The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes.
The following table provides disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers (in thousands).
 Three months ended December 31,Nine months ended December 31,
Net sales by geographic region:2023202220232022
United States$229,101 $127,457 $599,552 $343,869 
International41,842 19,080 103,237 47,618 
Total net sales$270,943 $146,537 $702,789 $391,487 
As of December 31, 2023, other than accounts receivable, the Company had no material contract assets, contract liabilities or deferred contract costs recorded on its unaudited condensed consolidated balance sheet.
Recent accounting pronouncements
No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restricted cash
9 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Restricted cash Restricted cash
Restricted cash amounting to $2.3 million as of December 31, 2023, included in prepaid expenses and other current assets on the accompanying unaudited condensed consolidated balance sheets, represents part of the purchase consideration held in escrow for the settlement of general representation and warranty provisions in connection with the Company’s acquisition of Naturium LLC (“Naturium”). The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.
The reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows are as follows (in thousands):
Nine months ended December 31,
 Balance sheet classification20232022
Cash and cash equivalentsCash and cash equivalents$72,705 $87,021 
Restricted cash held in escrowPrepaid expenses and other current assets2,250 — 
Cash, cash equivalents and restricted cash - end of period$74,955 $87,021 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investment in equity securities
9 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
Investment in equity securities Investment in equity securities
On April 14, 2017, the Company invested $2.9 million in a social media analytics company, which is included in investments on its unaudited condensed consolidated balance sheets. The Company has elected the measurement alternative for equity investments that do not have readily determinable fair values. The Company recorded an impairment charge of $1.7 million on its investment as a separate line under other income (expense), net during the three months ended June 30, 2023, as an identified event or change in circumstances resulted in an indicator of impairment. The Company did not record an additional impairment charge on its investment during the three months ended December 31, 2023.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition
9 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Acquisition Acquisition
On October 4, 2023, the Company, through its wholly owned subsidiary, e.l.f. Cosmetics, Inc., completed its acquisition of Naturium (including the indirect acquisition of equity interests in Naturium through the purchase of a “tax blocker” holding company) (the “Acquisition”), which furthered the Company’s mission to make the best of beauty accessible to every eye, lip, face and skin concern. Naturium is a skincare company that provides clinically effective products at an affordable price. The Company directly and indirectly acquired all rights, title and interest in and to the outstanding equity securities of Naturium for a purchase price of $333.0 million. The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):
Cash consideration
$275,266 
Equity consideration (common stock issued)(1)
57,772 
Total consideration transferred
333,038 
Less: Net assets acquired
Net assets acquired, excluding liability assumed for acquisition-related seller expenses
$175,042 
Liability assumed for acquisition-related seller expenses(2)
(10,549)
Net assets acquired
(164,493)
Goodwill
$168,545 
(1) The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.
(2) In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.
The Company incurred and expensed acquisition transaction costs of $0.6 million and $3.1 million during the three and nine months ended December 31, 2023, respectively, which are included as a component of selling, general and administrative expenses in the condensed consolidated statements of operations.
The Acquisition has been accounted for as a business combination under the acquisition method and, accordingly, the total purchase price is allocated to the tangible and intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date. The purchase price allocation, deferred tax calculations and residual goodwill are preliminary and pending finalization. Naturium’s results of operations have been included in the Company's condensed consolidated financial statements from the date of acquisition.
The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):
Cash$293 
Accounts receivable7,388 
Inventory16,282 
Prepaid expenses and other current assets1,899 
Property and equipment28 
Goodwill(1)
168,545 
Intangible assets 162,800 
Total assets acquired
357,235 
Accounts payable(15,897)
Accrued expenses and other current liabilities(6,077)
Net deferred tax liability(2,223)
Total liabilities assumed(24,197)
Total purchase price
$333,038 
(1) The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skincare products. A substantial amount of the goodwill is expected to be deductible for tax purposes.
Intangible assets
Fair ValueEstimated Useful Life
(in thousands)(in years)
Fair Value Methodology
Customer relationships – retailers$20,000 10
Excess earnings method
Customer relationships – e-commerce18,300 
3
Excess earnings method and with and without method
Trademarks124,500 15
Relief from Royalty method
Total identified intangible assets$162,800 
Certain financial information (unaudited)
The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022), are as follows (in thousands):
 
Amount
Actual Naturium net sales from October 4, 2023 to December 31, 2023
$22,458 
Supplemental pro forma combined net sales for the three months ended December 31, 2023
271,579 
Supplemental pro forma combined net sales for the nine months ended December 31, 2023
744,583 
Supplemental pro forma combined net sales for the three months ended December 31, 2022
159,811 
Supplemental pro forma combined net sales for the nine months ended December 31, 2022
425,423 
The unaudited pro forma financial information shown in the table above are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisition had taken place at April 1, 2022 (the beginning of comparable period presented).
The pro forma earnings of the combined companies are not presented as the effects of the Acquisition in earnings are not material in relation to the overall consolidated financial statements.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and intangible assets
9 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and intangible assets Goodwill and intangible assets
Information regarding the Company’s goodwill and intangible assets as of December 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$97,600 $(72,100)$25,500 
Customer relationships – e-commerce
3 years
22,240 (5,465)16,775 
Trademarks
10 to 15 years
128,000 (3,417)124,583 
Total finite-lived intangibles247,840 (80,982)166,858 
TrademarksIndefinite63,800 — 63,800 
Goodwill340,165 — 340,165 
Total goodwill and other intangibles$651,805 $(80,982)$570,823 
Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(65,780)$11,820 
Customer relationships – e-commerce3 years3,940 (3,940)— 
Trademarks10 years3,500 (1,079)2,421 
Total finite-lived intangibles85,040 (70,799)14,241 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(70,799)$249,661 
Information regarding the Company’s goodwill and intangible assets as of December 31, 2022 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(63,840)$13,760 
Customer relationships – e-commerce3 years3,940 (3,938)
Trademarks10 years3,500 (991)2,509 
Total finite-lived intangibles85,040 (68,769)16,271 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(68,769)$251,691 
Amortization expenses on finite-lived intangible assets were $6.1 million and $2.0 million in the three months ended December 31, 2023 and December 31, 2022, respectively, and $10.2 million and $6.1 million in the nine months ended December 31, 2023 and December 31, 2022, respectively. Certain trademark assets have been classified as indefinite-lived intangible assets and accordingly, are not subject to amortization. There were no impairments of goodwill or intangible assets recorded in the three and nine months ended December 31, 2023 and December 31, 2022.
The estimated future amortization expense related to finite-lived intangible assets, assuming no impairment as of December 31, 2023 is as follows (in thousands):
Remainder of fiscal 2024$4,981 
202517,630 
202617,630 
202714,580 
202811,530 
Thereafter100,507 
Total$166,858 
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued expenses and other current liabilities
9 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Accrued expenses and other current liabilities Accrued expenses and other current liabilities
Accrued expenses and other current liabilities as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Accrued expenses$44,979 $22,726 $19,298 
Accrued inventory23,562 1,330 468 
Accrued marketing21,241 23,761 7,036 
Current portion of operating lease liabilities7,010 4,510 4,528 
Accrued compensation16,588 13,098 10,591 
Taxes payable9,937 2,851 5,076 
Other current liabilities6,311 2,698 2,801 
Accrued expenses and other current liabilities$129,628 $70,974 $49,798 
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Debt
9 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Debt Debt
The Company’s outstanding debt as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Revolving line of credit(1)
$89,500 $— $— 
Term loan(1)
176,063 66,250 67,500 
Finance lease obligations144 633 832 
Total debt(2)
265,707 66,883 68,332 
Less: debt issuance costs(910)(427)(465)
Total debt, net of issuance costs264,797 66,456 67,867 
Less: current portion(100,394)(5,575)(5,690)
Long-term portion of debt$164,403 $60,881 $62,177 
(1) See further discussion below. As of December 31, 2023, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
(2) The gross carrying amounts of the Company’s long-term debt, before reduction of the debt issuance costs, and finance lease obligations approximate their fair values, based on Level 2 inputs (quoted prices for similar assets and liabilities in active markets or inputs that are observable), as the stated rates approximate market rates for loans with similar terms. The Company did not transfer any liabilities measured at fair value on a recurring basis to or from Level 2 for any of the periods presented.
Amended Credit Agreement
On April 30, 2021, the Company amended and restated its prior credit agreement (such amended and restated credit agreement, as further amended, supplemented or modified from time to time, the “Amended Credit Agreement”) and refinanced all loans under the prior credit agreement. The Amended Credit Agreement has a five year term and consists of (i) a $100 million revolving credit facility (the “Amended Revolving Credit Facility”) and (ii) a $100 million term loan facility (the “Amended Term Loan Facility”).
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility is collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on the Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provides for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan; however, all amounts drawn under the Amended Revolving Credit Facility cannot exceed $100 million. The unused balance of the Amended Revolving Credit Facility as of December 31, 2023 was $10.5 million.
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States (“US”) dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR plus 0.10%, subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
The interest rate as of December 31, 2023 for the Amended Revolving Credit Facility and the Amended Term Loan Facility was approximately 6.7%.
Second Amended Credit Agreement
On August 28, 2023, the Company entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, the Company may borrow incremental term loans in a principal amount equal to $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan will bear interest at a rate per annum equal to, at the Company’s election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, to be based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortizes at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ending on December 31, 2023. The Company used the Incremental Term Loan together with cash from its balance sheet and additional borrowings under its Amended Revolving Credit Facility to consummate the Acquisition (as defined in Note 5 hereto) and to pay related fees and expenses in connection with the Acquisition and Second Amendment.
The interest rate as of December 31, 2023 for the Incremental Term Loan was approximately 6.9%.
The Amended Credit Agreement contains a number of covenants that, among other things and subject to certain exceptions, restrict the Company’s ability to pay dividends and distributions or repurchase capital stock, incur additional indebtedness, create liens on assets, engage in mergers or consolidations and sell or otherwise dispose of assets. The Amended Credit Agreement also includes reporting, financial and maintenance covenants that require the Company to, among other things, comply with certain consolidated total net leverage ratios and consolidated fixed charge coverage ratios.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and contingencies
9 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
Legal contingencies
The Company is from time to time subject to, and is currently involved in legal proceedings, claims and litigation arising in the ordinary course of business. The Company is not currently a party to any matters that management expects will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income taxes
9 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income taxes Income taxes
The Company’s quarterly tax provision is based upon an estimated annual effective tax rate as adjusted for any discrete items. The Company’s provision for income taxes were $3.5 million and $4.3 million for the three months ended December 31, 2023 and December 31, 2022, respectively, and $16.7 million and $10.5 million for the nine months ended December 31, 2023 and December 31, 2022, respectively, with an effective tax rate of 11.6% and 18.3% for the three months ended December 31, 2023 and December 31, 2022, respectively, and an effective tax rate of 12.8% and 18.9% for the nine months ended December 31, 2023 and December 31, 2022, respectively. The effective tax rate differs from the U.S. statutory tax rate primarily due to discrete tax benefit related to stock-based compensation.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation
9 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-based compensation Stock-based compensation
Stock based compensation expense is recognized on a straight-line basis over the requisite service period. Total stock-based compensation is shown in the table below (in thousands):
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Service-based vesting options$41 $89 $128 $266 
Restricted stock and RSUs11,001 7,168 29,331 21,567 
Total stock compensation expense$11,042 $7,257 $29,459 $21,833 
As of December 31, 2023, there was $0.1 million and $88.3 million of total unrecognized stock-based compensation cost related to unvested service-based stock options and shares subject to RSAs and RSUs, respectively. The unrecognized stock-based compensation is expected to be recognized over the remaining weighted-average period of 1.8 years for service-based stock options and 2.0 years for shares subject to RSAs and RSUs, respectively.
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Repurchase of common stock
9 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Repurchase of common stock Repurchase of common stock
On May 8, 2019, the Company announced that its board of directors authorized a share repurchase program to acquire up to $25.0 million of the Company’s common stock (the “Share Repurchase Program”). Purchases under the Share Repurchase Program may be made from time to time, in such amounts as management deems appropriate, through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program does not have an expiration date, does not require the Company to repurchase any specific number of shares of its common stock, and may be modified, suspended or terminated at any time without notice. There is no guarantee that any additional shares will be purchased under the Share Repurchase Program and such shares are intended to be retired after purchase.
The covenants in the Amended Credit Agreement require the Company to be in compliance with certain leverage ratios to make repurchases under the Share Repurchase Program.
The Company did not repurchase any shares during the three and nine months ended December 31, 2023. A total of $17.1 million remains available for future share repurchases under the Share Repurchase Program as of December 31, 2023.
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net income per share
9 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net income per share Net income per share
The Company computes basic net income per share using the weighted-average number of shares of common stock outstanding. Diluted net income per share amounts are calculated using the treasury stock method for equity-based compensation awards. The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):
 Three months ended December 31,Nine months ended December 31,
 2023202220232022
Numerator:    
Net income $26,888 $19,105 $113,136 $45,284 
Denominator:    
Weighted-average common shares outstanding – basic55,140,887 52,707,406 54,503,518 52,239,761 
Dilutive common equivalent shares from equity awards2,889,228 3,132,731 3,046,576 2,666,304 
Weighted-average common shares outstanding – diluted58,030,115 55,840,137 57,550,094 54,906,065 
Net income per share:    
Basic$0.49 $0.36 $2.08 $0.87 
Diluted$0.46 $0.34 $1.97 $0.82 
Weighted-average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share31,021 9,215 58,792 257,292 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases
9 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Leases Leases
The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company's equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.
Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.
Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):
 ClassificationDecember 31, 2023March 31, 2023December 31, 2022
Assets
Operating lease assets Other assets$27,224 $14,071 $15,120 
Finance lease assets (a)
Other assets— 245 350 
Total leased assets$27,224 $14,316 $15,470 
Liabilities
Current
Operating Accrued expenses and other current liabilities$7,010 $4,510 $4,528 
FinanceCurrent portion of long-term debt and finance lease obligations144 575 690 
Noncurrent
Operating Long-term operating lease obligations21,720 11,201 12,329 
FinanceLong-term debt and finance lease obligations— 58 142 
Total lease liabilities$28,874 $16,344 $17,689 
_____________________
(a) Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.
For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands):
Three months ended December 31,Nine months ended December 31,
 Classification2023202220232022
Operating lease cost Selling, general and administrative (“SG&A”) expenses$2,203 $1,149 $4,905 $3,458 
Finance lease cost
Amortization of leased assetsSG&A expenses— 105 210 315 
Interest on lease liabilitiesInterest expense, net10 25 
Total lease cost $2,206 $1,261 $5,125 $3,798 
As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):
Operating
leases
Finance
leases
Total
Remainder of fiscal 2024$1,985 $87 $2,072 
20258,434 58 8,492 
20268,424 — 8,424 
20275,060 — 5,060 
20281,921 — 1,921 
Thereafter6,994 — 6,994 
Total lease payments32,818 145 32,963 
Less: Interest4,088 4,089 
Present value of lease liabilities$28,730 $144 $28,874 
For leases commencing prior to January 1, 2019, minimum lease payments exclude payments to landlords for real estate taxes and common area maintenance. These payments can be either fixed or variable, depending on the lease.
As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows:
 December 31, 2023December 31, 2022
Weighted-average remaining lease term
Operating leases4.8 years4.7 years
Finance leases0.4 years1.1 years
Weighted-average discount rate
Operating leases4.9 %2.6 %
Finance leases1.6 %2.8 %
Operating cash outflows from operating leases for the nine months ended December 31, 2023 and December 31, 2022 were $3.2 million and $3.6 million, respectively.
Leases Leases
The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company's equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.
Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.
Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):
 ClassificationDecember 31, 2023March 31, 2023December 31, 2022
Assets
Operating lease assets Other assets$27,224 $14,071 $15,120 
Finance lease assets (a)
Other assets— 245 350 
Total leased assets$27,224 $14,316 $15,470 
Liabilities
Current
Operating Accrued expenses and other current liabilities$7,010 $4,510 $4,528 
FinanceCurrent portion of long-term debt and finance lease obligations144 575 690 
Noncurrent
Operating Long-term operating lease obligations21,720 11,201 12,329 
FinanceLong-term debt and finance lease obligations— 58 142 
Total lease liabilities$28,874 $16,344 $17,689 
_____________________
(a) Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.
For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands):
Three months ended December 31,Nine months ended December 31,
 Classification2023202220232022
Operating lease cost Selling, general and administrative (“SG&A”) expenses$2,203 $1,149 $4,905 $3,458 
Finance lease cost
Amortization of leased assetsSG&A expenses— 105 210 315 
Interest on lease liabilitiesInterest expense, net10 25 
Total lease cost $2,206 $1,261 $5,125 $3,798 
As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):
Operating
leases
Finance
leases
Total
Remainder of fiscal 2024$1,985 $87 $2,072 
20258,434 58 8,492 
20268,424 — 8,424 
20275,060 — 5,060 
20281,921 — 1,921 
Thereafter6,994 — 6,994 
Total lease payments32,818 145 32,963 
Less: Interest4,088 4,089 
Present value of lease liabilities$28,730 $144 $28,874 
For leases commencing prior to January 1, 2019, minimum lease payments exclude payments to landlords for real estate taxes and common area maintenance. These payments can be either fixed or variable, depending on the lease.
As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows:
 December 31, 2023December 31, 2022
Weighted-average remaining lease term
Operating leases4.8 years4.7 years
Finance leases0.4 years1.1 years
Weighted-average discount rate
Operating leases4.9 %2.6 %
Finance leases1.6 %2.8 %
Operating cash outflows from operating leases for the nine months ended December 31, 2023 and December 31, 2022 were $3.2 million and $3.6 million, respectively.
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure                
Net income $ 26,888 $ 33,271 $ 52,977 $ 19,105 $ 11,710 $ 14,469 $ 113,136 $ 45,284
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies (Policies)
9 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, these interim financial statements contain all adjustments, including normal recurring adjustments, necessary for a fair statement of its financial position as of December 31, 2023, March 31, 2023 and December 31, 2022, and its results of operations and stockholders' equity for the three and nine months ended December 31, 2023 and December 31, 2022 and its cash flows for the nine months ended December 31, 2023 and December 31, 2022. All intercompany balances and transactions have been eliminated in consolidation.
These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Annual Report”). Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.
Use of estimates
Use of estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment reporting
Segment reporting
Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.
Business combinations
Business combinations
The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases
assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.
Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.
The Company made no other material changes in the application of its significant accounting policies that were disclosed in Note 2, “Summary of significant accounting policies,” to the audited consolidated financial statements as of and for the fiscal year ended March 31, 2023 included in the Annual Report.
Revenue recognition
Revenue recognition
The Company distributes products both through national and international retailers, as well as direct-to-consumers through its e-commerce channel. The marketing and consumer engagement benefits that the direct-to-consumer channel provides are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams.
The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes.
Recent accounting pronouncements
Recent accounting pronouncements
No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies (Tables)
9 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Disaggregation of Revenue
The following table provides disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers (in thousands).
 Three months ended December 31,Nine months ended December 31,
Net sales by geographic region:2023202220232022
United States$229,101 $127,457 $599,552 $343,869 
International41,842 19,080 103,237 47,618 
Total net sales$270,943 $146,537 $702,789 $391,487 
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restricted cash (Tables)
9 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash
The reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows are as follows (in thousands):
Nine months ended December 31,
 Balance sheet classification20232022
Cash and cash equivalentsCash and cash equivalents$72,705 $87,021 
Restricted cash held in escrowPrepaid expenses and other current assets2,250 — 
Cash, cash equivalents and restricted cash - end of period$74,955 $87,021 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition (Tables)
9 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Consideration Transferred The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):
Cash consideration
$275,266 
Equity consideration (common stock issued)(1)
57,772 
Total consideration transferred
333,038 
Less: Net assets acquired
Net assets acquired, excluding liability assumed for acquisition-related seller expenses
$175,042 
Liability assumed for acquisition-related seller expenses(2)
(10,549)
Net assets acquired
(164,493)
Goodwill
$168,545 
(1) The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.
(2) In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.
Schedule of Purchase Price Allocation and Intangible Assets and Liabilities Acquired
The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):
Cash$293 
Accounts receivable7,388 
Inventory16,282 
Prepaid expenses and other current assets1,899 
Property and equipment28 
Goodwill(1)
168,545 
Intangible assets 162,800 
Total assets acquired
357,235 
Accounts payable(15,897)
Accrued expenses and other current liabilities(6,077)
Net deferred tax liability(2,223)
Total liabilities assumed(24,197)
Total purchase price
$333,038 
(1) The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skincare products. A substantial amount of the goodwill is expected to be deductible for tax purposes.
Intangible assets
Fair ValueEstimated Useful Life
(in thousands)(in years)
Fair Value Methodology
Customer relationships – retailers$20,000 10
Excess earnings method
Customer relationships – e-commerce18,300 
3
Excess earnings method and with and without method
Trademarks124,500 15
Relief from Royalty method
Total identified intangible assets$162,800 
Schedule of Acquisition Net Sales
The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022), are as follows (in thousands):
 
Amount
Actual Naturium net sales from October 4, 2023 to December 31, 2023
$22,458 
Supplemental pro forma combined net sales for the three months ended December 31, 2023
271,579 
Supplemental pro forma combined net sales for the nine months ended December 31, 2023
744,583 
Supplemental pro forma combined net sales for the three months ended December 31, 2022
159,811 
Supplemental pro forma combined net sales for the nine months ended December 31, 2022
425,423 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and intangible assets (Tables)
9 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Information Regarding Company's Goodwill and Intangible Assets
Information regarding the Company’s goodwill and intangible assets as of December 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$97,600 $(72,100)$25,500 
Customer relationships – e-commerce
3 years
22,240 (5,465)16,775 
Trademarks
10 to 15 years
128,000 (3,417)124,583 
Total finite-lived intangibles247,840 (80,982)166,858 
TrademarksIndefinite63,800 — 63,800 
Goodwill340,165 — 340,165 
Total goodwill and other intangibles$651,805 $(80,982)$570,823 
Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(65,780)$11,820 
Customer relationships – e-commerce3 years3,940 (3,940)— 
Trademarks10 years3,500 (1,079)2,421 
Total finite-lived intangibles85,040 (70,799)14,241 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(70,799)$249,661 
Information regarding the Company’s goodwill and intangible assets as of December 31, 2022 is as follows (in thousands):
 Estimated useful lifeGross carrying amountAccumulated amortizationNet carrying amount
Customer relationships – retailers10 years$77,600 $(63,840)$13,760 
Customer relationships – e-commerce3 years3,940 (3,938)
Trademarks10 years3,500 (991)2,509 
Total finite-lived intangibles85,040 (68,769)16,271 
TrademarksIndefinite63,800 — 63,800 
Goodwill171,620 — 171,620 
Total goodwill and other intangibles$320,460 $(68,769)$251,691 
Schedule of Future Amortization Expense for Intangible Assets
The estimated future amortization expense related to finite-lived intangible assets, assuming no impairment as of December 31, 2023 is as follows (in thousands):
Remainder of fiscal 2024$4,981 
202517,630 
202617,630 
202714,580 
202811,530 
Thereafter100,507 
Total$166,858 
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued expenses and other current liabilities (Tables)
9 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Accrued expenses$44,979 $22,726 $19,298 
Accrued inventory23,562 1,330 468 
Accrued marketing21,241 23,761 7,036 
Current portion of operating lease liabilities7,010 4,510 4,528 
Accrued compensation16,588 13,098 10,591 
Taxes payable9,937 2,851 5,076 
Other current liabilities6,311 2,698 2,801 
Accrued expenses and other current liabilities$129,628 $70,974 $49,798 
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Debt (Tables)
9 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Outstanding Debt
The Company’s outstanding debt as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):
 December 31, 2023March 31, 2023December 31, 2022
Revolving line of credit(1)
$89,500 $— $— 
Term loan(1)
176,063 66,250 67,500 
Finance lease obligations144 633 832 
Total debt(2)
265,707 66,883 68,332 
Less: debt issuance costs(910)(427)(465)
Total debt, net of issuance costs264,797 66,456 67,867 
Less: current portion(100,394)(5,575)(5,690)
Long-term portion of debt$164,403 $60,881 $62,177 
(1) See further discussion below. As of December 31, 2023, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.
(2) The gross carrying amounts of the Company’s long-term debt, before reduction of the debt issuance costs, and finance lease obligations approximate their fair values, based on Level 2 inputs (quoted prices for similar assets and liabilities in active markets or inputs that are observable), as the stated rates approximate market rates for loans with similar terms. The Company did not transfer any liabilities measured at fair value on a recurring basis to or from Level 2 for any of the periods presented.
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation (Tables)
9 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount Total stock-based compensation is shown in the table below (in thousands):
Three months ended December 31,Nine months ended December 31,
 2023202220232022
Service-based vesting options$41 $89 $128 $266 
Restricted stock and RSUs11,001 7,168 29,331 21,567 
Total stock compensation expense$11,042 $7,257 $29,459 $21,833 
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net income per share (Tables)
9 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Numerator and Denominator in Basic and Diluted Net Income Per Common Share Computations The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):
 Three months ended December 31,Nine months ended December 31,
 2023202220232022
Numerator:    
Net income $26,888 $19,105 $113,136 $45,284 
Denominator:    
Weighted-average common shares outstanding – basic55,140,887 52,707,406 54,503,518 52,239,761 
Dilutive common equivalent shares from equity awards2,889,228 3,132,731 3,046,576 2,666,304 
Weighted-average common shares outstanding – diluted58,030,115 55,840,137 57,550,094 54,906,065 
Net income per share:    
Basic$0.49 $0.36 $2.08 $0.87 
Diluted$0.46 $0.34 $1.97 $0.82 
Weighted-average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share31,021 9,215 58,792 257,292 
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases (Tables)
9 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Balance Sheet Information
Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):
 ClassificationDecember 31, 2023March 31, 2023December 31, 2022
Assets
Operating lease assets Other assets$27,224 $14,071 $15,120 
Finance lease assets (a)
Other assets— 245 350 
Total leased assets$27,224 $14,316 $15,470 
Liabilities
Current
Operating Accrued expenses and other current liabilities$7,010 $4,510 $4,528 
FinanceCurrent portion of long-term debt and finance lease obligations144 575 690 
Noncurrent
Operating Long-term operating lease obligations21,720 11,201 12,329 
FinanceLong-term debt and finance lease obligations— 58 142 
Total lease liabilities$28,874 $16,344 $17,689 
_____________________
(a) Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.
As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows:
 December 31, 2023December 31, 2022
Weighted-average remaining lease term
Operating leases4.8 years4.7 years
Finance leases0.4 years1.1 years
Weighted-average discount rate
Operating leases4.9 %2.6 %
Finance leases1.6 %2.8 %
Schedule of Components of Lease Expense
For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands):
Three months ended December 31,Nine months ended December 31,
 Classification2023202220232022
Operating lease cost Selling, general and administrative (“SG&A”) expenses$2,203 $1,149 $4,905 $3,458 
Finance lease cost
Amortization of leased assetsSG&A expenses— 105 210 315 
Interest on lease liabilitiesInterest expense, net10 25 
Total lease cost $2,206 $1,261 $5,125 $3,798 
Schedule of Maturities of Operating Lease Liabilities
As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):
Operating
leases
Finance
leases
Total
Remainder of fiscal 2024$1,985 $87 $2,072 
20258,434 58 8,492 
20268,424 — 8,424 
20275,060 — 5,060 
20281,921 — 1,921 
Thereafter6,994 — 6,994 
Total lease payments32,818 145 32,963 
Less: Interest4,088 4,089 
Present value of lease liabilities$28,730 $144 $28,874 
Schedule of Maturities of Finance Lease Liabilities
As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):
Operating
leases
Finance
leases
Total
Remainder of fiscal 2024$1,985 $87 $2,072 
20258,434 58 8,492 
20268,424 — 8,424 
20275,060 — 5,060 
20281,921 — 1,921 
Thereafter6,994 — 6,994 
Total lease payments32,818 145 32,963 
Less: Interest4,088 4,089 
Present value of lease liabilities$28,730 $144 $28,874 
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies - Additional Information (Details)
9 Months Ended
Dec. 31, 2023
segment
distribution_channel
Accounting Policies [Abstract]  
Number of operating segments 1
Number of reporting segments 1
Number of distribution channels | distribution_channel 2
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of significant accounting policies - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]        
Total net sales $ 270,943 $ 146,537 $ 702,789 $ 391,487
United States        
Disaggregation of Revenue [Line Items]        
Total net sales 229,101 127,457 599,552 343,869
International        
Disaggregation of Revenue [Line Items]        
Total net sales $ 41,842 $ 19,080 $ 103,237 $ 47,618
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restricted cash - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 74,955 $ 120,778 $ 87,021 $ 43,353
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 2,250   $ 0  
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 74,955 $ 120,778 $ 87,021 $ 43,353
Cash and cash equivalents        
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash, cash equivalents, restricted cash and restricted cash equivalents 72,705   87,021  
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash, cash equivalents, restricted cash and restricted cash equivalents $ 2,250   $ 0  
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investment in equity securities - (Details) - USD ($)
3 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Apr. 14, 2017
Debt and Equity Securities, FV-NI [Line Items]          
Investments $ 1,155,000   $ 2,875,000 $ 2,875,000  
Impairment charge $ 0 $ 1,700,000      
Social Media Analytics Company          
Debt and Equity Securities, FV-NI [Line Items]          
Investments         $ 2,900,000
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 04, 2023
Dec. 31, 2023
Dec. 31, 2023
Business Acquisition [Line Items]      
Acquisition transaction cost   $ 600 $ 3,100
Naturium LLC      
Business Acquisition [Line Items]      
Total consideration transferred $ 333,038    
Equity consideration (common stock issued) $ 57,772    
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition - Schedule of Consideration Transferred (Details) - USD ($)
$ / shares in Units, $ in Thousands
Oct. 04, 2023
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill   $ 340,165 $ 171,620 $ 171,620
Naturium LLC        
Business Acquisition [Line Items]        
Cash consideration $ 275,266      
Equity consideration (common stock issued) 57,772      
Total consideration transferred 333,038      
Net assets acquired, excluding liability assumed for acquisition-related seller expenses 175,042      
Liability assumed for acquisition-related seller expenses (10,549)      
Net assets acquired (164,493)      
Goodwill $ 168,545      
Common stock issued (in shares) 577,659      
Business acquisition, share price (in usd per share) $ 100.01      
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition - Schedule of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Oct. 04, 2023
Mar. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill $ 340,165   $ 171,620 $ 171,620
Naturium LLC        
Business Acquisition [Line Items]        
Cash   $ 293    
Accounts receivable   7,388    
Inventory   16,282    
Prepaid expenses and other current assets   1,899    
Property and equipment   28    
Goodwill   168,545    
Intangible assets   162,800    
Total assets acquired   357,235    
Accounts payable   (15,897)    
Accrued expenses and other current liabilities   (6,077)    
Net deferred tax liability   (2,223)    
Total liabilities assumed   (24,197)    
Total purchase price   $ 333,038    
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Oct. 04, 2023
Mar. 31, 2023
Dec. 31, 2022
Customer relationships – e-commerce        
Business Acquisition [Line Items]        
Estimated useful life 3 years   3 years 3 years
Trademarks        
Business Acquisition [Line Items]        
Estimated useful life     10 years 10 years
Naturium LLC        
Business Acquisition [Line Items]        
Intangible assets   $ 162,800    
Naturium LLC | Customer relationships – retailers        
Business Acquisition [Line Items]        
Intangible assets   $ 20,000    
Estimated useful life   10 years    
Naturium LLC | Customer relationships – e-commerce        
Business Acquisition [Line Items]        
Intangible assets   $ 18,300    
Estimated useful life   3 years    
Naturium LLC | Trademarks        
Business Acquisition [Line Items]        
Intangible assets   $ 124,500    
Estimated useful life   15 years    
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition - Schedule of Acquisition Net Sales (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Naturium LLC          
Business Acquisition [Line Items]          
Pro forma revenue $ 271,579 $ 22,458 $ 159,811 $ 744,583 $ 425,423
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Schedule Of Intangible Assets And Goodwill [Line Items]      
Finite-lived intangibles, Gross carrying amount $ 247,840 $ 85,040 $ 85,040
Finite-lived intangibles, Accumulated amortization (80,982) (70,799) (68,769)
Finite-lived intangibles, Net carrying amount 166,858 14,241 16,271
Goodwill 340,165 171,620 171,620
Goodwill and other intangibles, Gross carrying amount 651,805 320,460 320,460
Goodwill and other intangibles, Accumulated amortization (80,982) (70,799) (68,769)
Goodwill and other intangibles, Net carrying amount 570,823 249,661 251,691
Trademarks      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Indefinite lived intangibles, Net carrying amount 63,800 63,800 63,800
Customer relationships – retailers      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Finite-lived intangibles, Gross carrying amount 97,600 77,600 77,600
Finite-lived intangibles, Accumulated amortization (72,100) (65,780) (63,840)
Finite-lived intangibles, Net carrying amount $ 25,500 $ 11,820 $ 13,760
Estimated useful life 10 years 10 years 10 years
Customer relationships – e-commerce      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Finite-lived intangibles, Gross carrying amount $ 22,240 $ 3,940 $ 3,940
Finite-lived intangibles, Accumulated amortization (5,465) (3,940) (3,938)
Finite-lived intangibles, Net carrying amount $ 16,775 $ 0 $ 2
Estimated useful life 3 years 3 years 3 years
Trademarks      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Finite-lived intangibles, Gross carrying amount $ 128,000 $ 3,500 $ 3,500
Finite-lived intangibles, Accumulated amortization (3,417) (1,079) (991)
Finite-lived intangibles, Net carrying amount $ 124,583 $ 2,421 $ 2,509
Estimated useful life   10 years 10 years
Trademarks | Minimum      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Estimated useful life 10 years    
Trademarks | Maximum      
Schedule Of Intangible Assets And Goodwill [Line Items]      
Estimated useful life 15 years    
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and intangible assets - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Depreciation and amortization $ 6,100,000 $ 2,000,000 $ 10,200,000 $ 6,100,000
Goodwill and intangible asset impairment $ 0 $ 0 0 $ 0
Impairment of finite-lived intangible assets     $ 0  
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]      
Remainder of fiscal 2024 $ 4,981    
2025 17,630    
2026 17,630    
2027 14,580    
2028 11,530    
Thereafter 100,507    
Finite-lived intangibles, Net carrying amount $ 166,858 $ 14,241 $ 16,271
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]      
Accrued expenses $ 44,979 $ 22,726 $ 19,298
Accrued inventory 23,562 1,330 468
Accrued marketing 21,241 23,761 7,036
Current portion of operating lease liabilities 7,010 4,510 4,528
Accrued compensation 16,588 13,098 10,591
Taxes payable 9,937 2,851 5,076
Other current liabilities 6,311 2,698 2,801
Accrued expenses and other current liabilities $ 129,628 $ 70,974 $ 49,798
XML 57 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Debt - Schedule of Outstanding Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]      
Revolving line of credit $ 89,500 $ 0 $ 0
Finance lease obligations 144 633 832
Total debt 265,707 66,883 68,332
Less: debt issuance costs (910) (427) (465)
Total debt, net of issuance costs 264,797 66,456 67,867
Less: current portion (100,394) (5,575) (5,690)
Long-term portion of debt 164,403 60,881 62,177
Term Loan      
Debt Instrument [Line Items]      
Term loan $ 176,063 $ 66,250 $ 67,500
XML 58 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Debt - Additional Information (Details) - USD ($)
Aug. 28, 2023
Mar. 29, 2023
Apr. 30, 2021
Dec. 31, 2023
Revolving Credit Facility        
Debt Instrument [Line Items]        
Basis spread on variable rate   0.00%    
Revolving Credit Facility | SOFR        
Debt Instrument [Line Items]        
Basis spread on variable rate   0.10%    
Revolving Credit Facility | SOFR | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate   1.25%    
Revolving Credit Facility | SOFR | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate   2.125%    
Amended Credit Agreement | Revolving Credit Facility        
Debt Instrument [Line Items]        
Debt instrument, term     5 years  
Remaining borrowing capacity       $ 10,500,000
Interest rate at period end       6.70%
Amended Credit Agreement | Revolving Credit Facility | Minimum        
Debt Instrument [Line Items]        
Unused fee percentage     0.10%  
Amended Credit Agreement | Revolving Credit Facility | Maximum        
Debt Instrument [Line Items]        
Unused fee percentage     0.30%  
Amended Credit Agreement | Revolving Credit Facility | Minimum Floor        
Debt Instrument [Line Items]        
Basis spread on variable rate     0.00%  
Amended Credit Agreement | Revolving Credit Facility | LIBOR | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate     1.25%  
Amended Credit Agreement | Revolving Credit Facility | LIBOR | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate     2.125%  
Amended Credit Agreement | Revolving Credit Facility | Base Rate | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate     0.25%  
Amended Credit Agreement | Revolving Credit Facility | Base Rate | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate     1.125%  
Amended Credit Agreement | Letter of Credit        
Debt Instrument [Line Items]        
Maximum borrowing capacity     $ 7,000,000  
Amended Credit Agreement | Line of Credit        
Debt Instrument [Line Items]        
Maximum borrowing capacity     $ 5,000,000  
Amended Credit Agreement | Term Loan | Minimum Floor        
Debt Instrument [Line Items]        
Basis spread on variable rate     0.00%  
Amended Credit Agreement | Term Loan | LIBOR | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate     1.25%  
Amended Credit Agreement | Term Loan | LIBOR | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate     2.125%  
Amended Credit Agreement | Term Loan | Base Rate | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate     0.25%  
Amended Credit Agreement | Term Loan | Base Rate | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate     1.125%  
Amended Revolving Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing capacity     $ 100,000,000  
Amended Revolving Credit Facility | Term Loan        
Debt Instrument [Line Items]        
Interest rate at period end       6.70%
Amended Term Loan Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Maximum borrowing capacity     $ 100,000,000  
Second Amendment | Base Rate | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 1.00%      
Second Amendment | Incremental Term Loan        
Debt Instrument [Line Items]        
Maximum borrowing capacity $ 115,000,000      
Interest rate at period end       6.90%
Interest rate, amortization 5.00%      
Quarterly installment rate 1.25%      
Second Amendment | Incremental Term Loan | Base Rate | Minimum | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 0.50%      
Second Amendment | Incremental Term Loan | Base Rate | Maximum | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 1.375%      
Second Amendment | Incremental Term Loan | SOFR | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 0.00%      
Second Amendment | Incremental Term Loan | SOFR | Minimum | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 1.50%      
Second Amendment | Incremental Term Loan | SOFR | Maximum | Consolidated Total Net Leverage Ratio Levels        
Debt Instrument [Line Items]        
Basis spread on variable rate 2.375%      
XML 59 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]        
Income tax provision $ 3,528 $ 4,277 $ 16,673 $ 10,531
Effective income tax rate (percentage) 11.60% 18.30% 12.80% 18.90%
XML 60 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock compensation expense $ 11,042 $ 7,257 $ 29,459 $ 21,833
Service-based vesting options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock compensation expense 41 89 128 266
Restricted stock and RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock compensation expense $ 11,001 $ 7,168 $ 29,331 $ 21,567
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based compensation - Additional Information (Details)
$ in Millions
9 Months Ended
Dec. 31, 2023
USD ($)
Service-based vesting options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation cost $ 0.1
Unrecognized stock-based compensation cost, expected weighted-average period of recognition 1 year 9 months 18 days
Restricted stock and RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation cost $ 88.3
Unrecognized stock-based compensation cost, expected weighted-average period of recognition 2 years
XML 62 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Repurchase of common stock (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2023
May 08, 2019
Equity [Abstract]      
Amount authorized under share repurchase program     $ 25,000,000
Repurchase of common stock (in shares) 0 0  
Remaining authorized repurchase amount $ 17,100,000 $ 17,100,000  
XML 63 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Numerator:                
Net income $ 26,888 $ 33,271 $ 52,977 $ 19,105 $ 11,710 $ 14,469 $ 113,136 $ 45,284
Denominator:                
Weighted average common shares outstanding - basic (in shares) 55,140,887     52,707,406     54,503,518 52,239,761
Dilutive common equivalent shares from equity awards (in shares) 2,889,228     3,132,731     3,046,576 2,666,304
Weighted average common shares outstanding - diluted (in shares) 58,030,115     55,840,137     57,550,094 54,906,065
Net income per share:                
Basic (in USD per share) $ 0.49     $ 0.36     $ 2.08 $ 0.87
Diluted (in USD per share) $ 0.46     $ 0.34     $ 1.97 $ 0.82
Anti-dilutive securities excluded from diluted EPS:                
Weighted average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share (in shares) 31,021     9,215     58,792 257,292
XML 64 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Additional Information (Details)
$ in Millions
9 Months Ended
Dec. 31, 2023
USD ($)
renewal_option
Dec. 31, 2022
USD ($)
Leases [Abstract]    
Number of options to renew | renewal_option 1  
Lessee operating lease, option to extend 5 years  
Operating cash flows from operating leases | $ $ 3.2 $ 3.6
XML 65 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Balance Sheet Line Items (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Assets      
Operating lease assets $ 27,224 $ 14,071 $ 15,120
Finance lease assets 0 245 350
Total leased assets 27,224 14,316 15,470
Current      
Operating 7,010 4,510 4,528
Finance 144 575 690
Noncurrent      
Operating 21,720 11,201 12,329
Finance 0 58 142
Total lease liabilities $ 28,874 $ 16,344 $ 17,689
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other assets Other assets Other assets
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other assets Other assets Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued expenses and other current liabilities
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Current portion of long-term debt and finance lease obligations Current portion of long-term debt and finance lease obligations Current portion of long-term debt and finance lease obligations
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Long-term debt and finance lease obligations Long-term debt and finance lease obligations Long-term debt and finance lease obligations
Finance lease accumulated amortization $ 1,500 $ 3,400 $ 3,300
XML 66 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Components of Lease Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]        
Operating lease cost $ 2,203 $ 1,149 $ 4,905 $ 3,458
Finance lease cost        
Amortization of leased assets 0 105 210 315
Interest on lease liabilities 3 7 10 25
Total lease cost $ 2,206 $ 1,261 $ 5,125 $ 3,798
XML 67 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Future Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Operating leases      
Remainder of fiscal 2024 $ 1,985    
2025 8,434    
2026 8,424    
2027 5,060    
2028 1,921    
Thereafter 6,994    
Total lease payments 32,818    
Less: Interest 4,088    
Present value of lease liabilities 28,730    
Finance leases      
Remainder of fiscal 2024 87    
2025 58    
2026 0    
2027 0    
2028 0    
Thereafter 0    
Total lease payments 145    
Less: Interest 1    
Present value of lease liabilities 144 $ 633 $ 832
Total      
Remainder of fiscal 2024 2,072    
2025 8,492    
2026 8,424    
2027 5,060    
2028 1,921    
Thereafter 6,994    
Total lease payments 32,963    
Less: Interest 4,089    
Total lease liabilities $ 28,874 $ 16,344 $ 17,689
XML 68 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Weighted Average Assumptions (Details)
Dec. 31, 2023
Dec. 31, 2022
Weighted-average remaining lease term    
Operating leases 4 years 9 months 18 days 4 years 8 months 12 days
Finance leases 4 months 24 days 1 year 1 month 6 days
Weighted-average discount rate    
Operating leases 4.90% 2.60%
Finance leases 1.60% 2.80%
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 146 271 1 false 34 0 false 7 false false R1.htm 0000001 - Document - Cover page Sheet http://www.elfcosmetics.com/role/Coverpage Cover page Cover 1 false false R2.htm 0000002 - Statement - Condensed consolidated balance sheets (unaudited) Sheet http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited Condensed consolidated balance sheets (unaudited) Statements 2 false false R3.htm 0000003 - Statement - Condensed consolidated balance sheets (unaudited) (Parenthetical) Sheet http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical Condensed consolidated balance sheets (unaudited) (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed consolidated statements of operations (unaudited) Sheet http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited Condensed consolidated statements of operations (unaudited) Statements 4 false false R5.htm 0000005 - Statement - Statement of comprehensive income (Statement) Sheet http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement Statement of comprehensive income (Statement) Statements 5 false false R6.htm 0000006 - Statement - Condensed consolidated statements of stockholders' equity (unaudited) Sheet http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited Condensed consolidated statements of stockholders' equity (unaudited) Statements 6 false false R7.htm 0000007 - Statement - Condensed consolidated statements of cash flows (unaudited) Sheet http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited Condensed consolidated statements of cash flows (unaudited) Statements 7 false false R8.htm 0000008 - Disclosure - Nature of operations Sheet http://www.elfcosmetics.com/role/Natureofoperations Nature of operations Notes 8 false false R9.htm 0000009 - Disclosure - Summary of significant accounting policies Sheet http://www.elfcosmetics.com/role/Summaryofsignificantaccountingpolicies Summary of significant accounting policies Notes 9 false false R10.htm 0000010 - Disclosure - Restricted cash Sheet http://www.elfcosmetics.com/role/Restrictedcash Restricted cash Notes 10 false false R11.htm 0000011 - Disclosure - Investment in equity securities Sheet http://www.elfcosmetics.com/role/Investmentinequitysecurities Investment in equity securities Notes 11 false false R12.htm 0000012 - Disclosure - Acquisition Sheet http://www.elfcosmetics.com/role/Acquisition Acquisition Notes 12 false false R13.htm 0000013 - Disclosure - Goodwill and intangible assets Sheet http://www.elfcosmetics.com/role/Goodwillandintangibleassets Goodwill and intangible assets Notes 13 false false R14.htm 0000014 - Disclosure - Accrued expenses and other current liabilities Sheet http://www.elfcosmetics.com/role/Accruedexpensesandothercurrentliabilities Accrued expenses and other current liabilities Notes 14 false false R15.htm 0000015 - Disclosure - Debt Sheet http://www.elfcosmetics.com/role/Debt Debt Notes 15 false false R16.htm 0000016 - Disclosure - Commitments and contingencies Sheet http://www.elfcosmetics.com/role/Commitmentsandcontingencies Commitments and contingencies Notes 16 false false R17.htm 0000017 - Disclosure - Income taxes Sheet http://www.elfcosmetics.com/role/Incometaxes Income taxes Notes 17 false false R18.htm 0000018 - Disclosure - Stock-based compensation Sheet http://www.elfcosmetics.com/role/Stockbasedcompensation Stock-based compensation Notes 18 false false R19.htm 0000019 - Disclosure - Repurchase of common stock Sheet http://www.elfcosmetics.com/role/Repurchaseofcommonstock Repurchase of common stock Notes 19 false false R20.htm 0000020 - Disclosure - Net income per share Sheet http://www.elfcosmetics.com/role/Netincomepershare Net income per share Notes 20 false false R21.htm 0000021 - Disclosure - Leases Sheet http://www.elfcosmetics.com/role/Leases Leases Notes 21 false false R22.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 22 false false R23.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 23 false false R24.htm 9954471 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies Summary of significant accounting policies (Policies) Policies 24 false false R25.htm 9954472 - Disclosure - Summary of significant accounting policies (Tables) Sheet http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesTables Summary of significant accounting policies (Tables) Tables http://www.elfcosmetics.com/role/Summaryofsignificantaccountingpolicies 25 false false R26.htm 9954473 - Disclosure - Restricted cash (Tables) Sheet http://www.elfcosmetics.com/role/RestrictedcashTables Restricted cash (Tables) Tables http://www.elfcosmetics.com/role/Restrictedcash 26 false false R27.htm 9954474 - Disclosure - Acquisition (Tables) Sheet http://www.elfcosmetics.com/role/AcquisitionTables Acquisition (Tables) Tables http://www.elfcosmetics.com/role/Acquisition 27 false false R28.htm 9954475 - Disclosure - Goodwill and intangible assets (Tables) Sheet http://www.elfcosmetics.com/role/GoodwillandintangibleassetsTables Goodwill and intangible assets (Tables) Tables http://www.elfcosmetics.com/role/Goodwillandintangibleassets 28 false false R29.htm 9954476 - Disclosure - Accrued expenses and other current liabilities (Tables) Sheet http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesTables Accrued expenses and other current liabilities (Tables) Tables http://www.elfcosmetics.com/role/Accruedexpensesandothercurrentliabilities 29 false false R30.htm 9954477 - Disclosure - Debt (Tables) Sheet http://www.elfcosmetics.com/role/DebtTables Debt (Tables) Tables http://www.elfcosmetics.com/role/Debt 30 false false R31.htm 9954478 - Disclosure - Stock-based compensation (Tables) Sheet http://www.elfcosmetics.com/role/StockbasedcompensationTables Stock-based compensation (Tables) Tables http://www.elfcosmetics.com/role/Stockbasedcompensation 31 false false R32.htm 9954479 - Disclosure - Net income per share (Tables) Sheet http://www.elfcosmetics.com/role/NetincomepershareTables Net income per share (Tables) Tables http://www.elfcosmetics.com/role/Netincomepershare 32 false false R33.htm 9954480 - Disclosure - Leases (Tables) Sheet http://www.elfcosmetics.com/role/LeasesTables Leases (Tables) Tables http://www.elfcosmetics.com/role/Leases 33 false false R34.htm 9954481 - Disclosure - Summary of significant accounting policies - Additional Information (Details) Sheet http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesAdditionalInformationDetails Summary of significant accounting policies - Additional Information (Details) Details 34 false false R35.htm 9954482 - Disclosure - Summary of significant accounting policies - Disaggregation of Revenue (Details) Sheet http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails Summary of significant accounting policies - Disaggregation of Revenue (Details) Details 35 false false R36.htm 9954483 - Disclosure - Restricted cash - Narrative (Details) Sheet http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails Restricted cash - Narrative (Details) Details 36 false false R37.htm 9954484 - Disclosure - Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) Details 37 false false R38.htm 9954485 - Disclosure - Investment in equity securities - (Details) Sheet http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails Investment in equity securities - (Details) Details http://www.elfcosmetics.com/role/Investmentinequitysecurities 38 false false R39.htm 9954486 - Disclosure - Acquisition - Narrative (Details) Sheet http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails Acquisition - Narrative (Details) Details 39 false false R40.htm 9954487 - Disclosure - Acquisition - Schedule of Consideration Transferred (Details) Sheet http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails Acquisition - Schedule of Consideration Transferred (Details) Details 40 false false R41.htm 9954488 - Disclosure - Acquisition - Schedule of Purchase Price Allocation (Details) Sheet http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails Acquisition - Schedule of Purchase Price Allocation (Details) Details 41 false false R42.htm 9954489 - Disclosure - Acquisition - Schedule of Goodwill (Details) Sheet http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails Acquisition - Schedule of Goodwill (Details) Details 42 false false R43.htm 9954490 - Disclosure - Acquisition - Schedule of Acquisition Net Sales (Details) Sheet http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails Acquisition - Schedule of Acquisition Net Sales (Details) Details 43 false false R44.htm 9954491 - Disclosure - Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details) Sheet http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details) Details 44 false false R45.htm 9954492 - Disclosure - Goodwill and intangible assets - Additional Information (Details) Sheet http://www.elfcosmetics.com/role/GoodwillandintangibleassetsAdditionalInformationDetails Goodwill and intangible assets - Additional Information (Details) Details 45 false false R46.htm 9954493 - Disclosure - Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details) Sheet http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details) Details 46 false false R47.htm 9954494 - Disclosure - Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details) Details 47 false false R48.htm 9954495 - Disclosure - Debt - Schedule of Outstanding Debt (Details) Sheet http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails Debt - Schedule of Outstanding Debt (Details) Details 48 false false R49.htm 9954496 - Disclosure - Debt - Additional Information (Details) Sheet http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 49 false false R50.htm 9954497 - Disclosure - Income taxes (Details) Sheet http://www.elfcosmetics.com/role/IncometaxesDetails Income taxes (Details) Details http://www.elfcosmetics.com/role/Incometaxes 50 false false R51.htm 9954498 - Disclosure - Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) Sheet http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) Details 51 false false R52.htm 9954499 - Disclosure - Stock-based compensation - Additional Information (Details) Sheet http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails Stock-based compensation - Additional Information (Details) Details 52 false false R53.htm 9954500 - Disclosure - Repurchase of common stock (Details) Sheet http://www.elfcosmetics.com/role/RepurchaseofcommonstockDetails Repurchase of common stock (Details) Details http://www.elfcosmetics.com/role/Repurchaseofcommonstock 53 false false R54.htm 9954501 - Disclosure - Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details) Sheet http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details) Details 54 false false R55.htm 9954502 - Disclosure - Leases - Additional Information (Details) Sheet http://www.elfcosmetics.com/role/LeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 55 false false R56.htm 9954503 - Disclosure - Leases - Balance Sheet Line Items (Details) Sheet http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails Leases - Balance Sheet Line Items (Details) Details 56 false false R57.htm 9954504 - Disclosure - Leases - Components of Lease Expense (Details) Sheet http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails Leases - Components of Lease Expense (Details) Details 57 false false R58.htm 9954505 - Disclosure - Leases - Future Minimum Lease Payments (Details) Sheet http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails Leases - Future Minimum Lease Payments (Details) Details 58 false false R59.htm 9954506 - Disclosure - Leases - Weighted Average Assumptions (Details) Sheet http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails Leases - Weighted Average Assumptions (Details) Details 59 false false All Reports Book All Reports elf-20231231.htm elf-20231231.xsd elf-20231231_cal.xml elf-20231231_def.xml elf-20231231_lab.xml elf-20231231_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 76 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "elf-20231231.htm": { "nsprefix": "elf", "nsuri": "http://www.elfcosmetics.com/20231231", "dts": { "inline": { "local": [ "elf-20231231.htm" ] }, "schema": { "local": [ "elf-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "elf-20231231_cal.xml" ] }, "definitionLink": { "local": [ "elf-20231231_def.xml" ] }, "labelLink": { "local": [ "elf-20231231_lab.xml" ] }, "presentationLink": { "local": [ "elf-20231231_pre.xml" ] } }, "keyStandard": 242, "keyCustom": 29, "axisStandard": 12, "axisCustom": 1, "memberStandard": 16, "memberCustom": 17, "hidden": { "total": 20, "http://fasb.org/us-gaap/2023": 15, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 146, "entityCount": 1, "segmentCount": 34, "elementCount": 478, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 704, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.elfcosmetics.com/role/Coverpage", "longName": "0000001 - Document - Cover page", "shortName": "Cover page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "longName": "0000002 - Statement - Condensed consolidated balance sheets (unaudited)", "shortName": "Condensed consolidated balance sheets (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical", "longName": "0000003 - Statement - Condensed consolidated balance sheets (unaudited) (Parenthetical)", "shortName": "Condensed consolidated balance sheets (unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "longName": "0000004 - Statement - Condensed consolidated statements of operations (unaudited)", "shortName": "Condensed consolidated statements of operations (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R5": { "role": "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement", "longName": "0000005 - Statement - Statement of comprehensive income (Statement)", "shortName": "Statement of comprehensive income (Statement)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R6": { "role": "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited", "longName": "0000006 - Statement - Condensed consolidated statements of stockholders' equity (unaudited)", "shortName": "Condensed consolidated statements of stockholders' equity (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-39", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-43", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R7": { "role": "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited", "longName": "0000007 - Statement - Condensed consolidated statements of cash flows (unaudited)", "shortName": "Condensed consolidated statements of cash flows (unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R8": { "role": "http://www.elfcosmetics.com/role/Natureofoperations", "longName": "0000008 - Disclosure - Nature of operations", "shortName": "Nature of operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.elfcosmetics.com/role/Summaryofsignificantaccountingpolicies", "longName": "0000009 - Disclosure - Summary of significant accounting policies", "shortName": "Summary of significant accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.elfcosmetics.com/role/Restrictedcash", "longName": "0000010 - Disclosure - Restricted cash", "shortName": "Restricted cash", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.elfcosmetics.com/role/Investmentinequitysecurities", "longName": "0000011 - Disclosure - Investment in equity securities", "shortName": "Investment in equity securities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.elfcosmetics.com/role/Acquisition", "longName": "0000012 - Disclosure - Acquisition", "shortName": "Acquisition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.elfcosmetics.com/role/Goodwillandintangibleassets", "longName": "0000013 - Disclosure - Goodwill and intangible assets", "shortName": "Goodwill and intangible assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.elfcosmetics.com/role/Accruedexpensesandothercurrentliabilities", "longName": "0000014 - Disclosure - Accrued expenses and other current liabilities", "shortName": "Accrued expenses and other current liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.elfcosmetics.com/role/Debt", "longName": "0000015 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.elfcosmetics.com/role/Commitmentsandcontingencies", "longName": "0000016 - Disclosure - Commitments and contingencies", "shortName": "Commitments and contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.elfcosmetics.com/role/Incometaxes", "longName": "0000017 - Disclosure - Income taxes", "shortName": "Income taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.elfcosmetics.com/role/Stockbasedcompensation", "longName": "0000018 - Disclosure - Stock-based compensation", "shortName": "Stock-based compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.elfcosmetics.com/role/Repurchaseofcommonstock", "longName": "0000019 - Disclosure - Repurchase of common stock", "shortName": "Repurchase of common stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.elfcosmetics.com/role/Netincomepershare", "longName": "0000020 - Disclosure - Net income per share", "shortName": "Net income per share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.elfcosmetics.com/role/Leases", "longName": "0000021 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeFinanceLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-6", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies", "longName": "9954471 - Disclosure - Summary of significant accounting policies (Policies)", "shortName": "Summary of significant accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesTables", "longName": "9954472 - Disclosure - Summary of significant accounting policies (Tables)", "shortName": "Summary of significant accounting policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.elfcosmetics.com/role/RestrictedcashTables", "longName": "9954473 - Disclosure - Restricted cash (Tables)", "shortName": "Restricted cash (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.elfcosmetics.com/role/AcquisitionTables", "longName": "9954474 - Disclosure - Acquisition (Tables)", "shortName": "Acquisition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsTables", "longName": "9954475 - Disclosure - Goodwill and intangible assets (Tables)", "shortName": "Goodwill and intangible assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesTables", "longName": "9954476 - Disclosure - Accrued expenses and other current liabilities (Tables)", "shortName": "Accrued expenses and other current liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.elfcosmetics.com/role/DebtTables", "longName": "9954477 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.elfcosmetics.com/role/StockbasedcompensationTables", "longName": "9954478 - Disclosure - Stock-based compensation (Tables)", "shortName": "Stock-based compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.elfcosmetics.com/role/NetincomepershareTables", "longName": "9954479 - Disclosure - Net income per share (Tables)", "shortName": "Net income per share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.elfcosmetics.com/role/LeasesTables", "longName": "9954480 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "elf:AssetsAndLiabilitiesLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "elf:AssetsAndLiabilitiesLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesAdditionalInformationDetails", "longName": "9954481 - Disclosure - Summary of significant accounting policies - Additional Information (Details)", "shortName": "Summary of significant accounting policies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails", "longName": "9954482 - Disclosure - Summary of significant accounting policies - Disaggregation of Revenue (Details)", "shortName": "Summary of significant accounting policies - Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-65", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R36": { "role": "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "longName": "9954483 - Disclosure - Restricted cash - Narrative (Details)", "shortName": "Restricted cash - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails", "longName": "9954484 - Disclosure - Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)", "shortName": "Restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-74", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R38": { "role": "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails", "longName": "9954485 - Disclosure - Investment in equity securities - (Details)", "shortName": "Investment in equity securities - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R39": { "role": "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "longName": "9954486 - Disclosure - Acquisition - Narrative (Details)", "shortName": "Acquisition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "longName": "9954487 - Disclosure - Acquisition - Schedule of Consideration Transferred (Details)", "shortName": "Acquisition - Schedule of Consideration Transferred (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-78", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R41": { "role": "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails", "longName": "9954488 - Disclosure - Acquisition - Schedule of Purchase Price Allocation (Details)", "shortName": "Acquisition - Schedule of Purchase Price Allocation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-79", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R42": { "role": "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "longName": "9954489 - Disclosure - Acquisition - Schedule of Goodwill (Details)", "shortName": "Acquisition - Schedule of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-89", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R43": { "role": "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "longName": "9954490 - Disclosure - Acquisition - Schedule of Acquisition Net Sales (Details)", "shortName": "Acquisition - Schedule of Acquisition Net Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-84", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails", "longName": "9954491 - Disclosure - Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details)", "shortName": "Goodwill and intangible assets - Information Regarding Company's Goodwill and Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsAdditionalInformationDetails", "longName": "9954492 - Disclosure - Goodwill and intangible assets - Additional Information (Details)", "shortName": "Goodwill and intangible assets - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails", "longName": "9954493 - Disclosure - Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details)", "shortName": "Goodwill and intangible assets - Future Amortization Expense for Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails", "longName": "9954494 - Disclosure - Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Accrued expenses and other current liabilities - Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-3", "name": "elf:AccruedExpenses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "elf:AccruedExpenses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails", "longName": "9954495 - Disclosure - Debt - Schedule of Outstanding Debt (Details)", "shortName": "Debt - Schedule of Outstanding Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LineOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:LineOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "longName": "9954496 - Disclosure - Debt - Additional Information (Details)", "shortName": "Debt - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-124", "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-124", "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.elfcosmetics.com/role/IncometaxesDetails", "longName": "9954497 - Disclosure - Income taxes (Details)", "shortName": "Income taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R51": { "role": "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails", "longName": "9954498 - Disclosure - Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details)", "shortName": "Stock-based compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "longName": "9954499 - Disclosure - Stock-based compensation - Additional Information (Details)", "shortName": "Stock-based compensation - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-144", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-144", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.elfcosmetics.com/role/RepurchaseofcommonstockDetails", "longName": "9954500 - Disclosure - Repurchase of common stock (Details)", "shortName": "Repurchase of common stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-146", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-146", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails", "longName": "9954501 - Disclosure - Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details)", "shortName": "Net income per share - Reconciliation of Numerator and Denominator in Basic and Diluted Net Income (Loss) Per Common Share Computations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "unique": true } }, "R55": { "role": "http://www.elfcosmetics.com/role/LeasesAdditionalInformationDetails", "longName": "9954502 - Disclosure - Leases - Additional Information (Details)", "shortName": "Leases - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "elf:LesseeOperatingLeaseNumberOfOptionsToRenew", "unitRef": "renewal_option", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "elf:LesseeOperatingLeaseNumberOfOptionsToRenew", "unitRef": "renewal_option", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails", "longName": "9954503 - Disclosure - Leases - Balance Sheet Line Items (Details)", "shortName": "Leases - Balance Sheet Line Items (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "elf:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "elf:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails", "longName": "9954504 - Disclosure - Leases - Components of Lease Expense (Details)", "shortName": "Leases - Components of Lease Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails", "longName": "9954505 - Disclosure - Leases - Future Minimum Lease Payments (Details)", "shortName": "Leases - Future Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails", "longName": "9954506 - Disclosure - Leases - Weighted Average Assumptions (Details)", "shortName": "Leases - Weighted Average Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "elf-20231231.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Accruedexpensesandothercurrentliabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r539" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r205", "r206" ] }, "elf_AccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AccruedExpenses", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accrued Expenses", "documentation": "Accrued expenses." } } }, "auth_ref": [] }, "elf_AccruedInventoryCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AccruedInventoryCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued inventory", "label": "Accrued Inventory, Current", "documentation": "Accrued Inventory, Current" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued marketing", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r27", "r28", "r76", "r132", "r408", "r422", "r423" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r13", "r28", "r358", "r361", "r391", "r418", "r419", "r633", "r634", "r635", "r640", "r641", "r642" ] }, "elf_AcquisitionRelatedSellerExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AcquisitionRelatedSellerExpenses", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition-related seller expenses", "label": "Acquisition Related, Seller Expenses", "documentation": "Acquisition Related, Seller Expenses" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r588" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r71" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r329", "r330", "r331", "r429", "r640", "r641", "r642", "r661", "r678" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r594" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r594" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r594" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r594" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r51", "r52", "r294" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r559", "r570", "r580", "r605" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r562", "r573", "r583", "r608" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r594" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r601" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r566", "r574", "r584", "r601", "r609", "r613", "r621" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r619" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r324", "r332" ] }, "elf_AmendedCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AmendedCreditAgreementMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended Credit Agreement", "label": "Amended Credit Agreement [Member]", "documentation": "Amended Credit Agreement" } } }, "auth_ref": [] }, "elf_AmendedRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AmendedRevolvingCreditFacilityMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended Revolving Credit Facility", "label": "Amended Revolving Credit Facility [Member]", "documentation": "Amended Revolving Credit Facility" } } }, "auth_ref": [] }, "elf_AmendedTermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AmendedTermLoanFacilityMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended Term Loan Facility", "label": "Amended Term Loan Facility [Member]", "documentation": "Amended Term Loan Facility" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs and discount on debt", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r261", "r376", "r523", "r524", "r637" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r40", "r45" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r177" ] }, "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferredTransactionCost", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition transaction cost", "label": "Asset Acquisition, Consideration Transferred, Transaction Cost", "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition." } } }, "auth_ref": [ "r537", "r658", "r659", "r660" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r105", "r131", "r150", "r182", "r195", "r199", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r353", "r355", "r369", "r402", "r456", "r539", "r550", "r651", "r652", "r666" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "elf_AssetsAndLiabilitiesLesseeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Balance Sheet Information", "label": "Assets And Liabilities, Lessee [Table Text Block]", "documentation": "Assets and Liabilities, Lessee [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r125", "r134", "r150", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r353", "r355", "r369", "r539", "r651", "r652", "r666" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r616" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r617" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r612" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r612" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r612" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r612" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r612" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r612" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r615" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r614" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r613" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r613" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r59", "r60" ] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base Rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r350", "r533", "r534" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r54", "r55", "r350", "r533", "r534" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued (in shares)", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r101" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r350" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Acquisition Net Sales", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r629", "r630" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business acquisition, share price (in usd per share)", "label": "Business Acquisition, Share Price", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma revenue", "label": "Business Acquisition, Pro Forma Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r348", "r349" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total consideration transferred", "totalLabel": "Total consideration transferred", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r11" ] }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity consideration (common stock issued)", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination." } } }, "auth_ref": [ "r1", "r2" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Acquisition" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r99", "r351" ] }, "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpensesAndOtherCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accrued expenses and other current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses And Other Current Liabilities, Other", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Expenses And Other Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accounts payable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net deferred tax liability", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r57" ] }, "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilityAssumedForAcquisitionSellerRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilityAssumedForAcquisitionSellerRelatedExpenses", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsAcquired", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability assumed for acquisition-related seller expenses", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liability Assumed For Acquisition Seller Related Expenses", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liability Assumed For Acquisition Seller Related Expenses" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total purchase price", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r56", "r57" ] }, "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsAcquired", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Acquired", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Acquired" } } }, "auth_ref": [] }, "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsExcludingLiabilityForAcquisitionRelatedSellerExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsExcludingLiabilityForAcquisitionRelatedSellerExpenses", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": "elf_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAssetsAcquired", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net assets acquired, excluding liability assumed for acquisition-related seller expenses", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Excluding Liability For Acquisition Related Seller Expenses", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Assets Excluding Liability For Acquisition Related Seller Expenses" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r56", "r57" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business combinations", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r53" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r34", "r127", "r512" ] }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Restrictedcash" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Cash and Cash Equivalents Disclosure [Text Block]", "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify." } } }, "auth_ref": [ "r127", "r406" ] }, "us-gaap_CashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsMember", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents [Member]", "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited", "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash - beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash - end of period", "terseLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r34", "r84", "r146" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r84" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r592" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r593" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r593" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 9)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r25", "r65", "r405", "r443" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Commitmentsandcontingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r93", "r224", "r225", "r498", "r650" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r541", "r542", "r543", "r545", "r546", "r547", "r548", "r640", "r641", "r661", "r677", "r678" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in USD per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r70" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r70", "r444" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r70" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.elfcosmetics.com/role/CondensedconsolidatedbalancesheetsunauditedParenthetical", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r70", "r444", "r462", "r678", "r679" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value of $0.01 per share; 250,000,000 shares authorized as of December 31, 2023, March\u00a031, 2023 and December 31, 2022; 55,412,234, 53,770,482 and 53,165,462 shares issued and outstanding as of December 31, 2023, March\u00a031, 2023 and December 31, 2022, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r70", "r407", "r539" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r598" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r597" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r599" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r596" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r29", "r137", "r139", "r143", "r398", "r414" ] }, "elf_ConsolidatedTotalNetLeverageRatioLevelsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "ConsolidatedTotalNetLeverageRatioLevelsMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Total Net Leverage Ratio Levels", "label": "Consolidated Total Net Leverage Ratio Levels [Member]", "documentation": "Consolidated Total Net Leverage Ratio Levels" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r80", "r394" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "elf_CustomerRelationshipsRetailersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "CustomerRelationshipsRetailersMember", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships\u00a0\u2013 retailers", "label": "Customer Relationships Retailers [Member]", "documentation": "Customer relationships retailers." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r94", "r148", "r239", "r245", "r246", "r247", "r248", "r249", "r250", "r255", "r262", "r263", "r265" ] }, "elf_DebtInstrumentAnnualPrincipalAmortizationRate": { "xbrltype": "percentItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "DebtInstrumentAnnualPrincipalAmortizationRate", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate, amortization", "label": "Debt Instrument, Annual Principal Amortization Rate", "documentation": "Debt Instrument, Annual Principal Amortization Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r16", "r67", "r68", "r106", "r107", "r152", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r377", "r520", "r521", "r522", "r523", "r524", "r638" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": "elf_LongTermDebtGrossAndLeaseObligation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r16", "r107", "r266" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r152", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r377", "r520", "r521", "r522", "r523", "r524", "r638" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r23", "r152", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r377", "r520", "r521", "r522", "r523", "r524", "r638" ] }, "elf_DebtInstrumentQuarterlyInstallmentRate": { "xbrltype": "percentItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "DebtInstrumentQuarterlyInstallmentRate", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly installment rate", "label": "Debt Instrument, Quarterly Installment Rate", "documentation": "Debt Instrument, Quarterly Installment Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r23", "r48", "r49", "r61", "r62", "r64", "r66", "r96", "r97", "r152", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r377", "r520", "r521", "r522", "r523", "r524", "r638" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r63", "r654" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r334", "r335", "r403" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r86" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r185" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r289", "r526", "r527", "r528", "r529", "r530", "r531", "r532" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r289", "r526", "r527", "r528", "r529", "r530", "r531", "r532" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r655" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Stockbasedcompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r292", "r297", "r325", "r326", "r328", "r536" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r554" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r587" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in USD per share)", "verboseLabel": "Basic (in USD per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r144", "r158", "r159", "r160", "r161", "r162", "r167", "r169", "r174", "r175", "r176", "r180", "r365", "r366", "r399", "r415", "r514" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in USD per share)", "verboseLabel": "Diluted (in USD per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r144", "r158", "r159", "r160", "r161", "r162", "r169", "r174", "r175", "r176", "r180", "r365", "r366", "r399", "r415", "r514" ] }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "presentation": [ "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive securities excluded from diluted EPS:", "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareReconciliationAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income per share:", "verboseLabel": "Net income per share:", "label": "Earnings Per Share Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Netincomepershare" ], "lang": { "en-us": { "role": { "terseLabel": "Net income per share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r166", "r177", "r178", "r179" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r663" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.elfcosmetics.com/role/IncometaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate (percentage)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r337" ] }, "elf_ElectronicCommerceCustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "ElectronicCommerceCustomerRelationshipsMember", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships\u00a0\u2013 e-commerce", "label": "Electronic Commerce Customer Relationships [Member]", "documentation": "Electronic commerce customer relationships." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r21" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation cost, expected weighted-average period of recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r327" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r657" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r657" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r552" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r552" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r552" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r626" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r552" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r552" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r552" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r552" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r123", "r140", "r141", "r142", "r153", "r154", "r155", "r157", "r163", "r165", "r181", "r215", "r216", "r279", "r329", "r330", "r331", "r341", "r342", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r391", "r418", "r419", "r420", "r429", "r481" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r211", "r212", "r213" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r209" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charge", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount", "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r210" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment of equity investment", "terseLabel": "Impairment of equity investment", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r210" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r595" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r559", "r570", "r580", "r605" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r556", "r567", "r577", "r602" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r601" ] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest on lease liabilities", "label": "Finance Lease, Interest Expense", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r382", "r385", "r538" ] }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leases", "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": "elf_LongTermDebtGrossAndLeaseObligation", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails", "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance lease obligations", "terseLabel": "Present value of lease liabilities", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r380", "r390" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance", "label": "Finance Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r380" ] }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]", "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current finance lease liability." } } }, "auth_ref": [ "r381" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturities of Finance Lease Liabilities", "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r665" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseLiability", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r380" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability." } } }, "auth_ref": [ "r381" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Finance Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearOne", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finance Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearFour", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finance Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearThree", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finance Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearTwo", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finance Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsRemainderOfFiscalYear", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of fiscal 2024", "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r665" ] }, "elf_FinanceLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueAfterYearFour", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finance Lease, Liability, To Be Paid, After Year Four", "documentation": "Finance Lease, Liability, To Be Paid, After Year Four" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityUndiscountedExcessAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Interest", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r390" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseRightOfUseAsset", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease assets", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r379" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease accumulated amortization", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease." } } }, "auth_ref": [ "r628", "r631" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of leased assets", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r382", "r385", "r538" ] }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]", "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset." } } }, "auth_ref": [ "r381" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leases", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r389", "r538" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance leases", "label": "Finance Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r388", "r538" ] }, "elf_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful life", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Finite-lived intangibles, Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r129", "r221" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of fiscal 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r91" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r218", "r220", "r221", "r223", "r395", "r396" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "elf_IntangibleAssetsGrossIncludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived intangibles, Gross carrying amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r90", "r396" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r41", "r44" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsFutureAmortizationExpenseforIntangibleAssetsDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Finite-lived intangibles, Net carrying amount", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r90", "r395" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r563", "r574", "r584", "r609" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r563", "r574", "r584", "r609" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r563", "r574", "r584", "r609" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r563", "r574", "r584", "r609" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r563", "r574", "r584", "r609" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 5.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "negatedTerseLabel": "Loss on extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r9", "r46", "r47" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "elf_IntangibleAssetsGrossIncludingGoodwill", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails", "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r128", "r217", "r397", "r519", "r539", "r646", "r647" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and intangible asset impairment", "label": "Goodwill and Intangible Asset Impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Goodwillandintangibleassets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and intangible assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r89" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r79", "r150", "r182", "r194", "r198", "r200", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r369", "r516", "r651" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of finite-lived intangible assets", "label": "Impairment of Intangible Assets, Finite-Lived", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r637", "r648" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income before provision for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r77", "r109", "r182", "r194", "r198", "r200", "r400", "r412", "r516" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Incometaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r151", "r333", "r338", "r339", "r340", "r343", "r345", "r346", "r347", "r428" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/IncometaxesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax provision", "terseLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r113", "r119", "r164", "r165", "r186", "r336", "r344", "r416" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive common equivalent shares from equity awards (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r170", "r171", "r172", "r176", "r296" ] }, "elf_IncrementalTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "IncrementalTermLoanMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental Term Loan", "label": "Incremental Term Loan [Member]", "documentation": "Incremental Term Loan" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r219", "r222" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "elf_IntangibleAssetsGrossIncludingGoodwill", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite lived intangibles, Net carrying amount", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r92" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r42", "r92" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r566", "r574", "r584", "r601", "r609", "r613", "r621" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r619" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r555", "r625" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r555", "r625" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r555", "r625" ] }, "elf_IntangibleAssetsGrossIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "IntangibleAssetsGrossIncludingGoodwill", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Goodwill and other intangibles, Gross carrying amount", "label": "Intangible Assets Gross Including Goodwill", "documentation": "Intangible assets gross including goodwill." } } }, "auth_ref": [] }, "elf_IntangibleAssetsIncludingGoodwillAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "IntangibleAssetsIncludingGoodwillAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Goodwill and other intangibles, Accumulated amortization", "label": "Intangible Assets Including Goodwill, Accumulated Amortization", "documentation": "Intangible assets including goodwill accumulated amortization." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r39", "r43" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Goodwill and other intangibles, Net carrying amount", "label": "Intangible Assets, Net (Including Goodwill)", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Income (Expense), Nonoperating, Net", "documentation": "The net amount of nonoperating interest income (expense)." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, net", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r133", "r513", "r539" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, All Other Investments [Abstract]", "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Investmentinequitysecurities" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in equity securities", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r103", "r111", "r112", "r122", "r207", "r208", "r367", "r368" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r384", "r538" ] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease cost", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Lease Expense", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r664" ] }, "elf_LeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Lease, Liabilities, Payments, Due [Abstract]", "documentation": "Lease, Liabilities, Payments, Due [Abstract]" } } }, "auth_ref": [] }, "elf_LeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiability", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails", "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease liabilities", "label": "Lease, Liability", "documentation": "Lease, Liability" } } }, "auth_ref": [] }, "elf_LeaseLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Lease, Liability [Abstract]", "documentation": "Lease, Liability [Abstract]" } } }, "auth_ref": [] }, "elf_LeaseLiabilityCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityCurrentAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current", "label": "Lease Liability, Current [Abstract]", "documentation": "Lease Liability, Current [Abstract]" } } }, "auth_ref": [] }, "elf_LeaseLiabilityNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityNoncurrentAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent", "label": "Lease, Liability, Noncurrent [Abstract]", "documentation": "Lease, Liability, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lease Liability, Payments, Due", "documentation": "Lease Liability, Payments, Due" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDueAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDueAfterYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Thereafter", "label": "Lease Liability, Payments, Due After Year Four", "documentation": "Lease Liability, Payments, Due After Year Four" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2028", "label": "Lease Liability, Payments, Due Year Four", "documentation": "Lease Liability, Payments, Due Year Four" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDueYearOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDueYearOne", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2025", "label": "Lease Liability, Payments, Due Year One", "documentation": "Lease Liability, Payments, Due Year One" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2027", "label": "Lease Liability, Payments, Due Year Three", "documentation": "Lease Liability, Payments, Due Year Three" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2026", "label": "Lease Liability, Payments, Due Year Two", "documentation": "Lease Liability, Payments, Due Year Two" } } }, "auth_ref": [] }, "elf_LeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Remainder of fiscal 2024", "label": "Lease Liability, Payments, Remainder Of Fiscal Year", "documentation": "Lease Liability, Payments, Remainder Of Fiscal Year" } } }, "auth_ref": [] }, "elf_LeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Less: Interest", "label": "Lease Liability, Undiscounted Excess Amount", "documentation": "Lease Liability, Undiscounted Excess Amount" } } }, "auth_ref": [] }, "elf_LeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total leased assets", "label": "Lease, Right-Of-Use Asset", "documentation": "Lease, Right-Of-Use Asset" } } }, "auth_ref": [] }, "elf_LeaseRightOfUseAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeaseRightOfUseAssetAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Lease, Right-Of-Use Asset [Abstract]", "documentation": "" } } }, "auth_ref": [] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "elf_LeasesWeightedAverageDiscountRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LeasesWeightedAverageDiscountRateAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average discount rate", "label": "Leases, Weighted Average Discount Rate [Abstract]", "documentation": "Leases, Weighted Average Discount Rate [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeasesTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Finance Leases [Text Block]", "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability." } } }, "auth_ref": [ "r378" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturities of Operating Lease Liabilities", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r665" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearOne", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearFour", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearThree", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueYearTwo", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r390" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsRemainderOfFiscalYear", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of fiscal 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r665" ] }, "elf_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityPaymentsDueAfterYearFour", "weight": 1.0, "order": 2.0 }, "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiabilityUndiscountedExcessAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r390" ] }, "elf_LesseeOperatingLeaseNumberOfOptionsToRenew": { "xbrltype": "integerItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LesseeOperatingLeaseNumberOfOptionsToRenew", "presentation": [ "http://www.elfcosmetics.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of options to renew", "label": "Lessee Operating Lease, Number Of Options To Renew", "documentation": "Lessee Operating Lease, Number Of Options To Renew" } } }, "auth_ref": [] }, "elf_LesseeOperatingLeaseOptionToExtendTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LesseeOperatingLeaseOptionToExtendTerm", "presentation": [ "http://www.elfcosmetics.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee operating lease, option to extend", "label": "Lessee, Operating Lease, Option to Extend, Term", "documentation": "Lessee, Operating Lease, Option to Extend, Term" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r378" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r20", "r150", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r354", "r355", "r356", "r369", "r442", "r515", "r550", "r651", "r666", "r667" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r75", "r108", "r410", "r539", "r639", "r645", "r662" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and stockholders' equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r22", "r126", "r150", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r354", "r355", "r356", "r369", "r539", "r651", "r666", "r667" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": "elf_LongTermDebtGrossAndLeaseObligation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving line of credit", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r16", "r107", "r674" ] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate at period end", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r18" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r18" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining borrowing capacity", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r18" ] }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused fee percentage", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "elf_LondonInterBankOfferedRateLIBOR1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LondonInterBankOfferedRateLIBOR1Member", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "LIBOR", "label": "London Inter Bank Offered Rate (LIBOR) 1 [Member]", "documentation": "London Inter Bank Offered Rate (LIBOR) 1" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails_1": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt and finance lease obligations", "verboseLabel": "Long-term portion of debt", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r16", "r404" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails_1": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt and finance lease obligations", "negatedLabel": "Less: current portion", "label": "Long-Term Debt and Lease Obligation, Current", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r21" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt, net of issuance costs", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "documentation": "Amount of long-term debt and lease obligation, including portion classified as current." } } }, "auth_ref": [] }, "elf_LongTermDebtGrossAndLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "LongTermDebtGrossAndLeaseObligation", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Long-Term Debt, Gross And Lease Obligation", "documentation": "Long-Term Debt, Gross And Lease Obligation" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r291", "r393", "r417", "r434", "r435", "r486", "r488", "r490", "r491", "r493", "r508", "r509", "r518", "r525", "r535", "r540", "r653", "r668", "r669", "r670", "r671", "r672", "r673" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r593" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r593" ] }, "elf_MinimumFloorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "MinimumFloorMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum Floor", "label": "Minimum Floor [Member]", "documentation": "Minimum Floor [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r291", "r393", "r417", "r434", "r435", "r486", "r488", "r490", "r491", "r493", "r508", "r509", "r518", "r525", "r535", "r540", "r653", "r668", "r669", "r670", "r671", "r672", "r673" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r612" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r620" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r594" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.elfcosmetics.com/role/Natureofoperations" ], "lang": { "en-us": { "role": { "terseLabel": "Nature of operations", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r114", "r120" ] }, "elf_NaturiumLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "NaturiumLLCMember", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Naturium LLC", "label": "Naturium LLC [Member]", "documentation": "Naturium LLC" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r145" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r84", "r85", "r86" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails", "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r78", "r86", "r110", "r124", "r135", "r138", "r142", "r150", "r156", "r158", "r159", "r160", "r161", "r164", "r165", "r173", "r182", "r194", "r198", "r200", "r214", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r366", "r369", "r413", "r464", "r479", "r480", "r516", "r549", "r651" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent accounting pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r593" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r563", "r574", "r584", "r601", "r609" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r591" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r590" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r601" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r620" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r620" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r680", "r681", "r682", "r683" ] }, "elf_NumberOfDistributionChannels": { "xbrltype": "integerItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "NumberOfDistributionChannels", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of distribution channels", "label": "Number Of Distribution Channels", "documentation": "Number Of Distribution Channels" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r644" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r644" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r182", "r194", "r198", "r200", "r516" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesComponentsofLeaseExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r386", "r538" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails": { "parentTag": "elf_LeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesFutureMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Present value of lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r380" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of operating lease liabilities", "verboseLabel": "Operating", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r380" ] }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current operating lease liability." } } }, "auth_ref": [ "r381" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseLiability", "weight": 1.0, "order": 3.0 }, "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term operating lease obligations", "verboseLabel": "Operating", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r380" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r383", "r387" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails": { "parentTag": "elf_LeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r379" ] }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://www.elfcosmetics.com/role/LeasesBalanceSheetLineItemsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset." } } }, "auth_ref": [ "r381" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r389", "r538" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r388", "r538" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r21" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r130" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited", "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/StatementofcomprehensiveincomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r7", "r12", "r102", "r136", "r139" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r24" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r82" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r593" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r561", "r572", "r582", "r607" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r564", "r575", "r585", "r610" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r564", "r575", "r585", "r610" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r589" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Payables and Accruals [Abstract]", "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance costs paid", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash consideration", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r30", "r352" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Acquisition, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r30" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r83" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r592" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r592" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r591" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r601" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r594" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r590" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r632" ] }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expenses and Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cash received from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r31", "r425" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from revolving line of credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r31", "r638" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r627", "r636" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r401", "r411", "r539" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r589" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r589" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r290", "r291", "r320", "r321", "r322", "r392", "r393", "r417", "r434", "r435", "r486", "r488", "r490", "r491", "r493", "r508", "r509", "r518", "r525", "r535", "r540", "r543", "r649", "r653", "r669", "r670", "r671", "r672", "r673" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r226", "r227", "r228", "r229", "r290", "r291", "r320", "r321", "r322", "r392", "r393", "r417", "r434", "r435", "r486", "r488", "r490", "r491", "r493", "r508", "r509", "r518", "r525", "r535", "r540", "r543", "r649", "r653", "r669", "r670", "r671", "r672", "r673" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r556", "r567", "r577", "r602" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r32", "r426" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r557", "r568", "r578", "r603" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r558", "r569", "r579", "r604" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r565", "r576", "r586", "r611" ] }, "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsItemsLineItems", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]", "label": "Restricted Cash and Cash Equivalents Items [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r675" ] }, "elf_RestrictedStockUnitsAndRestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "RestrictedStockUnitsAndRestrictedStockMember", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock and RSUs", "label": "Restricted Stock Units And Restricted Stock [Member]", "documentation": "Restricted Stock Units and Restricted Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_RetailMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetailMember", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships \u2013 retailers", "label": "Retail [Member]", "documentation": "Sale of product directly to consumer." } } }, "auth_ref": [ "r656" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r72", "r98", "r409", "r421", "r423", "r427", "r445", "r539" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r123", "r153", "r154", "r155", "r157", "r163", "r165", "r215", "r216", "r329", "r330", "r331", "r341", "r342", "r357", "r359", "r360", "r362", "r364", "r418", "r420", "r429", "r678" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net sales", "terseLabel": "Total net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r183", "r184", "r193", "r196", "r197", "r201", "r202", "r204", "r288", "r289", "r394" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognition", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r121", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r510" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r620" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r620" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionNarrativeDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofAcquisitionNetSalesDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofConsiderationTransferredDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/AcquisitionScheduleofPurchasePriceAllocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r54", "r55", "r350" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Consideration Transferred", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r54", "r55" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Outstanding Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/NetincomepershareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Numerator and Denominator in Basic and Diluted Net Income Per Common Share Computations", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r643" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r50" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r211", "r212", "r213" ] }, "elf_ScheduleOfIntangibleAssetsAndGoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "ScheduleOfIntangibleAssetsAndGoodwillLineItems", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Intangible Assets And Goodwill [Line Items]", "label": "Schedule Of Intangible Assets And Goodwill [Line Items]", "documentation": "Schedule of intangible assets and goodwill." } } }, "auth_ref": [] }, "elf_ScheduleOfIntangibleAssetsAndGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTable", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Intangible Assets And Goodwill [Table]", "label": "Schedule Of Intangible Assets And Goodwill [Table]", "documentation": "Schedule of intangible assets and goodwill." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information Regarding Company's Goodwill and Intangible Assets", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Purchase Price Allocation and Intangible Assets and Liabilities Acquired", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r100" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashNarrativeDetails", "http://www.elfcosmetics.com/role/RestrictedcashScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]", "label": "Restrictions on Cash and Cash Equivalents [Table]", "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r15", "r104", "r675" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/RestrictedcashTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash, Cash Equivalents, and Restricted Cash", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r15", "r104", "r675" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r293", "r295", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323" ] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]", "label": "Debt and Equity Securities, FV-NI [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Amortization Expense for Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r44" ] }, "elf_SecondAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "SecondAmendmentMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Second Amendment", "label": "Second Amendment [Member]", "documentation": "Second Amendment" } } }, "auth_ref": [] }, "elf_SecuredOvernightFinancingRateSOFRMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "SecuredOvernightFinancingRateSOFRMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "documentation": "Secured Overnight Financing Rate (SOFR)" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r551" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r553" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r202", "r203", "r431", "r432", "r433", "r487", "r489", "r492", "r494", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r511", "r527", "r543", "r655", "r676" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment reporting", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r187", "r188", "r189", "r190", "r191", "r192", "r202", "r517" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r81" ] }, "elf_ServiceBasedStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "ServiceBasedStockOptionsMember", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Service-based vesting options", "label": "Service Based Stock Options [Member]", "documentation": "Service-based stock options." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r293", "r295", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.elfcosmetics.com/role/StockbasedcompensationAdditionalInformationDetails", "http://www.elfcosmetics.com/role/StockbasedcompensationScheduleofShareBasedPaymentArrangementExpensedandCapitalizedAmountDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Award", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Summaryofsignificantaccountingpolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of significant accounting policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r87", "r147" ] }, "elf_SocialMediaAnalyticsCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "SocialMediaAnalyticsCompanyMember", "presentation": [ "http://www.elfcosmetics.com/role/InvestmentinequitysecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Social Media Analytics Company", "label": "Social Media Analytics Company [Member]", "documentation": "Social Media Analytics Company [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r26", "r123", "r140", "r141", "r142", "r153", "r154", "r155", "r157", "r163", "r165", "r181", "r215", "r216", "r279", "r329", "r330", "r331", "r341", "r342", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r391", "r418", "r419", "r420", "r429", "r481" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r202", "r203", "r431", "r432", "r433", "r487", "r489", "r492", "r494", "r497", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r511", "r527", "r543", "r655", "r676" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r153", "r154", "r155", "r181", "r394", "r424", "r430", "r436", "r437", "r438", "r439", "r440", "r441", "r444", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r457", "r458", "r459", "r460", "r461", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r481", "r544" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r153", "r154", "r155", "r181", "r394", "r424", "r430", "r436", "r437", "r438", "r439", "r440", "r441", "r444", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r457", "r458", "r459", "r460", "r461", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r481", "r544" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r560", "r571", "r581", "r606" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock as consideration for acquisition (in shares)", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r69", "r70", "r98" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of stock options and vesting of restricted stock (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r14", "r69", "r70", "r98", "r306" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock as consideration for acquisition", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r14", "r26", "r98" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise of stock options and vesting of restricted stock", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r14", "r26", "r98" ] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/RepurchaseofcommonstockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount authorized under share repurchase program", "label": "Stock Repurchase Program, Authorized Amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.elfcosmetics.com/role/RepurchaseofcommonstockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining authorized repurchase amount", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "documentation": "Amount remaining of a stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.elfcosmetics.com/role/RepurchaseofcommonstockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase of common stock (in shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r14", "r69", "r70", "r98", "r426", "r481", "r495" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited", "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r70", "r73", "r74", "r88", "r446", "r462", "r482", "r483", "r539", "r550", "r639", "r645", "r662", "r678" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedbalancesheetsunaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.elfcosmetics.com/role/Repurchaseofcommonstock" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase of common stock", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r95", "r149", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r363", "r484", "r485", "r496" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r600" ] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrent", "crdr": "credit", "calculation": { "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/AccruedexpensesandothercurrentliabilitiesAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes payable", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r19" ] }, "elf_TermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "TermLoanFacilityMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Term Loan Facility [Member]", "documentation": "Term loan member." } } }, "auth_ref": [] }, "elf_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "TermLoanMember", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Term Loan [Member]", "documentation": "Term Loan" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r592" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r599" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.elfcosmetics.com/role/AcquisitionScheduleofGoodwillDetails", "http://www.elfcosmetics.com/role/GoodwillandintangibleassetsInformationRegardingCompanysGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks", "verboseLabel": "Trademarks", "label": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r58" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r619" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r621" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.elfcosmetics.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r622" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r623" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r621" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r621" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r624" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r622" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r618" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.elfcosmetics.com/role/SummaryofsignificantaccountingpoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r35", "r36", "r37", "r115", "r116", "r117", "r118" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "elf_VariableRateComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "VariableRateComponentsAxis", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Components [Axis]", "label": "Variable Rate Components [Axis]", "documentation": "Variable Rate Components" } } }, "auth_ref": [] }, "elf_VariableRateComponentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "VariableRateComponentsDomain", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate Components [Domain]", "label": "Variable Rate Components [Domain]", "documentation": "Variable Rate Components [Domain]" } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.elfcosmetics.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding - diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r168", "r176" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding:", "verboseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.elfcosmetics.com/role/Condensedconsolidatedstatementsofoperationsunaudited", "http://www.elfcosmetics.com/role/NetincomepershareReconciliationofNumeratorandDenominatorinBasicandDilutedNetIncomeLossPerCommonShareComputationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r167", "r176" ] }, "elf_WeightedAverageRemainingLeaseTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.elfcosmetics.com/20231231", "localname": "WeightedAverageRemainingLeaseTermAbstract", "presentation": [ "http://www.elfcosmetics.com/role/LeasesWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term", "label": "Weighted Average Remaining Lease Term [Abstract]", "documentation": "Weighted Average Remaining Lease Term [Abstract]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r519": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r520": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r522": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r523": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r524": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r525": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r526": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r539": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r540": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r541": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r543": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r618": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r619": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r620": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r621": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r622": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r623": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r624": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r625": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r626": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 77 0001600033-24-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001600033-24-000008-xbrl.zip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�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end XML 78 elf-20231231_htm.xml IDEA: XBRL DOCUMENT 0001600033 2023-04-01 2023-12-31 0001600033 2024-02-01 0001600033 2023-12-31 0001600033 2023-03-31 0001600033 2022-12-31 0001600033 2023-10-01 2023-12-31 0001600033 2022-10-01 2022-12-31 0001600033 2022-04-01 2022-12-31 0001600033 us-gaap:CommonStockMember 2023-03-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001600033 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001600033 us-gaap:RetainedEarningsMember 2023-03-31 0001600033 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001600033 2023-04-01 2023-06-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001600033 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001600033 us-gaap:CommonStockMember 2023-06-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001600033 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001600033 us-gaap:RetainedEarningsMember 2023-06-30 0001600033 2023-06-30 0001600033 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001600033 2023-07-01 2023-09-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001600033 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001600033 us-gaap:CommonStockMember 2023-09-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001600033 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001600033 us-gaap:RetainedEarningsMember 2023-09-30 0001600033 2023-09-30 0001600033 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001600033 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001600033 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001600033 us-gaap:CommonStockMember 2023-12-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001600033 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001600033 us-gaap:RetainedEarningsMember 2023-12-31 0001600033 us-gaap:CommonStockMember 2022-03-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001600033 us-gaap:RetainedEarningsMember 2022-03-31 0001600033 2022-03-31 0001600033 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001600033 2022-04-01 2022-06-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001600033 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001600033 us-gaap:CommonStockMember 2022-06-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001600033 us-gaap:RetainedEarningsMember 2022-06-30 0001600033 2022-06-30 0001600033 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001600033 2022-07-01 2022-09-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001600033 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001600033 us-gaap:CommonStockMember 2022-09-30 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001600033 us-gaap:RetainedEarningsMember 2022-09-30 0001600033 2022-09-30 0001600033 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001600033 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001600033 us-gaap:CommonStockMember 2022-12-31 0001600033 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001600033 us-gaap:RetainedEarningsMember 2022-12-31 0001600033 country:US 2023-10-01 2023-12-31 0001600033 country:US 2022-10-01 2022-12-31 0001600033 country:US 2023-04-01 2023-12-31 0001600033 country:US 2022-04-01 2022-12-31 0001600033 us-gaap:NonUsMember 2023-10-01 2023-12-31 0001600033 us-gaap:NonUsMember 2022-10-01 2022-12-31 0001600033 us-gaap:NonUsMember 2023-04-01 2023-12-31 0001600033 us-gaap:NonUsMember 2022-04-01 2022-12-31 0001600033 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-12-31 0001600033 us-gaap:CashAndCashEquivalentsMember 2023-12-31 0001600033 us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001600033 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-12-31 0001600033 elf:SocialMediaAnalyticsCompanyMember 2017-04-14 0001600033 elf:NaturiumLLCMember 2023-10-04 2023-10-04 0001600033 elf:NaturiumLLCMember 2023-10-04 0001600033 elf:NaturiumLLCMember us-gaap:RetailMember 2023-10-04 0001600033 elf:NaturiumLLCMember elf:ElectronicCommerceCustomerRelationshipsMember 2023-10-04 0001600033 elf:NaturiumLLCMember us-gaap:TrademarksMember 2023-10-04 0001600033 elf:NaturiumLLCMember 2023-10-04 2023-12-31 0001600033 elf:NaturiumLLCMember 2023-10-01 2023-12-31 0001600033 elf:NaturiumLLCMember 2023-04-01 2023-12-31 0001600033 elf:NaturiumLLCMember 2022-10-01 2022-12-31 0001600033 elf:NaturiumLLCMember 2022-04-01 2022-12-31 0001600033 elf:CustomerRelationshipsRetailersMember 2023-12-31 0001600033 elf:ElectronicCommerceCustomerRelationshipsMember 2023-12-31 0001600033 srt:MinimumMember us-gaap:TrademarksMember 2023-12-31 0001600033 srt:MaximumMember us-gaap:TrademarksMember 2023-12-31 0001600033 us-gaap:TrademarksMember 2023-12-31 0001600033 us-gaap:TrademarksMember 2023-12-31 0001600033 elf:CustomerRelationshipsRetailersMember 2023-03-31 0001600033 elf:ElectronicCommerceCustomerRelationshipsMember 2023-03-31 0001600033 us-gaap:TrademarksMember 2023-03-31 0001600033 us-gaap:TrademarksMember 2023-03-31 0001600033 elf:CustomerRelationshipsRetailersMember 2022-12-31 0001600033 elf:ElectronicCommerceCustomerRelationshipsMember 2022-12-31 0001600033 us-gaap:TrademarksMember 2022-12-31 0001600033 us-gaap:TrademarksMember 2022-12-31 0001600033 elf:TermLoanFacilityMember 2023-12-31 0001600033 elf:TermLoanFacilityMember 2023-03-31 0001600033 elf:TermLoanFacilityMember 2022-12-31 0001600033 us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember 2021-04-30 2021-04-30 0001600033 us-gaap:RevolvingCreditFacilityMember elf:AmendedRevolvingCreditFacilityMember 2021-04-30 0001600033 us-gaap:RevolvingCreditFacilityMember elf:AmendedTermLoanFacilityMember 2021-04-30 0001600033 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember 2021-04-30 2021-04-30 0001600033 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember 2021-04-30 2021-04-30 0001600033 us-gaap:LetterOfCreditMember elf:AmendedCreditAgreementMember 2021-04-30 0001600033 us-gaap:LineOfCreditMember elf:AmendedCreditAgreementMember 2021-04-30 0001600033 us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember 2023-12-31 0001600033 us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember elf:MinimumFloorMember 2021-04-30 2021-04-30 0001600033 elf:TermLoanMember elf:AmendedCreditAgreementMember elf:MinimumFloorMember 2021-04-30 2021-04-30 0001600033 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember elf:LondonInterBankOfferedRateLIBOR1Member 2021-04-30 2021-04-30 0001600033 srt:MinimumMember elf:TermLoanMember elf:AmendedCreditAgreementMember elf:LondonInterBankOfferedRateLIBOR1Member 2021-04-30 2021-04-30 0001600033 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember elf:LondonInterBankOfferedRateLIBOR1Member 2021-04-30 2021-04-30 0001600033 srt:MaximumMember elf:TermLoanMember elf:AmendedCreditAgreementMember elf:LondonInterBankOfferedRateLIBOR1Member 2021-04-30 2021-04-30 0001600033 srt:MinimumMember elf:TermLoanMember elf:AmendedCreditAgreementMember us-gaap:BaseRateMember 2021-04-30 2021-04-30 0001600033 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember us-gaap:BaseRateMember 2021-04-30 2021-04-30 0001600033 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember elf:AmendedCreditAgreementMember us-gaap:BaseRateMember 2021-04-30 2021-04-30 0001600033 srt:MaximumMember elf:TermLoanMember elf:AmendedCreditAgreementMember us-gaap:BaseRateMember 2021-04-30 2021-04-30 0001600033 us-gaap:RevolvingCreditFacilityMember elf:SecuredOvernightFinancingRateSOFRMember 2023-03-29 2023-03-29 0001600033 us-gaap:RevolvingCreditFacilityMember 2023-03-29 2023-03-29 0001600033 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember elf:SecuredOvernightFinancingRateSOFRMember 2023-03-29 2023-03-29 0001600033 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember elf:SecuredOvernightFinancingRateSOFRMember 2023-03-29 2023-03-29 0001600033 elf:TermLoanMember elf:AmendedRevolvingCreditFacilityMember 2023-12-31 0001600033 elf:IncrementalTermLoanMember elf:SecondAmendmentMember 2023-08-28 0001600033 srt:MinimumMember elf:IncrementalTermLoanMember elf:SecondAmendmentMember elf:SecuredOvernightFinancingRateSOFRMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 srt:MaximumMember elf:IncrementalTermLoanMember elf:SecondAmendmentMember elf:SecuredOvernightFinancingRateSOFRMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 elf:IncrementalTermLoanMember elf:SecondAmendmentMember elf:SecuredOvernightFinancingRateSOFRMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 srt:MinimumMember elf:IncrementalTermLoanMember elf:SecondAmendmentMember us-gaap:BaseRateMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 srt:MaximumMember elf:IncrementalTermLoanMember elf:SecondAmendmentMember us-gaap:BaseRateMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 elf:SecondAmendmentMember us-gaap:BaseRateMember elf:ConsolidatedTotalNetLeverageRatioLevelsMember 2023-08-28 2023-08-28 0001600033 elf:IncrementalTermLoanMember elf:SecondAmendmentMember 2023-12-31 0001600033 elf:ServiceBasedStockOptionsMember 2023-10-01 2023-12-31 0001600033 elf:ServiceBasedStockOptionsMember 2022-10-01 2022-12-31 0001600033 elf:ServiceBasedStockOptionsMember 2023-04-01 2023-12-31 0001600033 elf:ServiceBasedStockOptionsMember 2022-04-01 2022-12-31 0001600033 elf:RestrictedStockUnitsAndRestrictedStockMember 2023-10-01 2023-12-31 0001600033 elf:RestrictedStockUnitsAndRestrictedStockMember 2022-10-01 2022-12-31 0001600033 elf:RestrictedStockUnitsAndRestrictedStockMember 2023-04-01 2023-12-31 0001600033 elf:RestrictedStockUnitsAndRestrictedStockMember 2022-04-01 2022-12-31 0001600033 elf:ServiceBasedStockOptionsMember 2023-12-31 0001600033 elf:RestrictedStockUnitsAndRestrictedStockMember 2023-12-31 0001600033 2019-05-08 shares iso4217:USD iso4217:USD shares elf:segment elf:distribution_channel pure elf:renewal_option false 2024 Q3 0001600033 --03-31 http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations 10-Q true 2023-12-31 false 001-37873 e.l.f. Beauty, Inc. DE 46-4464131 570 10th Street Oakland, CA 94607 (510) 778-7787 Common Stock, par value $0.01 per share ELF NYSE Yes Yes Large Accelerated Filer false false false 55506934 72705000 120778000 87021000 121061000 67928000 66237000 204504000 81323000 81250000 56630000 33296000 28382000 454900000 303325000 262890000 12805000 7874000 8726000 230658000 78041000 80071000 340165000 171620000 171620000 1155000 2875000 2875000 68601000 31866000 29743000 1108284000 595601000 555925000 100394000 5575000 5690000 72917000 31427000 32049000 129628000 70974000 49798000 302939000 107976000 87537000 164403000 60881000 62177000 4281000 3742000 7783000 21720000 11201000 12329000 717000 784000 795000 494060000 184584000 170621000 0.01 0.01 0.01 250000000 250000000 250000000 55412234 55412234 53770482 53770482 53165462 53165462 553000 535000 528000 922592000 832481000 823021000 -58000 0 0 -308863000 -421999000 -438245000 614224000 411017000 385304000 1108284000 595601000 555925000 270943000 146537000 702789000 391487000 78986000 47812000 205895000 130217000 191957000 98725000 496894000 261270000 160121000 75434000 364246000 201172000 31836000 23291000 132648000 60098000 2565000 730000 1902000 -2195000 0 0 1720000 0 -3985000 -463000 -3021000 -1912000 0 -176000 0 -176000 30416000 23382000 129809000 55815000 3528000 4277000 16673000 10531000 26888000 19105000 113136000 45284000 0.49 0.36 2.08 0.87 0.46 0.34 1.97 0.82 55140887 52707406 54503518 52239761 58030115 55840137 57550094 54906065 26888000 19105000 113136000 45284000 -58000 0 -58000 0 -58000 0 -58000 0 26830000 19105000 113078000 45284000 53571577 535000 832481000 0 -421999000 411017000 52977000 52977000 7223000 7223000 754953 8000 477000 485000 54326530 543000 840181000 0 -369022000 471702000 33271000 33271000 11190000 11190000 203982 2000 263000 265000 54530512 545000 851634000 0 -335751000 516428000 26888000 26888000 11051000 11051000 213014 2000 2141000 2143000 577659 6000 57766000 57772000 -58000 -58000 55321185 553000 922592000 -58000 -308863000 614224000 51524307 515000 795443000 -483529000 312429000 14469000 14469000 6549000 6549000 558336 2000 2000 52082643 517000 801992000 -469060000 333449000 11710000 11710000 8022000 8022000 471966 8000 3771000 3779000 52554609 525000 813785000 -457350000 356960000 19105000 19105000 7239000 7239000 269051 3000 1997000 2000000 52823660 528000 823021000 -438245000 385304000 113136000 45284000 24247000 16496000 29459000 21833000 290000 271000 -1684000 -1819000 1720000 0 10549000 0 0 -176000 27000 -1000 45878000 20620000 106898000 -3248000 50696000 15223000 84733000 22610000 -3768000 -3254000 34139000 69001000 274973000 0 5984000 1647000 -280957000 -1647000 89500000 0 115000000 0 5188000 28750000 665000 0 2893000 5652000 -489000 -588000 201051000 -23686000 -56000 0 -45823000 43668000 120778000 43353000 74955000 87021000 Nature of operations<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.l.f. Beauty, Inc., a Delaware corporation (“e.l.f. Beauty” and together with its subsidiaries, the “Company”), is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skincare products. The Company's mission is to make the best of beauty accessible to every eye, lip, face and skin concern.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes its ability to deliver cruelty-free, clean, vegan and premium-quality products at accessible prices with broad appeal differentiates it in the beauty industry. The Company believes the combination of its value proposition, innovation engine, ability to attract and engage consumers, and its world-class team’s ability to execute with speed, has positioned the Company well to navigate the competitive beauty market.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People and Keys Soulcare. The Company's brands are available online and across leading beauty, mass-market and specialty retailers. The Company has strong relationships with its retail customers such as Target, Walmart, Ulta Beauty and other leading retailers that have enabled the Company to expand distribution both domestically and internationally.</span></div> Summary of significant accounting policies<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, these interim financial statements contain all adjustments, including normal recurring adjustments, necessary for a fair statement of its financial position as of December 31, 2023, March 31, 2023 and December 31, 2022, and its results of operations and stockholders' equity for the three and nine months ended December 31, 2023 and December 31, 2022 and its cash flows for the nine months ended December 31, 2023 and December 31, 2022. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Annual Report”). Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment reporting</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant accounting policies</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made no other material changes in the application of its significant accounting policies that were disclosed in Note 2, “Summary of significant accounting policies,” to the audited consolidated financial statements as of and for the fiscal year ended March 31, 2023 included in the Annual Report. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company distributes products both through national and international retailers, as well as direct-to-consumers through its e-commerce channel. The marketing and consumer engagement benefits that the direct-to-consumer channel provides are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers (in thousands).</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales by geographic region:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,101 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,457 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599,552 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,869 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,842 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,943 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,537 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,789 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,487 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, other than accounts receivable, the Company had no material contract assets, contract liabilities or deferred contract costs recorded on its unaudited condensed consolidated balance sheet. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of the Company, these interim financial statements contain all adjustments, including normal recurring adjustments, necessary for a fair statement of its financial position as of December 31, 2023, March 31, 2023 and December 31, 2022, and its results of operations and stockholders' equity for the three and nine months ended December 31, 2023 and December 31, 2022 and its cash flows for the nine months ended December 31, 2023 and December 31, 2022. All intercompany balances and transactions have been eliminated in consolidation.</span></div>These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “Annual Report”). Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year. <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment reporting</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are components of an enterprise for which separate financial information is available that is evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Utilizing these criteria, the Company manages its business on the basis of one operating segment and one reportable segment. It is impracticable for the Company to provide revenue by product line.</span></div> 1 1 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of a business acquisition is allocated to the assets acquired and liabilities assumed based upon their estimated fair values at the business combination date. The excess of purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining fair value of identifiable assets, particularly intangibles, and liabilities acquired also requires the Company to make estimates, which are based on all available information and in some cases </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assumptions with respect to the timing and amount of future revenues and expenses associated with an asset. Unanticipated events or circumstances may occur that could affect the accuracy of the Company’s fair value estimates, and under different assumptions, the resulting valuations could be materially different.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs that are incurred to complete the business combination, such as legal and other professional fees, are not considered as a part of consideration transferred and are charged to selling, general and administrative expense as they are incurred.</span></div>The Company made no other material changes in the application of its significant accounting policies that were disclosed in Note 2, “Summary of significant accounting policies,” to the audited consolidated financial statements as of and for the fiscal year ended March 31, 2023 included in the Annual Report. <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company distributes products both through national and international retailers, as well as direct-to-consumers through its e-commerce channel. The marketing and consumer engagement benefits that the direct-to-consumer channel provides are integral to the Company’s brand and product development strategy and drive sales across channels. As such, the Company views its two primary distribution channels as components of one integrated business, as opposed to discrete revenue streams. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells a variety of beauty products but does not consider them to be meaningfully different revenue streams given similarities in the nature of the products, the target consumer and the innovation and distribution processes.</span></div> 2 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated revenue from contracts with customers by geographical market, as the nature, amount, timing and uncertainty of revenue and cash flows can differ between domestic and international customers (in thousands).</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales by geographic region:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,101 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,457 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599,552 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,869 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,842 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,080 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,943 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,537 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,789 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,487 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 229101000 127457000 599552000 343869000 41842000 19080000 103237000 47618000 270943000 146537000 702789000 391487000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div> Restricted cash<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash amounting to $2.3 million as of December 31, 2023, included in prepaid expenses and other current assets on the accompanying unaudited condensed consolidated balance sheets, represents part of the purchase consideration held in escrow for the settlement of general representation and warranty provisions in connection with the Company’s acquisition of Naturium LLC (“Naturium”). The Company determines current or non-current classification of restricted cash based on the expected duration of the restriction.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:32.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,705 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,021 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash held in escrow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash - end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,955 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,021 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2300000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:32.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.641%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance sheet classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,705 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,021 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash held in escrow</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash - end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,955 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,021 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 72705000 87021000 2250000 0 74955000 87021000 Investment in equity securities<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2017, the Company invested $2.9 million in a social media analytics company, which is included in investments on its unaudited condensed consolidated balance sheets. The Company has elected the measurement alternative for equity investments that do not have readily determinable fair values. The Company recorded an impairment charge of $1.7 million on its investment as a separate line under other income (expense), net during the three months ended June 30, 2023, as an identified event or change in circumstances resulted in an indicator of impairment. The Company did not record an additional impairment charge on its investment during the three months ended December 31, 2023.</span></div> 2900000 1700000 0 Acquisition<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 4, 2023, the Company, through its wholly owned subsidiary, e.l.f. Cosmetics, Inc., completed its acquisition of Naturium (including the indirect acquisition of equity interests in Naturium through the purchase of a “tax blocker” holding company) (the “Acquisition”), which furthered the Company’s mission to make the best of beauty accessible to every eye, lip, face and skin concern. Naturium is a skincare company that provides clinically effective products at an affordable price. The Company directly and indirectly acquired all rights, title and interest in and to the outstanding equity securities of Naturium for a purchase price of $333.0 million. The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity consideration (common stock issued)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,772 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired, excluding liability assumed for acquisition-related seller expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability assumed for acquisition-related seller expenses</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,545 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred and expensed acquisition transaction costs of $0.6 million and $3.1 million during the three and nine months ended December 31, 2023, respectively, which are included as a component of selling, general and administrative expenses in the condensed consolidated statements of operations.</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Acquisition has been accounted for as a business combination under the acquisition method and, accordingly, the total purchase price is allocated to the tangible and intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date. The purchase price allocation, deferred tax calculations and residual goodwill are preliminary and pending finalization. Naturium’s results of operations have been included in the Company's condensed consolidated financial statements from the date of acquisition.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,235 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,197)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skincare products. A substantial amount of the goodwill is expected to be deductible for tax purposes.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:32.083%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Methodology</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess earnings method</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess earnings method and with and without method</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relief from Royalty method</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identified intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,800 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain financial information (unaudited)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022), are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual Naturium net sales from October 4, 2023 to December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the three months ended December 31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the nine months ended December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the three months ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,811 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the nine months ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information shown in the table above are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisition had taken place at April 1, 2022 (the beginning of comparable period presented).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma earnings of the combined companies are not presented as the effects of the Acquisition in earnings are not material in relation to the overall consolidated financial statements.</span></div> 333000000 The following table summarizes the fair market value of the consideration transferred and how the Company calculates the goodwill resulting from the acquisition (in thousands):<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity consideration (common stock issued)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,772 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired, excluding liability assumed for acquisition-related seller expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,042 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability assumed for acquisition-related seller expenses</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,549)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,545 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair market value of the $57.8 million common stock issued (equivalent to 577,659 shares of common stock) was determined on the basis of the opening market price of the Company’s stock of $100.01 per share on the acquisition date.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Acquisition, the Company paid Naturium’s acquisition-related expenses of $10.5 million recognized as an assumed liability at the acquisition date.</span></div> 275266000 57772000 333038000 175042000 -10549000 -164493000 168545000 57800000 577659 100.01 -10500000 600000 3100000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the preliminary purchase price allocation recorded in the Company's condensed consolidated balance sheet on the acquisition date (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,235 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,197)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The goodwill represents the excess value over both tangible and intangible assets acquired and liabilities assumed. The goodwill recognized in this transaction is primarily attributable to the Company’s expectation that Naturium can continue to expand distribution and deliver new skincare products. A substantial amount of the goodwill is expected to be deductible for tax purposes.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:32.083%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Methodology</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess earnings method</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess earnings method and with and without method</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relief from Royalty method</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identified intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,800 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 293000 7388000 16282000 1899000 28000 168545000 162800000 357235000 15897000 6077000 2223000 24197000 333038000 20000000 P10Y 18300000 P3Y 124500000 P15Y 162800000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts of Naturium’s net sales included in the Company's condensed consolidated financial statements from the date of acquisition and the net sales of the combined companies on an unaudited pro forma basis, had the acquisition date been April 1, 2022), are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual Naturium net sales from October 4, 2023 to December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the three months ended December 31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the nine months ended December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the three months ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,811 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental pro forma combined net sales for the nine months ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 22458000 271579000 744583000 159811000 425423000 Goodwill and intangible assets<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of December 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,100)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,240 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,465)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 to 15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,840 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,982)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,858 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,165 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,165 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,805 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,600 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,780)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,820 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,799)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,241 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,460 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,799)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,661 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of December 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,600 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,840)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,760 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,769)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,460 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,769)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,691 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expenses on finite-lived intangible assets were $6.1 million and $2.0 million in the three months ended December 31, 2023 and December 31, 2022, respectively, and $10.2 million and $6.1 million in the nine months ended December 31, 2023 and December 31, 2022, respectively. Certain trademark assets have been classified as indefinite-lived intangible assets and accordingly, are not subject to amortization. There were no impairments of goodwill or intangible assets recorded in the three and nine months ended December 31, 2023 and December 31, 2022. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to finite-lived intangible assets, assuming no impairment as of December 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,630 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,530 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,507 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,858 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of December 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,100)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,240 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,465)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 to 15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,840 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,982)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,858 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,165 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,165 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,805 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,982)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of March 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,600 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,780)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,820 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,940)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,799)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,241 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,460 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,799)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,661 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company’s goodwill and intangible assets as of December 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – retailers</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,600 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,840)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,760 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships – e-commerce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,040 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,769)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,800 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total goodwill and other intangibles</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,460 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,769)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,691 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P10Y 97600000 72100000 25500000 P3Y 22240000 5465000 16775000 P10Y P15Y 128000000 3417000 124583000 247840000 80982000 166858000 63800000 63800000 340165000 340165000 651805000 80982000 570823000 P10Y 77600000 65780000 11820000 P3Y 3940000 3940000 0 P10Y 3500000 1079000 2421000 85040000 70799000 14241000 63800000 63800000 171620000 171620000 320460000 70799000 249661000 P10Y 77600000 63840000 13760000 P3Y 3940000 3938000 2000 P10Y 3500000 991000 2509000 85040000 68769000 16271000 63800000 63800000 171620000 171620000 320460000 68769000 251691000 6100000 2000000 10200000 6100000 0 0 0 0 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to finite-lived intangible assets, assuming no impairment as of December 31, 2023 is as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:84.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,630 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,630 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,530 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,507 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,858 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 4981000 17630000 17630000 14580000 11530000 100507000 166858000 Accrued expenses and other current liabilities<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,979 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,726 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,761 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,628 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,974 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,979 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,726 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,562 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,330 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,241 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,761 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,698 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,628 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,974 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,798 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 44979000 22726000 19298000 23562000 1330000 468000 21241000 23761000 7036000 7010000 4510000 4528000 16588000 13098000 10591000 9937000 2851000 5076000 6311000 2698000 2801000 129628000 70974000 49798000 Debt<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,707 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,883 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,332 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,797 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,456 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,867 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,575)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,403 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,881 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,177 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See further discussion below. As of December 31, 2023, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The gross carrying amounts of the Company’s long-term debt, before reduction of the debt issuance costs, and finance lease obligations approximate their fair values, based on Level 2 inputs (quoted prices for similar assets and liabilities in active markets or inputs that are observable), as the stated rates approximate market rates for loans with similar terms. The Company did not transfer any liabilities measured at fair value on a recurring basis to or from Level 2 for any of the periods presented.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended Credit Agreement</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021, the Company amended and restated its prior credit agreement (such amended and restated credit agreement, as further amended, supplemented or modified from time to time, the “Amended Credit Agreement”) and refinanced all loans under the prior credit agreement. The Amended Credit Agreement has a five year term and consists of (i) a $100 million revolving credit facility (the “Amended Revolving Credit Facility”) and (ii) a $100 million term loan facility (the “Amended Term Loan Facility”).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility is collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on the Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provides for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan; however, all amounts drawn under the Amended Revolving Credit Facility cannot exceed $100 million. The unused balance of the Amended Revolving Credit Facility as of December 31, 2023 was $10.5 million.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States (“US”) dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR plus 0.10%, subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate as of December 31, 2023 for the Amended Revolving Credit Facility and the Amended Term Loan Facility was approximately 6.7%.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second Amended Credit Agreement</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, the Company entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, the Company may borrow incremental term loans in a principal amount equal to $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan will bear interest at a rate per annum equal to, at the Company’s election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, to be based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortizes at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ending on December 31, 2023. The Company used the Incremental Term Loan together with cash from its balance sheet and additional borrowings under its Amended Revolving Credit Facility to consummate the Acquisition (as defined in Note 5 hereto) and to pay related fees and expenses in connection with the Acquisition and Second Amendment.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate as of December 31, 2023 for the Incremental Term Loan was approximately 6.9%.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains a number of covenants that, among other things and subject to certain exceptions, restrict the Company’s ability to pay dividends and distributions or repurchase capital stock, incur additional indebtedness, create liens on assets, engage in mergers or consolidations and sell or otherwise dispose of assets. The Amended Credit Agreement also includes reporting, financial and maintenance covenants that require the Company to, among other things, comply with certain consolidated total net leverage ratios and consolidated fixed charge coverage ratios.</span></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt as of December 31, 2023, March 31, 2023 and December 31, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,707 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,883 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,332 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(427)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,797 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,456 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,867 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,575)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,690)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,403 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,881 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,177 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See further discussion below. As of December 31, 2023, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The gross carrying amounts of the Company’s long-term debt, before reduction of the debt issuance costs, and finance lease obligations approximate their fair values, based on Level 2 inputs (quoted prices for similar assets and liabilities in active markets or inputs that are observable), as the stated rates approximate market rates for loans with similar terms. The Company did not transfer any liabilities measured at fair value on a recurring basis to or from Level 2 for any of the periods presented.</span></div> 89500000 0 0 176063000 66250000 67500000 144000 633000 832000 265707000 66883000 68332000 910000 427000 465000 264797000 66456000 67867000 100394000 5575000 5690000 164403000 60881000 62177000 P5Y 100000000 100000000 0.0010 0.0030 7000000 5000000 100000000 10500000 0 0 0.0125 0.0125 0.02125 0.02125 0.0025 0.0025 0.01125 0.01125 0.0010 0.0010 0 0.0125 0.02125 0.067 0.067 115000000 0.0150 0.02375 0.0000 0.0000 0.0050 0.01375 0.0100 0.0100 0.0500 0.0125 0.069 Commitments and contingencies<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal contingencies</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is from time to time subject to, and is currently involved in legal proceedings, claims and litigation arising in the ordinary course of business. The Company is not currently a party to any matters that management expects will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.</span></div> Income taxes<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s quarterly tax provision is based upon an estimated annual effective tax rate as adjusted for any discrete items. The Company’s provision for income taxes were $3.5 million and $4.3 million for the three months ended December 31, 2023 and December 31, 2022, respectively, and $16.7 million and $10.5 million for the nine months ended December 31, 2023 and December 31, 2022, respectively, with an effective tax rate of 11.6% and 18.3% for the three months ended December 31, 2023 and December 31, 2022, respectively, and an effective tax rate of 12.8% and 18.9% for the nine months ended December 31, 2023 and December 31, 2022, respectively. The effective tax rate differs from the U.S. statutory tax rate primarily due to discrete tax benefit related to stock-based compensation.</span></div> 3500000 4300000 16700000 10500000 0.116 0.183 0.128 0.189 Stock-based compensation<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense is recognized on a straight-line basis over the requisite service period. Total stock-based compensation is shown in the table below (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based vesting options</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock and RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,001 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock compensation expense</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,042 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,257 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,459 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,833 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, there was $0.1 million and $88.3 million of total unrecognized stock-based compensation cost related to unvested service-based stock options and shares subject to RSAs and RSUs, respectively. The unrecognized stock-based compensation is expected to be recognized over the remaining weighted-average period of 1.8 years for service-based stock options and 2.0 years for shares subject to RSAs and RSUs, respectively.</span></div> Total stock-based compensation is shown in the table below (in thousands):<div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service-based vesting options</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock and RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,001 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,168 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,331 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock compensation expense</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,042 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,257 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,459 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,833 </span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 41000 89000 128000 266000 11001000 7168000 29331000 21567000 11042000 7257000 29459000 21833000 100000 88300000 P1Y9M18D P2Y Repurchase of common stock<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2019, the Company announced that its board of directors authorized a share repurchase program to acquire up to $25.0 million of the Company’s common stock (the “Share Repurchase Program”). Purchases under the Share Repurchase Program may be made from time to time, in such amounts as management deems appropriate, through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, or by any combination of such methods. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program does not have an expiration date, does not require the Company to repurchase any specific number of shares of its common stock, and may be modified, suspended or terminated at any time without notice. There is no guarantee that any additional shares will be purchased under the Share Repurchase Program and such shares are intended to be retired after purchase. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The covenants in the Amended Credit Agreement require the Company to be in compliance with certain leverage ratios to make repurchases under the Share Repurchase Program.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any shares during the three and nine months ended December 31, 2023. A total of $17.1 million remains available for future share repurchases under the Share Repurchase Program as of December 31, 2023.</span></div> 25000000 0 0 17100000 Net income per share<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes basic net income per share using the weighted-average number of shares of common stock outstanding. Diluted net income per share amounts are calculated using the treasury stock method for equity-based compensation awards. The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,888 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding – basic</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,140,887 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,707,406 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,503,518 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,239,761 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive common equivalent shares from equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,046,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,666,304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding – diluted</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,030,115 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,840,137 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,550,094 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,906,065 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> The following is a reconciliation of the numerator and denominator in the basic and diluted net income per common share computations (in thousands, except share and per share data):<div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,888 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,284 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding – basic</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,140,887 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,707,406 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,503,518 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,239,761 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive common equivalent shares from equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889,228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132,731 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,046,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,666,304 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding – diluted</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,030,115 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,840,137 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,550,094 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,906,065 </span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 26888000 19105000 113136000 45284000 55140887 52707406 54503518 52239761 2889228 3132731 3046576 2666304 58030115 55840137 57550094 54906065 0.49 0.36 2.08 0.87 0.46 0.34 1.97 0.82 31021 9215 58792 257292 Leases<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company's equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:19.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-682"><span style="-sec-ix-hidden:f-683"><span style="-sec-ix-hidden:f-684">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-688"><span style="-sec-ix-hidden:f-689"><span style="-sec-ix-hidden:f-690">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,316 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,470 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-697"><span style="-sec-ix-hidden:f-698"><span style="-sec-ix-hidden:f-699">Accrued expenses and other current liabilities</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703"><span style="-sec-ix-hidden:f-704"><span style="-sec-ix-hidden:f-705">Current portion of long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-712"><span style="-sec-ix-hidden:f-713"><span style="-sec-ix-hidden:f-714">Long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,689 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands): </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (“SG&amp;A”) expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,818 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For leases commencing prior to January 1, 2019, minimum lease payments exclude payments to landlords for real estate taxes and common area maintenance. These payments can be either fixed or variable, depending on the lease.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Operating cash outflows from operating leases for the nine months ended December 31, 2023 and December 31, 2022 were $3.2 million and $3.6 million, respectively. Leases<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases warehouses, distribution centers, office space and equipment. The majority of the Company's leases include one or more options to renew, with renewal terms that can extend the lease term for up to five years. The exercise of lease renewal options is at the Company's sole discretion and such renewal options are included in the lease term if they are reasonably certain to be exercised. Certain leases also include options to purchase the leased asset. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants. Most of the Company's equipment leases are finance leases of assets used to operate its distribution center in Ontario, California.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to determine whether commercial contracts contain a lease for purposes of ASC 842. The Company uses its incremental borrowing rate to determine the present value of lease payments.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:19.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-682"><span style="-sec-ix-hidden:f-683"><span style="-sec-ix-hidden:f-684">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-688"><span style="-sec-ix-hidden:f-689"><span style="-sec-ix-hidden:f-690">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,316 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,470 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-697"><span style="-sec-ix-hidden:f-698"><span style="-sec-ix-hidden:f-699">Accrued expenses and other current liabilities</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703"><span style="-sec-ix-hidden:f-704"><span style="-sec-ix-hidden:f-705">Current portion of long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-712"><span style="-sec-ix-hidden:f-713"><span style="-sec-ix-hidden:f-714">Long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,689 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands): </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (“SG&amp;A”) expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,818 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For leases commencing prior to January 1, 2019, minimum lease payments exclude payments to landlords for real estate taxes and common area maintenance. These payments can be either fixed or variable, depending on the lease.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>Operating cash outflows from operating leases for the nine months ended December 31, 2023 and December 31, 2022 were $3.2 million and $3.6 million, respectively. 1 P5Y <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December 31, 2023, March 31, 2023 and December 31, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:19.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.644%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-682"><span style="-sec-ix-hidden:f-683"><span style="-sec-ix-hidden:f-684">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-688"><span style="-sec-ix-hidden:f-689"><span style="-sec-ix-hidden:f-690">Other assets</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,224 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,316 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,470 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-697"><span style="-sec-ix-hidden:f-698"><span style="-sec-ix-hidden:f-699">Accrued expenses and other current liabilities</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-703"><span style="-sec-ix-hidden:f-704"><span style="-sec-ix-hidden:f-705">Current portion of long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,720 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-712"><span style="-sec-ix-hidden:f-713"><span style="-sec-ix-hidden:f-714">Long-term debt and finance lease obligations</span></span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,344 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,689 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Finance leases are recorded net of accumulated amortization of $1.5 million, $3.4 million and $3.3 million as of December 31, 2023, March 31, 2023 and December 31, 2022, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022, the weighted-average remaining lease term (in years) and discount rate were as follows: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 27224000 14071000 15120000 0 245000 350000 27224000 14316000 15470000 7010000 4510000 4528000 144000 575000 690000 21720000 11201000 12329000 0 58000 142000 28874000 16344000 17689000 1500000 3400000 3300000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 31, 2023 and December 31, 2022, the components of operating and finance lease costs were as follows (in thousands): </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative (“SG&amp;A”) expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,206 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2203000 1149000 4905000 3458000 0 105000 210000 315000 3000 7000 10000 25000 2206000 1261000 5125000 3798000 <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,818 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the aggregate future minimum lease payments under non-cancellable leases presented in accordance with ASC 842 are as follows (in thousands):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:52.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.565%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance <br/>leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,818 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,963 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,730 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,874 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1985000 87000 2072000 8434000 58000 8492000 8424000 0 8424000 5060000 0 5060000 1921000 0 1921000 6994000 0 6994000 32818000 145000 32963000 4088000 1000 4089000 28730000 144000 28874000 P4Y9M18D P4Y8M12D P0Y4M24D P1Y1M6D 0.049 0.026 0.016 0.028 3200000 3600000 false false false false

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